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A bstract
Aerobic fermentations of Escherichia coli grown with glucose accumulate organic acids in 
the culture medium. These by-products of glucose metabolism are synthesised and 
excreted when the glucose uptake rate is greater than its conversion to biomass and 
carbon dioxide. Acetate is the most abundant overflow metabolite produced in aerobic 
cultures of E. coli. Its production is strain and media specific, being greatest in dense 
nutrient-rich cultures. In industrial fermentations, E. coli is widely employed for production 
of recombinant proteins. However, acetate excretion reduces process efficiency by 
lowering cell growth rate, and decreasing the amount of substrate carbon converted to 
recombinant protein product.
This thesis describes the construction of three plasmid vectors designed to express 
antisense RNA targeted against phosphotransacetylase and acetate kinase, which 
convert acetyl CoA to acetate. Antisense RNA was used as a metabolic engineering tool 
in this study, to enable examination of the central carbon flux distribution before, during 
and after enzyme downregulation. The aim was to decrease expression of these 
enzymes in E. coli, and thus decrease acetate production. E. coli MG1655 was 
transformed with a) a plasmid construct encoding an antisense RNA fragment, b) two 
compatible plasmids encoding different antisense RNA fragments. The resulting strains 
were cultivated in a 2L bioreactor, and the effect of antisense RNA expression evaluated. 
Assays to monitor the enzyme activities of phosphotransacetylase and acetate kinase 
were conducted, along with metabolite analysis to determine organic acid excretion 
profiles. Flux balance analysis, which is a method of modelling metabolism, was applied 
to the central carbon pathways in E. coli to provide insight into the partitioning of internal 
carbon fluxes. Information about the mechanisms used by E. coli to cope with partial 
shutdown of the acetate synthesis pathway was gained by comparing the flux distribution 
of a control strain with an antisense RNA-expressing strain.
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Chapter 1: Introduction
Escherichia coli is one of the most widely used hosts for recombinant protein production 
(Demain, 2000; Lee, 1996). It is particularly suitable for this role due to its ability to grow 
rapidly to high cell densities using inexpensive substrates. Furthermore, E. coli genetics 
and physiology are well characterised and there are an increasingly large number of 
mutant E. coli strains and cloning vectors available (Baneyx, 1999). However, under the 
commonly used fermentation conditions of aerobic growth in excess glucose, E. coli 
produces the toxic by-product acetate, which accumulates in the culture medium and 
reduces cell growth and recombinant protein production (Jensen and Carlsen, 1990; Luli 
and Strohl, 1990). In an attempt to overcome this problem, a great deal of research has 
focused on understanding why acetate is produced by E. coli and on developing strains 
with reduced acetate production.
Strain optimisation has traditionally been accomplished by using chemical mutagens and 
ionising radiation, combined with screening and selection techniques to identify superior 
strains. There are many examples of success with this approach in the areas of amino 
acid, antibiotic, solvent and vitamin production, however mutagenesis is essentially a 
random process (Stephanopoulos et al., 1998). In contrast, Metabolic Engineering is a 
rational, directed approach to strain optimisation that combines molecular biology 
techniques for DNA recombination with advanced tools for metabolic pathway analysis 
(Koffas et al., 1999; Nielsen, 2001).
Metabolic engineering is usually an iterative process that involves several stages. For 
example, the process may begin with design and construction of a recombinant strain, 
followed by analysis of the resulting strain compared with the original strain background 
and then identification of the next target for genetic engineering. Alternatively, detailed 
analysis of the metabolic network may be required in order to identify the targets for 
genetic engineering before proceeding to the construction stage and subsequent analysis 
of the recombinant strain. Consequently, metabolic engineering entails continuous 
improvement of cellular properties. The main areas of research where metabolic 
engineering has been applied are: heterologous protein production; extension of 
substrate range; pathways leading to new products; pathways for degradation of 
xenobiotics; engineering of cellular physiology for process improvement; elimination or 
reduction of by-product formation and improvement of yield or productivity (Nielsen, 
2001).
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This research aimed to reduce acetate production by E. coli, using a metabolic 
engineering approach. To this end, recombinant E. coli strains were developed to 
express antisense RNA targeted against the enzymes of the primary acetate production 
pathway. Antisense RNA-expressing cultures were analysed using experimental and 
mathematical tools, and compared with the original strain background. The challenge is 
to determine the effectiveness of antisense RNA in suppressing expression of the target 
enzymes and redirecting the central carbon metabolism of E. coli.
1.1 A e ro b ic  A c e ta te  P ro d u ctio n  by E. c o u
In E. coli the uptake rate of some carbon sources such as glycerol, is tightly regulated to 
permit the precise balance of carbon flux to biosynthesis and energy production. These 
carbon sources are converted to new biomass and carbon dioxide with no by-product 
formation, however the control imposed on carbon uptake limits the cellular growth rate. 
For other carbon sources such as glucose, the uptake rate is not as rigorously controlled 
and carbon flux through the central metabolic pathways exceeds the demands for 
biosynthesis and energy production (Holms, 1986). In particular, carbon flux through 
glycolysis is thought to exceed the capacity of the TCA cycle and result in acetate 
production (El-Mansi and Holms, 1989; Han et al., 1992; Majewski and Domach, 1989). 
This outlet for excess carbon allows E  coli to maintain a rapid growth rate and in 
addition, the acetate production pathway (ackA-pta pathway) generates ATP, unlike the 
lactate or ethanol by-product pathways. It is commonly observed that 10-30% of glucose 
is excreted as acetate even in a fully aerated culture, depending on the particular strain 
type.
1.1.1 A c e t a t e  P r o d u c t io n  a n d  C o n s u m p t io n  P a t h w a y s
There are two known pathways for production of acetate in E. coli, which are illustrated in 
Figure 1.1. Acetate can be produced directly from pyruvate by the enzyme pyruvate 
oxidase (poxB). However, the main acetate production pathway is the ackA-pta pathway, 
which involves a two-step conversion of acetyl CoA to acetate. In the first step acetyl 
CoA is converted to acetyl phosphate by phosphotransacetylase (Pta), and in the second 
step acetate kinase (Ack) converts acetyl phosphate to acetate with concomitant 
production of ATP (Brown et al., 1977). The ackA-pta pathway is reversible, although 
acetate kinase has a low affinity for acetate. Consequently, the pathway is only thought 
to function in the reverse mode when acetate is present in high concentrations in the 
media (e.g. when it is utilised as the main carbon source). In summary, the ackA-pta
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pathway functions primarily in a catabolic role, excreting acetate and generating ATP 
during growth on excess glucose (Brown et al., 1977).
The ackA-pta pathway intermediate acetyl phosphate is a high-energy phosphate 
compound that has been implicated in a range of important cellular functions. These 
include the glucose phosphotransferase system, flagellar expression and expression of 
porin proteins that control the permeability of the E. coli outer membrane (Fox et al., 
1986b; Heyde et al., 2000; PruB, 1998; PruB and Wolfe, 1994; Shin and Park, 1995). In 
addition, acetyl phosphate is thought to function as a phosphate donor for many signal 
transduction response regulators including CheY, PhoB, NR1, and OmpR (McCleary and 
Stock, 1994). Perturbations in the production of acetyl phosphate have been shown to 
affect expression of the phosphate regulon (Pho) (Wanner and Wilmes-Riesenberg,
1992), the nitrogen regulon (Ntr) (Feng et al., 1992), and the glucose starvation stimulon 
(Nystrom, 1994). Intracellular levels of acetyl phosphate vary widely with carbon source 
(McCleary and Stock, 1994), cell growth phase and temperature (PruB and Wolfe, 1994). 
In summary, perturbations in acetyl phosphate production are likely to have far-reaching 
affects on E. coli cellular activities.
There are two pathways for acetate consumption in E. coli, which are illustrated in Figure 
1.1. As mentioned above, the reversible ackA-pta pathway is thought to consume acetate 
when it is present in relatively high concentrations in the media, and activate it to acetyl 
CoA. The second route for acetate uptake comprises a two-step pathway catalysed by 
the enzyme acetyl CoA synthetase (Acs). This enzyme is thought to function as a 
scavenger when acetate is present at a low concentration in the culture (Kumari et al., 
1995). In the first step of this pathway, acetate is converted to the intermediary 
compound acetyl-AMP by acetyl CoA synthetase and in the second step acetyl-AMP is 
converted to acetyl CoA by acetyl CoA synthetase. As the first reaction is irreversible, the 
pathway can only consume acetate. Once acetate has been activated to acetyl CoA, it 
can be further metabolised through the TCA cycle and the glyoxylate bypass. 
Incidentally, acetyl CoA synthetase is cotranscribed with the acetate membrane-carrier 
protein, acetate permease (acfP; formerly designated yjcG) (Gimenez et al., 2003). An 
additional gene, yjcH, is cotranscribed with acs and actP. The yjcH gene codes for a 
putative membrane protein of 104 amino acids and is highly conserved in many bacterial 
species but still has no defined function (Gimenez et al., 2003).
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1.1.2 S tra in  Specific D iffe re n c e s  in A c e ta te  P ro d u c tio n  b y  E. c o u
Acetate production in E. coli is strain-specific. For example, E. coli B derivatives, such as 
BL21, are low acetate producers, whereas E  coli K derivatives, such as JM109, are high 
acetate producers. The difference is thought to be due to different expression levels of 
the enzymes responsible for acetate production and consumption in E. coli (van de Walle 
and Shiloach, 1998). A recent study has confirmed that the glyoxylate shunt and acetyl 
CoA synthetase are constitutively expressed in the low-acetate producing E. coli BL21, 
while the same enzymes are repressed in E. coli JM109, which produces high levels of 
acetate (Phue and Shiloach, 2004). This trend was consistently observed in both low and 
high glucose growth. It is possible that expression of the glyoxylate shunt pathway is 
correlated with expression of acetyl CoA synthetase, because the glyoxylate shunt 
requires additional acetyl CoA that is supplied through acetate uptake by acetyl CoA 
synthetase. The findings suggest that the ability of E. coli B to grow on glucose without 
producing high levels of acetate is a result of its capability to operate the TCA cycle and 
the glyoxylate pathway simultaneously. No clear difference was observed in expression 
levels of the ackA-pta pathway between the two strains, however higher transcription 
levels of pyruvate oxidase were found in the high-acetate producing E. coli JM109 (Phue 
and Shiloach, 2004).
In addition to the inherent strain-specific differences in acetate production, growth phase- 
related changes in the operation of acetate production and consumption pathways in E. 
coli have been observed. Some E. coli cultures undergo a metabolic switch from glucose 
to acetate utilisation, as the cells enter stationary phase (Kleman and Strohl, 1994). It has 
been proposed that as the cells divide exponentially, they excrete acetate via the ackA- 
pta pathway. Then when they begin the transition to stationary phase, they resorb 
acetate, even in the presence of remaining glucose, using acetyl CoA synthetase, and 
utilise it to generate energy and biosynthetic components via the TCA cycle and the 
glyoxylate shunt respectively (Kumari et al., 2000).
1.1.3 E f fe c t  o f  A c e ta te  on E. c o u  Physio logy
Acetate is a weak acid and a well-known growth inhibitor. The undissociated form 
produced intracellularly freely permeates the cell membrane and accumulates in the 
culture medium. Subsequently, undissociated extracellular acetate re-enters the cell 
where it dissociates due to the higher intracellular pH. Consequently, acetate dissipates 
the pH component of the proton motive force and lowers the cytoplasmic pH, causing 
growth stasis due to irreversible denaturation of DNA and protein (Stephanopoulos et al.,
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1998). In addition, acetate reduces the cellular efficiency for recombinant protein 
production. Acetate levels of 40 mM have been shown to reduce recombinant protein 
production by 35% without significantly effecting biomass yield (Jensen and Carlsen,
1990).
Global analysis of the effect of acetate accumulation (100 mM) on E. coli gene 
expression revealed a complex cellular response, involving significant change in the 
expression level of 86 genes (Arnold et al., 2001). The expression of 60 genes was 
reduced by at least two-fold, including 48 genes that encode components of the 
transcription-translation machinery. Expression of 26 genes was increased two-fold or 
more, and of these, six encoded products are known to be important for survival at low 
pH. In addition, proteomic studies using 2D-gel electrophoresis have led to the 
identification of 37 proteins whose expression is increased and 17 proteins whose 
expression is decreased, by acetate accumulation (50 mM) in the culture media 
(Kirkpatrick et al., 2001).
It is well established that acetate has a detrimental effect on E. coli that is brought about 
by reducing the intracellular pH, however a recent study has shown that acetate-treated 
cells accumulate the toxic intermediate homocysteine (Roe et al., 2002). Therefore, it has 
been proposed that acetate may inhibit the activity of an enzyme in the lower part of the 
methionine biosynthetic pathway, leading to accumulation of toxic homocysteine. This 
theory agrees with a previous observation that the growth inhibition of E. coli caused by 
acetate can be alleviated by supplementing the culture with methionine (Han et al.,
1993). Growth inhibition caused by acetate can therefore be partly attributed to a partial 
auxotrophy for methionine combined with accumulation of an inhibitory pathway 
intermediate (Roe et al., 2002).
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1.2 M e ta b o lic  E ng ineering
1.2.1 Ba c k g r o u n d
Metabolic engineering was defined in 1991 as the ‘improvement of cellular activities by 
manipulation of enzymatic, transport and regulatory functions of the cell with the use of 
recombinant DNA technology’ (Bailey, 1991). At that time, metabolic engineering 
consisted of little more than a collection of examples and most of the research involved 
changes in a single gene, operon or gene cluster. However many potential applications 
for metabolic engineering were identified and grouped into the following two categories: 
(1) recruiting heterologous activities for strain improvement, and (2) redirecting 
metabolite flow.
Early research that used enzyme amplification to enhance production of a specific 
metabolite had limited success, which highlighted the complexities of metabolic 
regulation. Consequently, the term metabolic network rigidity was coined to describe the 
inherent resistance of metabolism to alterations in flux. In addition, a methodology to 
define the flexibility of metabolic nodes was proposed (Stephanopoulos and Vallino,
1991). According to the system, nodes can be described as flexible, weakly rigid or rigid, 
depending on how readily flux partitioning into each branch changes to meet metabolic 
demands. A ‘principle node’ is defined as a branch point in which the partitioning of flux 
into each branch affects the rate of formation of a specific product. Application of these 
concepts can improve the identification of targets for metabolic engineering.
In recent years, advances in genomics and analytical tools have facilitated the rapid 
expansion of the field of metabolic engineering. Whole genome sequencing and new and 
improved techniques for gene cloning have increased the repertoire of heterologous 
genes that can be recruited from many different organisms and expressed in novel hosts. 
Also, additional tools for expression of heterologous genes have been generated, such 
as segregationally stable plasmids present in low copy numbers (Jones and Keasling,
1998) and RNA secondary structures that reduce mRNA degradation (Carrier and 
Keasling, 1997). In addition, powerful experimental techniques have been developed for 
analysis of gene expression and protein levels, including microarrays, RT-PCR and 2- 
dimensional gel electrophoresis (Lee and Lee, 2003).
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1.2.2 Exper im e n ta l  and  Ma th em a tic a l  M ethods  for  A nalysing  
C o m plex  M etabolic  Netw o rks
An integral part of metabolic engineering is Metabolic Pathway Analysis, which is the 
study of complex metabolic networks. There are three distinct areas, described as 1) 
identification of metabolic network structure, 2) quantification of flux through pathways of 
the metabolic network, and 3) identification of control structures within the metabolic 
network (Nielsen, 2001). Incidentally, metabolic flux is defined as ‘the rate at which 
material is processed through a metabolic pathway’ (Stephanopoulos, 1999).
1.2.2.1 Id e n t if ic a t io n  o f  M e t a b o lic  N e t w o r k  S tr u c t u r e
A powerful experimental method that can be used to determine the structure of a 
metabolic network or specific metabolic flux distribution, involves isotopic tracer 
experiments’ with 13C-labelled substrate (Kelleher, 2001). The labelling pattern of 13C in 
intracellular metabolites is analysed using nuclear magnetic resonance (NMR) or gas 
chromatography and mass spectrometry (GC-MS). The 13C NMR technique has the 
disadvantage of relatively low sensitivity and therefore requires a large amount of 
sample. By contrast, GC-MS is highly sensitive and cheaper than NMR, which makes it 
more suitable for metabolic pathway analysis (Zhao and Shimizu, 2003).
Mathematical approaches can also be employed to examine the structure of complex 
metabolic networks. Two closely related methods that were developed for this purpose 
are elementary flux mode analysis and extreme pathway analysis. Elementary flux 
modes (EFM) are defined as the complete set of routes that convert a given substrate to 
a specific product. Elementary flux mode analysis aims to identify the number of 
alternative routes for a certain task, the ‘optimal’ routes, and the sensitivity of these 
pathways towards disturbances such as mutations. Extreme pathways (EP) are a subset 
of elementary modes, which are intended to represent a minimal set of pathways capable 
of describing all steady-state flux distributions (Klamt and Stelling, 2003). Due to the tight 
constraints, there is a danger that extreme pathways may exclude physiologically 
important pathways, and therefore elementary flux mode analysis is generally viewed as 
the most suitable method of the two for analysing metabolic pathways.
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1.2 .2 .2  Q u a n t if ic a t io n  o f  F lu x  T h r o u g h  P a t h w a y s  o f  t h e  M e t a b o l ic  N e t w o r k
The study and quantification of metabolic fluxes through the branches of a metabolic 
network can be achieved by Metabolic Flux Analysis (Edwards et al., 1999; Holms,
1999). This is a mathematical method, which is used to calculate a specific set of 
intracellular fluxes by formulating a stoichiometric model of the metabolic reaction 
network and applying mass balances around the intracellular metabolites. Measured 
extracellular fluxes, such as the substrate uptake and product secretion rates, are used 
as inputs for the calculation. The outcome is a flux map, which shows the reaction 
pathways included in the model, along with an estimated steady-state rate (flux) for each 
reaction. Individual metabolic flux maps contain information about the relative 
contributions of various pathways to the overall processes of substrate utilisation and 
product formation. However, the real value of these maps lies in the differences that are 
observed when flux maps that are obtained from different strains or under different 
conditions are compared (Stephanopoulos et al., 1998). Through these comparisons, the 
impact of genetic or environmental perturbations can be evaluated and the importance of 
specific pathways identified. Although metabolic flux analysis has been widely used, it 
has several important limitations. Information regarding gene expression levels and 
enzyme regulation is not incorporated, therefore the results should be carefully analysed 
in the light of current biochemical knowledge about the pathways involved. This may be 
possible for small reaction networks, but is a more daunting task for large, complex 
networks. Metabolic flux analysis is described in more detail in chapter 8.
1.2 .2 .3  Id e n t if ic a t io n  o f  C o n t r o l  S t r u c t u r e s  W it h in  t h e  M e t a b o l ic  N e t w o r k
An important goal of metabolic engineering is to understand the control of metabolic flux 
in order to approach the rational modification of metabolic pathways. Metabolic Control 
Analysis (MCA) is a mathematical method which was developed in the 1960’s and 70’s to 
quantify flux control (Heinrich and Rapoport, 1974; Higgins, 1963; Kacser and Burns, 
1973). In this system the degree of flux control exercised by specific enzymes in a 
pathway is expressed in terms of a flux control coefficient (Fell, 1998). According to the 
theory, over-expressing an enzyme with a high flux control coefficient is likely to increase 
overall flux through the pathway. However, metabolic control analysis is essentially a 
‘linear perturbation theory’ of the inherently non-linear problem of enzyme kinetics of 
metabolic networks, therefore predictions and subsequent extrapolations made using this 
method should be regarded as tentative (Stephanopoulos et al., 1998).
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1.2.3 Use of C o n tin uo us  C ulture  M ethods  for  A nalysing  
M eta b o lism  a t  Stea d y  State
Cultivation of cells can be carried out in batch, fed-batch or continuous culture. In batch 
culture, the cells environment constantly changes due to substrate depletion, product 
formation and biomass accumulation. This is reflected in the different growth phases that 
are commonly observed in batch culture i.e. lag phase, exponential growth phase and 
stationary phase. In fed-batch culture, nutrients are added in a stepwise fashion 
throughout the course of fermentation, which allows some degree of control over the cells 
environment. This method is commonly used for achieving high cell densities. In 
continuous culture, an equilibrium concentration of the growth-controlling substrate is 
established, independently of culture density and time, which allows the culture to grow 
at the set dilution rate by maintaining stable environmental growth conditions and hence 
the same physiological state (Kovarova-Kovar and Egli, 1998).
For metabolic engineering purposes, it is desirable to study metabolism under steady 
state conditions. Therefore, continuous culture methods for cell cultivation are particularly 
well suited. Several types of continuous culture have been developed, including 
chemostat, where the dilution rate is kept constant, and turbidostat, where the biomass 
concentration is kept constant. However, these methods are time consuming to 
implement and use large volumes of medium. Typically, 4-5 cultures volumes are 
required to obtain the steady state. In recent years, modified continuous culture methods 
have been developed, such as the A-stat technique where the rate of change of the 
dilution rate is kept constant (Paalme et al., 1995). This system is thought to mimic the 
gradually changing growth conditions that are found in nature and many industrial 
processes, and may therefore be even more informative for practical purposes 
(Kasemets et al., 2003).
Several metabolic engineering studies have employed continuous culture methods for 
cell cultivation under steady state conditions. These include: use of an oxygen-limited 
chemostat culture to analyse carbon flow through the central metabolic pathways of 
Candida tropicalis grown on xylose (Granstrom et al., 2002); use of a phosphate-limited 
chemostat culture to study carbon flow and antibiotic production in Streptomyces lividans 
(Avignone Rossa et al., 2002); and use of a carbon-limited chemostat culture to analyse 
the effect of increasing NADH availability on the carbon flow through Escherichia coli 
central metabolism (Berrios-Rivera et al., 2002). In this study, batch fermentation was 
used in order to mimic the fermentation conditions that are most commonly employed in 
the Biotechnology industry.
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1.2.4 Exam ples  of M etabolic  E ng in eer in g  A ppr o a c hes  to  R educe
A c e ta te  P rod uction  b y  E. c o u
Many operational strategies have been proposed and tested to reduce acetate 
production and accumulation in E. coli culture (Yang et al., 1998). The approaches 
include: increasing the agitation speed or enriching the culture with pure oxygen to avoid 
dissolved oxygen limitation; controlled feeding to restricting the glucose uptake rate by E. 
coli; and removal of acetate from spent medium using devices such as a perfusion 
system (Akesson et al., 2001; Curless et al., 1991; Konstantinov et al., 1990). Although 
these methods can lead to improved process performance, they are often difficult to 
scale up and costly to implement. An alternative approach is to develop E. coli strains 
that inherently produce less acetate under optimal fermentation conditions. Metabolic 
engineering has been employed for this purpose and several examples are described 
below.
1.2.4.1 R e s t r ic t in g  t h e  R a t e  o f  G lu c o s e  U p t a k e  b y  E. c o u
It is well established that glucose uptake by E. coli is loosely regulated. When glucose is 
present in the culture medium in excess amounts, glucose uptake normally exceeds the 
cellular requirements for biosynthesis and energy production, resulting in acetate 
excretion. However, when glucose is the sole carbon source in minimal media it is used 
by E. coli to generate energy and for macromolecule synthesis, therefore its uptake rate 
plays a critical role in dictating cellular activities. Under these conditions, reducing the 
glucose uptake rate often results in a reduced specific growth rate. By contrast, E. coli 
grown in a complex medium derives most building blocks as already synthesised 
compounds from media components such as yeast extract and casamino acids, and 
uses glucose primarily as an energy supply. Therefore, decreasing the glucose uptake 
rate has less of an impact on cellular growth rate (Neidhardt et al., 1987).
The glucose uptake rate by E. coli can be reduced by supplementing the culture with 
methyl o-glucoside, which is a glucose analogue that is non-toxic and metabolically inert 
(Chou et al., 1994a). It acts as a competitive inhibitor to enzyme II of the glucose 
phosphotransferase system, thereby reducing the rate of glucose uptake into the cell. 
This strategy of partial disruption to the glucose phosphotransferase system has also 
been achieved by inactivating the ptsG gene, which encodes enzyme II in the glucose 
phosphotransferase system (Chou et al., 1994b). In batch cultures, the growth rate of the 
ptsG mutant strain was reduced by 20% in glucose minimal media, but was not affected 
in complex media. Furthermore, in complex media the ptsG mutant strain exhibited
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significantly reduced levels of acetate production and enhanced recombinant protein 
production. These results indicate that modulation of the glucose uptake rate is an 
effective approach to minimise the inhibitory effects of acetate accumulation by E. coli, 
grown under aerobic conditions in complex media.
1.2 .4 .2  E n g in e e r in g  E . c o u  to  P r o d u c e  a  U s e f u l  o r  L e s s  T o x ic  E n d -P r o d u c t  a t  th e
Ex p e n s e  o f  A c e t a t e  P r o d u c t io n
Advances in molecular biology tools allow metabolic engineers to clone and express 
heterologous genes in E. coli in order to generate novel pathways and produce new 
compounds of interest. However, as metabolism is inherently resistant to change it can 
be difficult to anticipate whether a heterologous enzyme will be able to compete 
successfully with native enzymes for a substrate in central metabolism. It is more 
straightforward if a heterologous enzyme is simply extending an existing linear pathway 
and does not have to compete with other enzymes for its substrate.
Flux partitioning at the pyruvate node in E. coli central metabolism can be altered by 
expressing the Bacillus subtilis acetolactate synthase (ALS) gene, which catalyses the 
conversion of pyruvate to acetoin, via the intermediary compound a-acetolactate (Figure 
1.2). This approach has been used with the aim of redirecting carbon flux away from 
acetate production and towards formation of acetoin, which is less toxic than acetate 
(Aristidou et al., 1994). Fermentation results from batch cultures revealed that 
recombinant E. coli grown under aerobic conditions, and expressing the active 
acetolactate synthase enzyme reached double the final cell density of the parent strain 
with a six-fold reduction in total acetate accumulated in the culture medium. In addition, 
the ALS strain was shown to be capable of enhancing the production of a recombinant 
CadA/beta-galactosidase fusion protein in E. coli by about 60% (Aristidou et al., 1995). 
These results indicate that expression of a heterologous enzyme can redirect carbon flux 
and reduce acetate production by E. coli, grown under aerobic conditions.
Under anaerobic conditions, E. coli excrete large quantities of the partially oxidised 
byproducts acetate, formate and ethanol (Figure 1.2). Metabolic flux analysis has been 
used to study the effects of Bacillus subtilis acetolactate synthase expression on the 
metabolic flux distribution in anaerobic E. coli (Aristidou et al., 1999). Batch fermentation 
results showed that anaerobic E. coli expressing Bacillus subtilis acetolactate synthase 
(ALS) produced three-fold less acetate and about 30% less formate compared to the 
parent strain. Ethanol production was not significantly affected. Metabolic flux analysis 
calculated that ALS expression resulted in a reduced flux from pyruvate to acetyl CoA,
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although flux to ethanol was unaffected at the expense of acetate production. The 
undisturbed flux to ethanol may be due to the crucial role of the ethanol production 
pathway in NADH regeneration in anaerobic E. coli, indicating that partitioning of flux at 
the acetyl CoA node into ethanol or acetate is determined by the redox state of the cell. 
As a result, the acetyl CoA branch point was classified as a ‘weakly rigid node’, 
characterised by a dominant branch (ethanol) and a subordinate branch (acetate). In 
addition, metabolic flux analysis showed that the ALS strain has the ability to channel 
excess pyruvate to acetoin. This study demonstrates that even under anaerobic 
conditions, expression of Bacillus subtilis acetolactate synthase has the ability to redirect 
central carbon flux and reduce acetate production by E. coli.
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Figure 1.2 Central metabolic pathways of anaerobically grown E. coli and the additional 
heterologous pathway for acetoin production (adapted from Aristidou et al., 1999). The 
principle fermentation products are represented in boldface.
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1.2.4.3 In a c t iv a t in g  P h o s p h o t r a n s a c e t y l a s e  a n d  A c e t a t e  k in a s e  t o  R ed u c e  
A c e t a t e  P r o d u c t io n
The major acetate production pathway in E. coli (ackA-pta pathway) consists of the 
enzymes phosphotransacetylase and acetate kinase, which convert acetyl CoA to 
acetate via the intermediate acetyl phosphate. The effect of deleting the ackA-pta 
pathway on the flux distribution in central carbon metabolism was studied in anaerobic E. 
coli using metabolic flux analysis (Yang et al., 1999a). Batch fermentation results showed 
that the ackA' pta' mutant strain exhibited an increased lactate production rate with a 
concomitant decrease in formate, ethanol, and acetate production. Excretion of pyruvate 
was also detected. Lactate dehydrogenase (LDH), which catalyses the conversion of 
pyruvate to lactate, is typically induced under anaerobic conditions at low pH and is 
allosterically activated by pyruvate (Ruijun et al., 2001). Therefore, it was suggested that 
deleting the ackA-pta pathway resulted in an elevated intercellular pyruvate pool, 
inducing allosteric activation of lactate dehydrogenase and subsequent lactate 
production. Alternatively, it has been suggested that acetyl phosphate, which is the ackA- 
pta pathway intermediate, may be involved in suppressing expression of lactate 
dehydrogenase (Bunch et al., 1997). If this were the case, abolishing acetyl phosphate 
production would deregulate lactate dehydrogenase and result in lactate production.
Expression of Bacillus subtilis acetolactate synthase (ALS), which converts pyruvate to 
acetoin, in the ackA' pta' mutant resulted in a further reduction in acetate excretion by 
anaerobic Escherichia and more importantly, the fluxes to lactate, formate and ethanol 
were restored to similar levels as the parent strain. This suggests that expression of ALS 
alleviates a probable elevated intracellular pyruvate pool in ackA' pta' mutants (Yang et 
al., 1999a). To investigate the flux distribution around the pyruvate node further, an E. 
coli strain bearing mutations in ackA, pta and IdhA was studied under anaerobic 
conditions (Yang et al., 1999b). These combined mutations were found to be detrimental 
to cell growth.
Following the observation that ackA' pta' mutant strains excrete increased lactate, an E. 
coli strain over-expressing lactate dehydrogenase (IdhA) was constructed and studied to 
determine whether over-expressing this enzyme in the parent strain could effectively 
divert carbon flux from central metabolism towards lactate production and thereby reduce 
acetate production (Yang et al., 1999b). However, batch fermentation results revealed 
that even a 10-fold increase in lactate dehydrogenase activity was unable to divert a 
significant fraction of the central carbon flux to lactate. Metabolic flux analysis revealed 
that carbon flux through pyruvate and to all products increased at the expense of flux to
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biomass. Measurement of intracellular pyruvate levels showed that over-expression of 
LDH in anaerobic E. coli depletes the intracellular pyruvate pool. Similarly, it has been 
reported that over-expression of LDH in aerobic E. coli inhibits growth in minimal media, 
presumably due to depletion of the intracellular pyruvate pool (Bunch et al., 1997).
1 .2 .4 .4  U p -R e g u l a t io n  o f  A n a p le u r o tic  R e a c t io n s  t o  U t il is e  Ex c e s s  C a r b o n  in 
C e n t r a l  M e t a b o lis m
Aerobic acetate production by E. coli is generally believed to arise from an imbalance 
between glucose uptake and cellular demands for biosynthesis and energy production, 
but the cause of this imbalance is largely unknown. Farmer and Liao (1997) hypothesised 
that increasing the flux through anapleurotic reactions in E. coli central metabolism would 
utilise the excess carbon and reduce acetate production. Anapleurotic pathways 
replenish the supply of important intermediate metabolites, such as oxaloacetate, which 
is crucial for the functioning of the TCA cycle. It is produced from phosphoenolpyruvate 
by PEP-carboxylase. Another example of an anapleurotic reaction is the glyoxylate 
bypass, which converts isocitrate to malate via glyoxylate. The enzymes of the glyoxylate 
bypass, isocitrate lyase and malate synthase, are active during growth of E. coli on 
acetate, but usually repressed in the presence of glucose or under anaerobic conditions.
Metabolic flux analysis indicated that increasing the expression of PEP-carboxylase and 
deregulating the glyoxylate bypass would reduce acetate production in glucose minimal 
media (Farmer and Liao, 1997). A recombinant E. coli strain was developed to test this 
theory. Batch fermentation results showed that under aerobic conditions in glucose 
minimal media the mutant strain exhibited a four-fold decrease in acetate accumulation 
compared to the parent strain, with no substantial decrease in growth rate. There was no 
evidence for simultaneous production and utilisation of acetate by the culture, suggesting 
that deregulation of the glyoxylate bypass reduces acetate production by promoting 
better utilisation of acetyl CoA. This study suggests that E. coli is not optimised for growth 
on glucose. The reason for this remains unclear, but it has been argued that during the 
course of E. coli evolution, glucose was not the major carbon source available (Holms, 
1986). Fructose and glycerol, which do not result in acetate production, may have 
predominated, however E. coli grows relatively slowly on these substrates, making them 
an unpopular choice for industrial fermentation.
Recent research has revealed that the glyoxylate bypass is constitutively expressed in 
the low acetate-producing strain E. coli BL21 (Phue and Shiloach, 2004; van de Walle 
and Shiloach, 1998). In contrast, in the high acetate-producing strain E. coli JM109 there
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is no apparent transcription of the enzymes of the glyoxylate bypass under the same 
conditions. These observations confirm that increasing flux through the anapleurotic 
pathways is a logical approach to reducing acetate production by E. coli.
1.3 A ntisen se  RNA
For a long time, RNA molecules were thought to function either as messengers (mRNA) 
or as part of the translational machinery (tRNA, rRNA). However, since the discovery of 
ribozymes, which have catalytic activity (Puerta-Fernandez et al., 2003), and antisense 
RNA and RNA interference, which are posttranscriptional regulators of gene expression 
(Brantl, 2002; Cottrell and Doering, 2003), it has become widely recognised that RNA has 
a diverse range of cellular functions. The following sections focus on antisense RNA, and 
highlight its use as an experimental tool to downregulate the expression of target genes 
in metabolic engineering research.
1.3.1 A n tisen se  RNA R egulated  System s  in P r o k a r yo tes
Antisense RNA occurs naturally in all three kingdoms of life, although most antisense 
RNA-regulated systems have been identified in prokaryotes and only a few examples are 
known from eukaryotes and one from archaea (Stolt and Zillig, 1993). By contrast, RNA 
interference (gene silencing triggered by double stranded RNA), only occurs in 
eukaryotes. RNA interference does not occur in prokaryotic cells due to the presence of 
RNase III, which is a fast and efficient enzyme that specifically degrades double-stranded 
RNA molecules as short as 12 bp. This enzyme prevents the short interfering RNAs 
(siRNA), which are the effectors of RNA interference, from stably existing long enough to 
bind to the target mRNA and induce cleavage and subsequent degradation (Brantl, 
2002).
Antisense RNAs are small, highly structured RNA molecules that bind via sequence 
complementarity to their target mRNAs. They are usually between 35 and 150 
nucleotides long and contain multiple stem-loop structures that are important for 
metabolic stability and target recognition. Antisense RNAs function as posttranscriptional 
regulators of target gene expression by either activating or repressing translation of their 
target mRNAs or destabilising the message. The majority of antisense RNAs repress 
translation by binding to the 5’ untranslated region of target mRNA, around the Shine- 
Dalgarno sequence, and physically blocking ribosome binding and subsequent 
translation of the mRNA into protein (Brantl, 2002).
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1.3.1.1 P l a s m id -E n c o d e d  A n t is e n s e  R N A  S y s t e m s
Many antisense RNA-regulated systems have been identified in plasmids, transposons 
and bacteriophages. In most cases, the antisense RNA is transcribed from a promoter 
located on the opposite strand of the same DNA molecule and is therefore fully 
complementary to the target mRNA. However, some antisense RNAs are encoded in a 
different location from the target mRNA (i.e. frans-encoded). Trans-encoded antisense 
RNAs have only partial complementarity to their targets and often have multiple mRNA 
targets. Antisense RNAs are involved in control of plasmid replication, conjugation and 
maintenance (Wagner and Simons, 1994). Several of the most well characterised 
examples are described below.
1.3.1.1.1 R eplication  C o n tro l  o f  Plasmid C o lE 1 : Antisense RNA R e g u la tes  Prim er RNA 
Conform ation
ColE1 is a small multicopy plasmid whose replication is initiated by transcription of the 
primer RNA II. RNA I is a 108 nucleotide antisense RNA which is expressed from the 
same region and is complementary to the 5’ end of RNA II. Binding of RNA I to RNA II 
triggers a conformational change in RNA II that prevents it binding to the ColE1 plasmid 
and initiating plasmid replication. A plasmid-encoded protein, Rom, binds to and 
stabilizes the RNA l-RNA II complex, enhancing antisense RNA control (Tomizawa, 
1984; Tomizawa, 1986; Tomizawa et al., 1981). The antisense RNA, RNA I, is rapidly 
synthesised and extremely unstable, therefore its concentration is proportional to the 
plasmid copy number. Consequently, if ColE1 copy number decreases the concentration 
of RNA I is reduced and plasmid replication proceeds. By contrast, if ColE1 copy number 
increases the concentration of RNA I also increased and plasmid replication ceases. 
Therefore, antisense RNA control of replication determines plasmid copy number 
(Tomizawa and Itoh, 1981). Antisense RNA control of plasmid replication also determines 
plasmid compatibility properties. Two distinguishable ColE1-type plasmids that have 
identical replication control will not stably co-exist in the same cell. This is because the 
control system cannot differentiate between the plasmid types, and since replication and 
segregation are random, the ratio of plasmid types will vary between cells and eventually 
result in the loss of one of the plasmid types (Wagner and Simons, 1994).
1.3.1.1.2 R eplication  C o n tro l  o f  Plasmid R1: Antisense RNA Inhibits T ra n s la tio n  o f  an 
In it ia to r  P ro te in
Plasmid R1 is a low copy number self-transmissible plasmid, whose replication is 
dependent on the initiator protein RepA. Expression of the repA gene is subject to
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posttranscriptional control by a 90 nucleotide antisense RNA called copA, which 
basepairs with the 5’ region of repA mRNA and indirectly inhibits its translation into 
protein (Riise et al., 1982; Stougaard et al., 1981). The region on repA mRNA to which 
copA binds is known as CopT (for cop target). Immediately downstream of the CopT site 
there is a short open reading frame that encodes a translational activator polypeptide 
{tap) for RepA, and its translation is inhibited by copA-CopT binding. Translation of tap is 
coupled to translation of repA, and therefore in the presence of copA antisense RNA 
RepA translation is suppressed. As with ColE1 type plasmids, the antisense RNA 
regulator is rapidly synthesised and extremely unstable therefore it efficiently regulates 
plasmid copy number and determines plasmid compatibility properties.
1.3.1.1.3 M aintenance  of  P lasmid  R 1: A ntisense  RNA Inhibits  Expressio n  of a  Ho st-K iller  G ene
Many bacterial plasmids employ host-killing systems to ensure that if plasmid-free cells 
arise they do not persist within a population (Summers, 1996). The hok/sok system of 
plasmid R1 is an example. Three genes are involved, namely hok (host killing), mok 
(modulator of killer) and sok (suppressor of killer). The ‘host-killing’ protein encoded by 
hok is a 50 amino acid membrane-associated polypeptide. Expression of this protein 
leads to loss of cell membrane potential, arrest of respiration, changes in cell morphology 
and ultimately cell death. Sok encodes a relatively unstable, trans-acting 67 nucleotide 
antisense RNA which protects plasmid-harbouring cells by indirectly blocking translation 
of hok mRNA. Translation of mok mRNA is required for hok mRNA translation. The 
system functions by sok antisense RNA basepairing with the ribosome-binding region of 
mok mRNA, which inhibits translation of mok and therefore indirectly blocks translation of 
hok. Hok mRNA is unusually stable, therefore if a plasmid-free cell arises the unstable 
sok antisense RNA degrades and allows the stable hok mRNA to be translated into a 
host killing protein which results in death of the plasmid-free cell (Gerdes et al., 1986b; 
Gerdes et al., 1986a).
1.3 .1 .2  C h r o m o s o m a l l y -E n c o d e d  A n t is e n s e  R N A  S y s t e m s  in  E. c o u
Only a small number of antisense RNAs have been identified in bacterial chromosomes 
and in contrast to most plasmid-encoded antisense RNAs, the majority of chromosomal 
antisense RNAs are frans-encoded i.e. at genetic loci other than their target genes. 
Generally, frans-encoded antisense RNAs have only partial complementarity to their 
target mRNA, and they often have multiple targets (Altuvia and Wagner, 2000; Brantl, 
2002). In E. coli, over 50 genes have been identified that encode small untranslated 
RNAs (sRNA), however most of these are uncharacterised and therefore their cellular 
roles are unknown (Hershberg et al., 2003). The number is set to increase further as
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many of the genes that have been predicted by computational methods to encode sRNAs 
are waiting for experimental testing. Many of these newly identified sRNAs could 
potentially function as antisense RNAs.
At present there are five identified sRNAs (micF, oxyS, dsrA, spf and ryhB) that are 
known to act as antisense regulators in E. coli (Altuvia et al., 1997; Lease et al., 1998; 
Masse and Gottesman, 2002; Mizuno et al., 1983; Moller et al., 2002b). They function by 
basepairing with their target mRNAs to activate or repress translation, or to destabilise 
the message. Many of the chromosomally encoded antisense RNAs are expressed in 
response to stress conditions in E. coli. They function by activating or repressing the 
translation of a global response regulator, which in turn controls the expression of a 
multitude of specific genes to protect the cell from stress, such as increased or reduced 
temperature, oxidative stress or exposure to toxic agents (Brescia et al., 2004). Several 
examples of the antisense RNA systems encoded by the E. coli genome are described 
below.
1.3.1.2.1 R egu lation  o f  O u te r  Membrane Porin  Expression by m icF  Antisense RNA
The first chromosomally-encoded antisense RNA to be identified in E. coli was the 93 
nucleotide micF antisense RNA (Mizuno et al., 1983; Mizuno et al., 1984). It regulates the 
expression of outer membrane protein F (OmpF) in response to stress conditions such as 
elevated temperature, high osmolarity and redox stress by basepairing with the ompF 
mRNA, inhibiting translational of the OmpF protein and inducing degradation of the 
message. Regulation of ompF gene expression is important for E. coli because the ability 
to control permeability of molecules through the outer membrane is a major factor in 
survival of the cell under conditions of environmental stress (Delihas and Forst, 2001). 
The micF gene is also present in Salmonella typhimurium, Klebsiella pneumonia and 
Pseudomonas aeruginosa, which are Gram-negative bacteria that are related to E. coli 
(Esterling and Delihas, 1994).
1.3.1.2.2 R egulation  of the  T ranscriptional A ctivator  F hlA  and  the  Stationary  Phase S igma
F a c to r  a *  by o x y S  Antisense RNA
The 109 nucleotide oxyS antisense RNA is induced in response to oxidative stress in E. 
coli and functions to protect the cell against DNA damage (Altuvia et al., 1997). It 
regulates expression of the fhIA gene, which encodes a transcriptional activator, by 
basepairing with fhIA mRNA and repressing translation (Altuvia et al., 1998; Argaman 
and Altuvia, 2000) . In addition, oxyS suppresses expression of the stationary phase 
sigma factor os encoded by rpoS, by basepairing with rpoS mRNA and inhibiting
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translation (Zhang et al., 1998).
1.3.1.2.3 R egu lation  o f  th e  S ta tio n a ry  Phase Sigma F a c to r  a 8 by d srA  Antisense RNA
In contrast to oxyS, basepairing of the 85 nucleotide dsrA antisense RNA with rpoS 
mRNA, leads to increased translation of the stationary phase sigma factor as (Lease et 
al., 1998; Majdalani et al., 1998). dsrA antisense RNA promotes translation by binding to 
the 5’ end of rpoS mRNA and preventing the formation of an inhibitory secondary 
structure with normally blocks the ribosome binding site. dsrA antisense RNA also 
regulates expression of the hns gene, which encodes a nucleoid-associated protein that 
mediates transcriptional silencing of multiple genes in E. coli. Consequently, dsrA 
indirectly regulates the transcription of many genes by overcoming H-NS-mediated 
transcriptional silencing. Hence, dsrA antisense RNA is a riboregulator that can either 
activate or repress translation.
1.3.1.2.4 R egu lation  o f  th e  G a la c to s e  O peron by s p f  Antisense RNA
The spf gene encodes a 109 nucleotide antisense RNA, which acts to differentially 
regulate expression from the E. coli galactose operon (Moller et al., 2002b). It specifically 
binds to the galK mRNA in the region of the ribosome binding site and blocks translation 
of the message. The physiological significance of differential expression of the gal operon 
genes is unclear. However, the GalE, T and K enzymes form part of a pathway that 
produces substrates for biosynthesis of lipopolysaccharides. When E. coli derives its 
energy from galactose all three of the enzymes are required, but when the cell derives its 
energy from other carbon sources, a relatively high level of GalE is required to produce 
UDP-galactose for biosynthetic glycosylations. Therefore, spf antisense RNA may be 
important for optimal utilisation of carbon sources in E. coli (Moller et al., 2002b).
1.3.1.2.5 A ccesso ry  P ro te in s  Involved in E. c o u  Antisense RN A -R eg u la te d  Systems
Basepairing between the antisense RNA and target mRNA is known to occur at 
recognition sites in stem-loop RNA structures. Additional accessory proteins are involved 
in many cases and function to modulate the stability of RNA-RNA duplexes. The protein 
Hfq is required in the majority of chromosomally-encoded antisense RNA systems in E. 
coli that have been characterised so far (Brescia et al., 2003; Moller et al., 2002a; 
Sledjeski et al., 2001; Storz et al., 2004; Zhang et al., 2002). Exactly how the Hfq protein 
functions is not well understood, but it has been suggested that it may act as a RNA 
chaperone to increase RNA unfolding and therefore ensure that the antisense RNA 
and/or target mRNA are in the correct conformation for binding. Alternatively it may bring
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together the antisense RNA and target mRNA by binding simultaneously to both 
molecules (Storz et al., 2004). A common feature of chromosomally-encoded antisense 
RNAs in E. coli is their susceptibility to digestion by RNase E (Schmidt and Delihas,
1995). However, Hfq binding sites and sites of RNase E cleavage share sequence 
similarity, therefore it is thought that Hfq protects antisense RNA from digestion by 
RNase E by blocking the cleavage site (Zhang et al., 2003). Furthermore it has been 
suggested that when Hfq-dependent antisense RNAs binds to their target mRNA, the Hfq 
protein is displaced, allowing access by RNase E and subsequent degradation of the 
RNA-RNA duplex (Masse et al., 2003). In addition, the DNA binding protein H-NS is 
thought to bind to and alter the stability of some antisense RNA-mRNA duplexes. Recent 
research has shown that it specifically binds to the antisense RNA dsrA and its target 
rpoS mRNA, and appears to enhance their degradation (Brescia et al., 2004).
1.3.2 Use of A r tific ia lly -D esigned  A n tisen se  RN A  as  a  Research  
T o o l  to  Do w n -R egulate  the  Expr essio n  of T a r g et  G enes
In recent years, functional synthetic RNA molecules have been used as experimental 
tools for proteomic and genomic research. The range of RNA tools includes small 
interfering RNAs (siRNAs); aptamers (protein-binding RNA motifs); ribozymes, 
maxizymes and aptazymes (catalytic RNAs); and antisense RNA (Famulok and Verma, 
2002). These molecules allow modulation of gene function at the mRNA or protein level 
and are effective and highly specific tools for elucidating the biological function of 
individual genes, and identifying essential genes for the growth of an organism (De 
Backer et al., 2001; van den Berg et al., 1991). In addition to applications in functional 
genomics and proteomics, genetic knockdown technologies such as RNA interference 
(RNAi) and antisense RNA have been used in medical research to identify drug targets 
and to develop therapeutics (Shuey et al., 2002; Thompson, 2002).
Artificially designed antisense RNAs can be used as specific inhibitors of gene 
expression, without directly manipulating the gene of interest. One of the first studies to 
employ artificial antisense RNA for gene-specific silencing was published in 1984 
(Coleman et al., 1984). Having studied the naturally-occurring micF antisense RNA, a 
174 nucleotide untranslated RNA that inhibits expression of the OmpF protein in E. coli 
(Mizuno et al., 1983; Mizuno et al., 1984), this group decided to develop an artificial ‘mic’ 
(mRNA-interfering complementary RNA) system. A plasmid was constructed to express 
antisense RNA targeted against the Ipp gene in E. coli, which encodes the major outer 
membrane lipoprotein. Results showed that induction of the Ipp antisense RNA 
significantly reduced the amount of Ipp mRNA and efficiently blocked lipoprotein
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production.
1.3.2.1 D e s ig n  o f  A n t is e n s e  R N A  O l ig o n u c l e o t id e s
Antisense RNA oligonucleotides are usually designed to bind to the 5’ region of the target 
mRNA, encompassing the ribosome-binding site and the translation initiation site. This 
strategy mirrors many naturally occurring antisense RNAs and aims to suppress 
translation of the target mRNA (Mirochnitchenko and Inouye, 2000). Several studies have 
confirmed that basepairing of the antisense RNA and target mRNA at the ribosome 
binding site is essential/optimal for effectiveness of antisense RNA-mediated gene 
silencing (Coleman et al., 1984; Stefan et al., 2003). There are two main mechanisms for 
artificial antisense RNA production. The first is to chemically synthesise the 
oligonucleotides in vitro and then introduce them into the cell. The second is to construct 
an expression system to produce antisense RNA in vivo, which can be achieved by 
cloning a fragment of the target gene into a plasmid vector in an antisense orientation, 
under the control of a promoter. Use of an inducible promoter allows conditional 
expression of antisense RNA during fermentation.
Although antisense RNA technology appears straightforward, its success is rather 
unpredictable and can vary widely depending on both the sense and antisense 
sequences involved. To address this problem several studies have aimed to develop 
methods for the rational design of antisense RNA oligonucleotides (Nellen and Sczakiel,
1996). The accessibility of an RNA strand, which is determined by its structure, and the 
extent of intramolecular interactions are likely to be important for efficient base pairing 
with a complimentary RNA strand, therefore attempts have been made to correlate these 
parameters with antisense RNA effectiveness. One study conducted in Clostridium 
acetobutylicum found that antisense RNA effectiveness increased as the extent of 
intramolecular binding increased, and concluded that this is likely to be due to greater 
metabolic stability and less RNase degradation (Tummala et al., 2003). Another study 
found that introducing a stem-loop stability element, at the 5’ end of an antisense RNA 
resulted in greater suppression of target gene expression (Engdahl et al., 2001). 
Therefore, it seems likely that stability of the antisense RNA oligonucleotide is a key 
factor in determining its effectiveness in suppressing target gene expression.
1.3 .2 .2  U se  o f  A n t is e n s e  R N A  fo r  M e t a b o l ic  E n g in e e r in g  R e s e a r c h
Antisense RNA has a number of potential advantages over gene inactivation for 
metabolic engineering purposes. It is relatively quick to implement compared to the time
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taken for gene knockouts and antisense RNA can avoid the pitfalls of lethal mutations, as 
complete gene silencing is not likely. Furthermore, by using an inducible promoter for 
conditional expression in vivo, antisense RNA can be used to study metabolism before 
and after gene downregulation. In addition, antisense RNA may be used to downregulate 
the products of multiple genes by expressing multiple antisense RNAs from a single 
plasmid, or from multiple compatible plasmids. Examples of using antisense RNA to 
suppress the expression of target genes and alter metabolism in E. coli and Clostridium 
acetobutylicum are described below.
1.3.2.2.1 Antisense RNA-M ediated D o w nreg u latio n  o f  th e  ^ -M e d ia te d  S tre s s  Response in E. 
cou
The o32-mediated stress response in E. coli is induced by ethanol or heat shock, and by 
over-expression of recombinant protein. Accumulation of cr32 results in the production of a 
number of chaperone proteins and proteases, however increased proteolytic activity can 
reduce the yield of recombinant protein. Therefore, in order to optimise recombinant 
protein production by E. coli, it may be desirable to downregulate the <732-mediated stress 
response.
Antisense RNA has been used to downregulate cr32 expression in E. coli, with the aim of 
enhancing production of the recombinant protein, organophosphorus hydrolase 
(Srivastava et al., 2000). A 284-nucleotide antisense RNA was designed to basepair with 
the 5’ region of the a32 mRNA encompassing the ribosome-binding site, and was 
expressed in vivo from a trc promoter on a multicopy plasmid. Northern blot analysis 
revealed that o32 mRNA levels were dramatically reduced in antisense RNA-expressing 
cultures compared with the control culture, 5-20 minutes after induction of antisense 
RNA. Downregulation of the cr32-mediated stress response was studied during production 
of the recombinant protein, organophosphorus hydrolase (OHP). Surprisingly the amount 
of OHP produced in the presence of o32 antisense RNA was only two thirds of the 
amount produced in the control culture. However, as both OHP and a32 antisense RNA 
were expressed from multicopy plasmids, it was suggested that the reduced OHP 
production might be due to a transcriptional limitation, arising from competition for RNA 
polymerase. Even though the yield of OHP was reduced, there was a 3-fold increase in 
biologically active OHP in the presence of o32 antisense RNA. The specific mechanisms 
for the reduced OHP level and increased OHP activity are not known, as many o32- 
regulated proteins in E. coli may have contributed to this phenomenon. In summary, this 
study demonstrates the use of antisense RNA to suppress expression of a global 
regulatory protein in E. coli and enhance specific activity of a recombinant protein product 
(Srivastava et al., 2000).
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1.3.2.2.2 Antisense RNA-M ediated D o w nreg u latio n  o f  B u ty ra te  P ro d uctio n  by Clostridium
ACETOBUTYLICUM
Clostridium acetobutylicum is a gram-positive, spore-forming, obligate anaerobe that 
produces acids (acetate and butyrate) and solvents (ethanol, acetone and butanol) by 
fermenting a variety of sugars. This organism was used was used to produce acetone 
and butanol up until the 1950s, when the petrochemical process became economically 
superior. Research in recent years, has focused on optimising solventogenic Clostridia for 
solvent production with the aim of reviving the industrial fermentation process (Desai and 
Papoutsakis, 1999).
The effectiveness of antisense RNA in redirecting Clostridium acetobutylicum central 
carbon metabolism to optimise solvent production has been investigated (Desai and 
Papoutsakis, 1999). Specifically, antisense RNA was employed to downregulate 
expression of the phosphotransbutyrylase gene {ptb) and the butyrate kinase gene (buk), 
which are responsible for butyrate formation in Clostridium acetobutylicum. Butyrate 
levels are thought to influence solvent production by Clostridium acetobutylicum, 
therefore downregulation of Ptb and Buk was expected to have a significant impact on 
primary metabolism. Two plasmids constructs were developed to express antisense RNA 
targeted against either the buk gene or the ptb gene. Both antisense RNA 
oligonucleotides were designed to basepair with the 5’ end of the target mRNA, in the 
region of the ribosome binding site. The impact of putative buk antisense RNA and 
putative ptb antisense RNA on enzyme levels and product formation in Clostridium 
acetobutylicum was evaluated. In addition, fermentation data was used for metabolic flux 
analysis to examine the effect of reduced levels of acid formation enzymes on the central 
carbon fluxes.
The research has many analogies with this thesis, including the experimental approach 
taken and the target pathway for downregulation by antisense RNA. The pathway for 
butyrate formation in Clostridium acetobutylicum is comprised of two reactions, which are 
similar to the two steps in the acetate production pathway of E. coli. In the first step 
butyryl CoA is converted to butyryl phosphate by phosphotransbutyrylase (Ptb), and in 
the second step, butyryl phosphate is converted to butyrate by butyrate kinase. The 
genes ptb and buk form an operon, however they are organised in the order ptb-buk, 
whereas the analogous genes for acetate production in E. coli are organised in the 
reverse order, ackA-pta, in an operon (described in more detail in section 4.2.3).
Cultures of Clostridium acetobutylicum expressing putative buk antisense RNA exhibited
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significantly lower peak levels of Ptb and Buk compared to the control strain. Cultures 
expressing putative ptb antisense RNA also exhibited lower levels of Ptb and Buk 
compared to the control, and higher peak levels of the enzyme lactate dehydrogenase, 
which converts pyruvate to lactate. As the enzymes ptb and buk are cotranscribed, it was 
expected that expression of antisense RNA targeting one of the genes might reduce 
expression of both. However, increased lactate dehydrogenase activity in the putative 
ptb-expressing culture was an unexpected result.
Analysis of the product formation profiles of both antisense RNA-expressing cultures 
revealed that even though Ptb and Buk levels were significantly lower compared to the 
control culture, butyrate production was not reduced. In fact, the peak butyrate 
concentration of the buk-antisense RNA expressing culture was -35%  higher than in the 
control culture. These results imply that flux through the butyrate formation pathway is 
not tightly controlled by enzyme levels (Desai and Papoutsakis, 1999). Although butyrate 
production was not reduced in the antisense RNA-expressing cultures, the pattern of 
solvent production was altered in both strains. In cultures expressing putative buk 
antisense RNA, acetone and butanol were detected earlier and accumulated to higher 
final concentrations than in the control culture. In contrast, cultures expressing putative 
ptb antisense RNA, exhibited much lower solvent production than the control culture, 
which was compensated for by a -100-fold increase in lactate production. The increased 
lactate production was assumed to be due to probable elevated levels of the lactate 
precursors, pyruvate and NADH. This research demonstrates that antisense RNA can be 
used to downregulate specific protein production and manipulate the primary metabolism 
of Clostridium acetobutylicum, but often with unexpected outcomes.
Subsequently, metabolic flux analysis was used to compare the impact of buk gene 
inactivation and antisense RNA-mediated buk downregulation on the central carbon flux 
distribution in Clostridium acetobutylicum (Desai et al., 1999). Results revealed that both 
strategies led to increased flux to butanol and acetone production. The patterns indicated 
by flux analysis suggested the possibility of butyryl-phosphate as an inducer of 
solventogenesis.
1.3.2.2.3 Antisense RNA-M ediated D o w nreg u latio n  o f  A c e ta te  P roduction  by E. c o u
At the beginning of this research thesis (in 2001), use of antisense RNA to downregulate 
enzymes of the acetate production pathway in E. coli had not been investigated. 
However, a recent publication (Kim and Cha, 2003) describes antisense RNA-mediated 
downregulation of the acetate production pathway, with the specific goal of enhancing 
recombinant protein production by E. coli. Three plasmid constructs were developed to
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express antisense RNA targeted against the pta gene, the ackA gene, or both genes 
simultaneously. The plasmids were introduced into E. coli BL21, a low acetate producer, 
and the effect of antisense RNA expression on acetate production and GFP (green 
fluorescent protein) production was evaluated.
All shake flask E. coli cultures expressing antisense RNA exhibited higher growth rates 
and final cell densities, and accumulated higher acetate levels than the control strain. 
However, even though the excreted acetate was not reduced, the antisense RNA- 
expressing cultures exhibited a 10-20% reduction in ackA mRNA and pta mRNA in the 
respective antisense RNA-expressing strains. In addition, Ack and Pta enzyme activity 
analysis confirmed a 15-25% reduction in enzyme levels. In contrast, shake flask E. coli 
cultures co-expressing GFP and ackA/pta/ackA-pta antisense RNA exhibited reduced 
levels of acetate accumulation compared to the control culture. The dual antisense RNA- 
expressing culture had the lowest level of acetate accumulation. Furthermore, the 
antisense RNA-expressing cultures exhibited higher levels of GFP production compared 
to the control culture. ackA antisense RNA-expressing cultures showed a 1.6-fold 
increase in GFP production compared to the control culture.
To investigate the effect of culture scale-up on antisense RNA regulation of the acetate 
pathway, E. coli producing GFP and expressing ackA antisense RNA was cultivated in a 
3 L stirred-tank bioreactor. The growth rate was reduced by about 20% compared to the 
control culture producing GFP. In addition, the pattern of acetate accumulation was 
altered by expression of ackA antisense RNA. The control culture accumulated acetate 
rapidly through growth phase, with a peak concentration of 3.36 mM, and then 
reconsumed it during early stationary phase, even though residual glucose levels were 
high. In contrast, the ackA antisense RNA-expressing culture showed a slower but 
steady increase in acetate accumulation until the end of the culture, with a final 
concentration of 2.69 mM. No acetate reconsumption was evident, which may be due to 
interference from ackA antisense RNA expression. GFP production was increased about 
2-fold in the antisense RNA-regulated culture, compared to the control. These results 
suggest that even a small decrease in target gene expression using antisense RNA can 
have a big impact on cellular metabolism and in particular recombinant protein 
expression.
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The key differences between the above study and this research thesis are:
■ E. coli strains: E. coli B (BL21) used in the study of Kim and Cha (2003) is a low 
acetate producer. In contrast, E. coli K-12 (MG1655) used in this research thesis is a 
high acetate producer (van de Walle and Shiloach, 1998). The strain-specific 
differences in acetate production between E. coli B and K derivatives have been 
attributed to differences in the expression levels of key metabolic genes involved in 
acetate production and consumption (Phue and Shiloach, 2004). Therefore, it is 
interesting to study the effect of ackA and pta antisense RNA expression in a high 
acetate producing E. coli strain.
■ Promoters for antisense RNA expression: Kim and Cha (2003) used the relatively 
weak ackA constitutive promoter for expression of antisense RNA oligonucleotides. 
The research described in this thesis uses the strong trc and tac promoters for 
conditional expression of ackA and pta antisense RNA.
■ Enzyme analysis: Kim and Cha (2003) analysed Pta and AckA enzyme activity 
levels at mid-log phase during fermentation. This study evaluates Pta and AckA 
enzyme activity levels periodically over a 24 h time course, allowing a more detailed 
analysis of the effect of antisense RNA on target protein expression.
■ Organic acid analysis: Kim and Cha (2003) focused on analysing acetate 
production. However, in order to determine the effectiveness of antisense RNA in 
redirecting central carbon metabolism, this study monitored the concentration of a 
range of organic acids in the culture medium, including pyruvate, lactate, succinate 
and acetate.
■ Metabolic flux analysis: this is the first study to use metabolic flux analysis to 
examine the effect of antisense targeted against ackA and pta on the central carbon 
flux distribution in E. coli.
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1.4 S pecific  A ims  of Ph D T hesis
The overall goal of this research thesis is to determine the effectiveness of antisense 
RNA in suppressing the expression of target enzymes and redirecting the central carbon 
metabolism of E. coli. Specifically, it was attempted to downregulate the expression of 
phosphotransacetylase and acetate kinase, which form the primary acetate production 
pathway in E. coli, and use a combination of physiological characterisation and metabolic 
flux analysis to examine the effect of pta and ackA antisense RNA on central carbon 
metabolism.
During the course of this research, three plasmid constructs were developed to produce 
antisense RNA targeted against either ackA mRNA or pta mRNA. Two ackA antisense 
RNA constructs were generated: one was developed from the expression vector 
pTrc99A, which was also used to generate the pta antisense construct, and one was 
developed from the expression vector pMMB66EH, which is compatible with pTrc99A 
and therefore facilitates co-expression of ackA and pta antisense RNA. Plasmid 
constructs were introduced into E. coli MG1655 for antisense RNA expression studies.
The effectiveness of putative pta and ackA antisense RNA in suppressing expression of 
phosphotransacetylase and acetate kinase was evaluated by monitoring the enzyme 
activity levels, and the effect on organic acid production by E. coli was examined by 
monitoring the concentration of acetate and other organic acids present in the culture 
medium. In addition, fermentation data was used for metabolic flux analysis, which 
predicts the intracellular flux distribution, and therefore gives a more detailed insight into 
the effect of antisense RNA on E. coli metabolism.
This thesis discusses the research that was carried out to achieve the overall goal, and is 
presented in chapters, which are described below.
■ Chapter 2 describes the materials and methods used during the course of the 
research, which included molecular biology techniques for DNA recombination, batch 
fermentation and HPLC.
■ Chapter 3 discusses the initial shake-flask studies performed with E. coli MG1655 to 
optimise the growth conditions and experimental procedures for physiological 
characterisation.
■ Chapter 4 discusses the construction of a series of plasmids to express antisense 
RNA targeted against E. coli MG1655 phosphotransacetylase and acetate kinase.
■ Chapter 5 discusses the shake flask and bioreactor experiments that were
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performed in order to determine the effect of putative pta and ackA antisense RNA on 
growth, enzyme levels, and organic acid production by E. coli MG 1655.
■ Chapter 6 discusses the results of metabolic flux analysis, which was used to 
examine the impact of putative pta and ackA antisense RNA on carbon flow through 
E. coli central metabolism.
■ Chapter 7 summarises the work as a whole, draws conclusions and suggests future 
work to explore further the results presented in this thesis.
Antisense RNA is a flexible and still relatively novel tool for metabolic engineering. 
Consequently, if it can be successfully applied in this research to suppress expression of 
target enzymes and redirect E. coli central carbon metabolism, then it might encourage 
further use of antisense RNA for partial gene inactivation in advanced metabolic 
engineering strategies.
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2.1 Ma ter ia ls
Chemicals, media components and enzymes were supplied by Sigma-Aldrich 
(www.sigma-aldrich.com), Oxoid (www.oxoid.co.uk), Invitrogen (www.invitrogen.com), 
Qiagen (www.qiagen.com), and New England Biolabs (www.neb.com). Double distilled 
water (equivalent of) was produced using an Elga Option 4 water purifier 
(www.elga.co.uk). Media and buffers were sterilized by autoclaving for 20 min at 121°C, 
or filtering through a 0.2 pm sterile syringe filter (www.millipore.com).
2.2 Ba c te r ia l  Strains  and  P lasm ids
The bacterial strains and plasmids used in this study are listed in Table 2.1.
2.2.1 E. cou Strains
E. coli MG 1655 is a K12 strain and was selected for antisense RNA expression studies 
due to the availability of it’s complete genome sequence (Blattner et al., 1997).
E. coli TOP10, supplied by Invitrogen, was used as a cloning host for pCR2.1-T0P0- 
derived plasmids.
E. coli DH5a was used as a routine cloning host (Woodcock et al., 1989).
2.2.2 Plasmids
pTrc99A and pMMB66EH were used to develop antisense RNA expressing-plasmids. 
pTrc99A (Amann et al., 1988) is a 4.2 kb plasmid which carries the pBR322 origin of 
replication. It provides high-level expression via a strong trc promoter upstream of the 
multiple cloning site, rmB terminator downstream of the multiple cloning site, and /aclq for 
/aclq mediated repression. A plasmid encoded p-lactamase confers resistance to 
ampicillin.
pMMB66EH is an 8.8 kb plasmid containing the RSF1010 replicon. This plasmid is a 
member of the IncQ incompatibility group, characterised by small size, low copy number 
and a broad host range among gram-negative bacteria (Morales et al., 1990). It 
possesses the strong tac promoter upstream of the multiple cloning site, rmB terminator 
downstream of the multiple cloning site, and /aclq for /aclq mediated repression. A 
plasmid encoded p-lactamase confers resistance to ampicillin.
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The tac promoter is a hybrid of the trp and lac UV5 promoters and was originally 
constructed in the early 1980’s (de Boer H.A. et al., 1983). Transcription from the 
promoter is induced by addition of 1mM IPTG. The trc promoter is derived from the tac 
promoter by the addition of 1 bp between the -35 and -10 consensus sequences, making 
the distance 17 bp. It was anticipated that this alteration would generate a stronger 
promoter, however the resulting trc promoter has only 90% activity of the original tac 
promoter (Brosius J. etal., 1985).
Contrasting replication mechanisms in pTrc99A and pMMB66EH facilitate co-existence in 
E. coli, allowing construction of a dual antisense RNA-expressing strain. pCR2.1-TOPO 
(Invitrogen) was used for direct capture of Taq polymerase-amplified PCR products. 
pl)C4K was used as a template for PCR-amplification of an aminoglycoside 3’- 
phosphotransferase (kan), which confers resistance to kanamycin. Plasmids pQR438- 
pQR446 were constructed during this study and are described in chapters 4-6.
Table 2.1 Bacterial strains and plasmids
Bacterial strain or plasmid Relevant characteristic(s)a Reference/Source
Strain
E. coli MG1655 F-, A-, ilvG-, rfb-50, rph-1. (Blattner etal., 1997)
E. coli DH5a F-, A -, thi-1, supE44, hsdR17, recA1, gyrA96, (Woodcock et al.,
endA1, relA1, deoR, A(laclZYA - argF) 1989)
E. coli TOP 10 Invitrogen
Plasmid
pT rc99A Ampr; trc promoter; lac lq; pBR322 ori (Amann etal., 1988)
pMMB66EH Ampr; tac promoter; lac lq; RSF1010 ori (Furste et al., 1986)
pUC4K Ampr, Kanr; pBR322 ori (Taylor and Rose,
1988)
pCR2.1-TOPO Ampr, Kanr, pUC ori Invitrogen
pQR438 Ampr, Kanr; pUC ori, antisense pta This study
pQR439 Ampr; trc promoter; lac lq; pBR322 ori; This study
antisense pta
PQR440 Ampr, Kanr; pUC ori, antisense ackA This study
pQR441 Ampr; trc promoter; lac lq; pBR322 ori; This study
antisense ackA
pQR444 Ampr, Kanr; pUC ori, kan This study
pQR445 Kanr; tac promoter; lac lq; RSF1010 ori This study
pQR446 Kanr; tac promoter; lac lq; RSF1010 ori; This study
antisense ackA
a Plasmid components are described in Chapter 4, Table 4.1.
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2.3 M o lec u la r  B iology
2.3.1 Pr epa ra tio n  o f  B uffers  a nd  S olu tio n s
(i) Ethidium Bromide
A stock solution of 10 mg ml'1 was prepared and stored in a foil-covered bottle at room 
temperature.
(ii) Gel loading buffer
A 6X stock solution was prepared containing 1 mg ml'1 bromophenol blue, 40%(v/v) 
sucrose and 0.1 M Na2EDTA, and stored at room temperature.
(iii) Lysozyme
A stock solution was prepared containing 10 mg ml'1 lysozyme in sterile TE buffer, and 
stored at -20 °C.
(iv) Pronase
A stock solution was prepared containing 10 mg ml'1 Pronase in sterile TE buffer, 
incubated at 37 °C for 2 h to destroy any endogenous DNAases, and stored at -20°C.
(v) RNAase A
A stock solution was prepared containing 10 mg ml'1 ribonuclease A in sterile TE buffer, 
boiled for 15 min to remove any trace DNAase activity, and stored at -20 °C.
(vi) TBE buffer
A 10X stock was prepared by dissolving 54 g Trizma Base, 27.5 g Boric acid and 3.75 g 
Na2EDTA in a final volume of 1 L. The solution was stored at room temperature.
(vii) TE buffer
A solution containing 10 mM Tris-HCI (pH 7.5) and 1mM Na2EDTA was prepared, and 
stored at room temperature.
(viii) X-Gal
A stock solution of 40 mg ml'1 X-Gal in dimethylformamide was prepared, and stored in a 
foil-covered bottle at -20°C.
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2.3.2 DNA P r e p a r a t io n
2.3.2.1 P rep ara tio n  o f  Chrom osom al DNA
Chromosomal DNA was isolated from cultures of E. coli MG1655, grown overnight in 50 
ml nutrient broth, as follows. Bacterial cells were harvested by centrifugation (9,000 rpm, 
10 min), before being resuspended in 5 ml TE buffer. Lysozyme was then added to a 
final concentration of 50 pg ml'1, and the solution incubated at 37°C for 15 min. 
Lysis was induced by the addition of SDS to a final concentration of 1%, followed by 
gentle mixing by inversion 4-6 times. Pronase and RNAase were added to final 
concentrations of 50 pg ml'1 and 20 pg ml'1 respectively, the solution was mixed as 
before, and incubated at 37°C for 2 h. Following incubation, 0.5 ml of 5 M NaCI was 
added, mixed by inversion, and 10 ml ethanol pipetted on to the surface of the lysate. A 
sterile glass rod was used to spool the DNA precipitate that collected at the interface. 
The DNA was then transferred to a sterile container and left to dissolve in 10 ml TE 
buffer. At this point, the DNA solution was frozen at -20°C.
Upon thawing, the DNA solution was gently mixed to, before testing for purity via agarose 
gel electrophoresis.
2.3.2.2 P re p ara tio n  o f  Plasmid DNA
Plasmid DNA was isolated from small-scale cultures of E. coli grown overnight in 5 ml 
selective nutrient broth using Miniprep preparative kits (Qiagen), according to 
manufacturer’s instructions. Plasmid DNA was eluted into 50 pi buffer EB (10 mM Tris- 
HCI, pH 8.5), and stored at -20°C.
Plasmid DNA was isolated from larger scale cultures grown overnight in 50 ml selective 
nutrient broth using Midiprep preparative kits (Qiagen), according to manufacturer’s 
instructions. Plasmid DNA was eluted 1 ml TE buffer (10 mM Tris-HCI (pH 7.5), 1mM 
Na2EDTA), and stored at -20°C.
2.3.3 Enzymatic Manipulations
2.3.3.1 R es tric tio n  Digests
Digestion of plasmid DNA with restriction enzymes was performed using enzymes and 
buffers supplied by New England Biolabs. When using the enzymes BamHI and Pvu\, 
BSA was added to a final concentration of 100 pg ml'1. Typically 10 pi plasmid DNA
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(prepared as above) was digested in a total volume of 20 pi, comprising 1 pi restriction 
enzyme, 2 pi 10X restriction buffer, and 7 pi TE buffer. The solution was incubated at 
37°C for 2 h. Digested DNA was analysed by agarose gel electrophoresis.
2.3 .3 .2  L ig a t io n
DNA fragments were ligated into plasmid vectors using enzymes and buffers supplied by 
New England Biolabs. A typical reaction was performed in a total volume of 100 pi, 
comprising 30 pi linearised plasmid, 30 pi DNA insert, 10 pi 10X ligation buffer, 3 pi T4 
DNA ligase and 27 pi TE buffer. The reaction was mixed gently and incubated at 16°C 
overnight. Subsequently, an aliquot of competent E. coli was transformed with 20-100 pi 
ligation mixture (refer to section 2.4.2).
The TOPO TA cloning system (Invitrogen) was used for direct capture of Taq 
polymerase-amplified PCR products. The reaction comprised 1 pi PCR product, 1 pl salt 
solution, 1pl pCR2.1-TOPO and 3pl sterile water. Ligation was performed by mixing the 
components gently and incubating at room temperature for 30 min. An aliquot of 
competent E. coli TOP10 (Invitrogen) was transformed with 3 pl of ligation reaction (refer 
to section 2.4.2).
2.3.4 Elec tro ph o r esis
2.3.4.1 E l e c t r o p h o r e s is  o f  DNA in  A g a r o s e  G els
Agarose gel electrophoresis was performed using 1, 1.5 or 2% (w/v) agarose, in TBE 
buffer. Gels were prepared by dissolving agarose powder in TBE by boiling, then cooling 
the molten agarose and adding ethidium bromide to a final concentration of 0.5 pg ml'1, 
before pouring the gel into a casting tray containing a comb of the required size to form 
sample wells. Once the gel was set, the comb was removed and the gel was fully 
submerged in TBE buffer. Electrophoresis was performed at 100 volts for 30 -90 min. 
When complete, gels were visualised using a short wave UV light transilluminator in 
conjunction with a UVI Tec CCD digital camera, linked to a PC operating the UVBand 
software package. Digital images were saved in TIF format.
2 .3 .4 .2  Iso l a t io n  o f  D N A  fr o m  A g a r o s e  G els
DNA fragments were isolated from agarose gels using a QIAquick Gel Extraction Kit 
(Giagen), according to manufacturer’s instructions. DNA bands were visualised using a
51
Chapter 2: Materials and Methods
UV light transilluminator, before being excised from the agarose gel using a clean scalpel 
and the DNA isolated. DNA was eluted into 30 pl buffer EB (10 mM Tris-HCI, pH 8.5) and 
stored at -20°C.
2.3.5 P olym erase Chain Reaction (PCR)
PCR was used to amplify sequences from plasmid DNA and E. coli chromosomal DNA. 
Reactions were performed in a Hybaid Omnigene thermal cycler (www.hybaid.co.uk), 
with enzymes and buffers supplied by Quiagen. A typical thermal cycle is shown in table
2.2
PCR reactions were performed in a total volume of 50 pl, comprising 1 unit Taq 
polymerase, 10 pl dNTP (0.2 mM), 1 pl forward primer (30 pM), 1 pl reverse primer (30 
pM), 5 pl Taq polymerase buffer (containing 1.5 mM MgCI), 5 pl Q solution, 26 pl sterile 
water, and 1 pl template DNA. Primers (synthesised by Qiagen), are detailed in table 2.3, 
which highlights the restriction sites incorporated to facilitate directional cloning of PCR 
products.
Table 2.2 PCR Program
Stage Temperature (°C) Time (min) Repetition (cycles)
Denatu ration 95 4 1
Denaturation 94 0.5
Primer Annealing 5 5 -6 3 0 .5 -1 .5 30
Elongation 72 0.5
Elongation 72 20 1
Table 2.3 PCR Primers
Primer Name Oligonucleotide sequence (5’-3’) Restriction Site 
Incorporated
ackA f. p. GC AAGCTTT AT C AATT AT AGGT ACT BamHI
ackA r. p. CGCTT AAGT AGT ATT AACGAT AAAG EcoRI
pta f. p. GCAAGCTTCGAAAGAGGATAAACCG Hind\\\
pta r. p. CGCTTAAGTGGAAGAGTTCGCACGC EcoR\
kan f. p. GCCGATCGGTCGACCTGCAGGGGGGGGGGGGCGCTGA Pvu\
kan r. p. GCCGATCGGCAGGGGGGGGGGGGAAGCCACGTTGTGT Pvu\
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2 .3 .6  DNA S e q u e n c in g
DNA sequencing was performed by the DNA Sequencing Service, Wolfson Institute for 
Biomedical Research, University College London (www.ucl.ac.uk/WIBR). DNA 
concentration was analysed by agarose gel electrophoresis, and provided for sequencing 
at 150-300 ng/pl. Sequencing results were analysed using freeware downloadable from 
the following websites: pDraw32, http://medlem.spray.se/acaclone; BioEdit,
www.mbio.ncsu.edu/BioEdit/bioedit.html.
2.4 E. cou T ransfo rm atio n
2.4.1 P r eparatio n  of C h em ic ally  Co m petent  E. c o u
Chemically competent coli MG1655 and DH5or cells were prepared as follows. A freshly 
streaked nutrient agar plate of the strain to be made competent was used to inoculate 10 
ml sterile nutrient broth in a universal bottle, and grown overnight at 37°C. The 10 ml 
culture was then used to inoculate 200 ml nutrient broth supplemented with 20 mM MgCh 
in a 1 L shake flask, which had been pre-warmed to 37°C. The culture was grown in an 
orbital shaker (37°C , 200 rpm) until A6oo of -0.6 was reached. Subsequently, the culture 
was chilled on ice before harvesting the cells by centrifugation (9,000 rpm, 5 min, 4°C) in 
a Sorvall centrifuge. The cell pellet was resuspended in 5 ml ice cold 75 mM calcium 
chloride, 15% (v/v) glycerol. 500 pl aliquots of competent cell suspension were stored at - 
80°C ready for use. Transformation efficiency was tested with the high copy number 
plasmid pUC19 (Yanisch-Perron etal., 1983).
2.4.2 T r ansfo rm atio n  of C o m peten t  E. c o u  C ells
Transformation of competent E. coli by plasmid DNA was performed as follows. 2 pl 
plasmid DNA, or up to 50 pl ligation reaction, was added to a 500 pl aliquot of chemically 
competent E. coli, mixed gently and incubated on ice for 45 min. The cells were heat- 
shocked at 37°C for 5 min, before adding to 5 ml nutrient broth and incubating (37°C, 200 
rpm) for 1 h. Transformants were selected by plating 100 pl transformation broth onto 
nutrient agar plates supplemented with appropriate antibiotics.
Transformation of pCR2.1-TOPO into One-Shot Chemically Competent E. coli TOP10 
(Invitrogen) was performed according to manufacturer’s instructions. Transformants were 
selected by plating 100 pl transformation broth onto selective nutrient agar plates, coated 
with 40 pl X-gal (40 mg ml'1) to facilitate blue-white colour screening.
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2.5 E. cou C ultures
2.5.1 M ain ten a n c e  of Ba c ter ia l  Str a in s
E. coli strains were maintained as 20% glycerol stocks. Cell stocks were prepared from 
selective nutrient agar plates by resuspending the colonies in 3 ml 20% glycerol using a 
sterile glass rod before harvesting the suspension with a sterile pipette. Alternatively, E. 
coli culture in selective nutrient broth was combined with an equal volume of 40% sterile 
glycerol. Cell suspensions were stored as 1 ml aliquots, at -80°C
2.5.2 M edia
E. coli growth media and media supplements are detailed in Table 4. For strain 
development, E. coli cultures were grown in nutrient broth (Oxoid Nutrient Broth No. 2) or 
on nutrient agar (Oxoid Nutrient agar) at 37°C. Liquid cultures were incubated in an 
orbital shaker (New Brunswick Scientific). Antisense RNA expression studies were 
performed with M9 minimal media (refer to Table 2.4) (Miller, 1972). M9 salts were 
prepared as a 10X stock solution, autoclaved and stored at room temperature. Glucose 
was prepared as a 10X stock, autoclaved and stored at room temperature. Calcium and 
magnesium salts were prepared as a 100X stock, autoclaved and stored at room 
temperature. The trace element solution was prepared as a 4,000X concentrated stock 
solution, autoclaved and stored at room temperature. Uracil was prepared as a 100X 
stock solution, filter sterilised and stored at -20°C. Thymidine was prepared as a 1,000X 
stock solution, filter sterilised and stored at -20°C.
Plasmid-harbouring strains were maintained by supplementing with appropriate 
antibiotics. Stock solutions of 50 mg ml'1 ampicillin (sodium salt) and 50 mg ml'1 
kanamycin sulphate were prepared, filter sterilised and stored at -20°C. Ampicillin was 
used at a working concentration of 100 - 500 pg ml'1, according to plasmid copy number. 
Kanamycin was used at a working concentration of 10 pg ml'1.
Induction of antisense RNA was achieved by addition of Isopropyl p-D- 
thiogalactopyranoside (IPTG) to a final concentration of 1 mM. A 100 mM stock solution 
of IPTG was prepared, filter sterilised and stored at 20°C.
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Table 2.4 E. coli Growth Medium and Media Supplements
Component Stock Concentration (g L'1) Working Concentration (g L'1)
Nutrient Agar (Oxoid) - 28
Nutrient Broth No. 2 (Oxoid) - 25
M9 salts
Na2P04.12H20 152 15.2
k h 2p o 4 30 3
NaCI 5 0.5
NH4CI 10 1
Calcium/Magnesium salts
CaCI2 1.47 0.0147
MgS04.7H20 24.6 0.246
Glucose 100 10
Trace element solution
FeCI3.6H20 2.7 6.75 X 10"4
ZnCI2.4H20 0.2 5 X 10'5
CoCI.6H20 0.2 5 X 10’5
NaMo04.2H20 0.2 5 X 10'5
CaCI2.2H20 0.1 2.5 X 10‘5
CuCI2.6H20 0.13 3.25X1 O'5
H3BO3 0.05 1.25 X 10'5
Cone. HCI 2.5 X 10-3
Strain-specific supplements
Uracil 2 0.02
Thymidine 5 0.005
Antibiotics
Ampicillin 50 0.1 -0 .5
Kanamycin 50 0.01
Inducer
IPTG 100 mM 1 mM
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2 .5 .3  S h a k e -F l a s k  E x p e r im e n t s
2.5.3.1 S hak e -Flask  C ultures
Shake-flask cultures were prepared from a single colony on a fresh, selective nutrient 
agar plate. Biomass from the colony was used to inoculate 25 ml glucose minimal media 
(refer to section 2.5.2) in a 100 ml flask and grown overnight in an orbital shaker (37°C, 
200 rpm). The pre-culture was transferred to 225 ml fresh glucose minimal media in a 2 L 
baffled flask and incubated in an orbital shaker (37°C, 200 rpm), for 24 h.
2.5.3.2 Sam pling  Pro cedur e , A ntisense  RNA Expr essio n  and  A nalysis  of P lasmid
Stab ility
5 ml samples were taken from shake flask cultures at 1 h intervals and placed on ice 
prior to analysis. Duplicate A6oo readings of culture broth were performed immediately. 
The remaining broth was pipetted into 3 x 1 ml aliquots and microfuged (5 min, 14,000 
rpm). Supernatant was transferred into clean eppendorf tubes and stored at -20°C for 
subsequent analysis of residual glucose and organic acid concentrations. Cell pellets 
were stored at -80°C for enzyme activity analysis.
Expression of antisense RNA was induced in early/mid exponential growth phase (A6oo
1.0 -  1.5) by addition of IPTG to a final concentration of 1 mM.
Plasmid stability was evaluated after 24 h growth by preparing two-fold serial dilutions of 
culture broth in saline, and plating 1 0 0  pl on selective and non-selective nutrient agar. 
Following overnight growth at 37°C, cell counts from selective and non-selective plates 
were determined.
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2 .5 .4  B a t c h  F e r m e n t a tio n
2.5.4.1 F e r m e n t a t io n  Eq u ip m e n t
Batch fermentations were performed in an Adaptive 2 L stirred-tank bioreactor (working 
volume 1 L), shown in Figure 2.1. The vessel consisted of a glass tank with a stainless 
steel head-plate containing ports for probes and additions, and a top-driven turbine. On­
line monitoring and control of temperature, pH and impeller speed was performed by the 
Bioview software package (Adaptive). pH was maintained at 7.0 by automatic addition of 
2M NaOH or 2M H3 P0 4 using a peristaltic pump. Temperature was maintained at 37°C 
by a heating element and cooling coils in the fermenter vessel. Process data was 
recorded every 2  min.
2 .5 .4 .2  Ex h a u s t  G a s  A n a ly s is
The concentrations of CO2 , O2 , and N2 in the inlet and exhaust gases were measured by 
mass spectrometry. Raw data was transferred into the computer of the fermenter digital 
control system, where derived variables (i.e. OUR, CER, RQ) were automatically 
calculated and stored. The formulas used to calculate OUR, CER and RQ were as 
follows:
Oxygen Uptake Rate:
OUR F 1
Vo V,
Carbon Dioxide Evolution Rate
F\
v l (l X02 XcQ2) v 0
2 ( l -  Y °  ]  2\ l A  0 2 ~  A  C02J
* 60*1000
CPR =
VoVm
Respiratory Quotient:
CPR
0 0 X 0 2  X c o i )  1
A c ° 2 X Tl 7^ 0 C T ^ - A C 0 2  
y  A  02  A  C 0 2 )
* 60*1000
RQ =
OUR
Where F1 = air flow rate (L/min)
V0 = working volume liquid phase (L) 
Vm = molar volume of gas (22.4 L/mol) 
Xy‘ = mol fraction gas y at inlet 
Xy° = mol fraction gas y at outlet
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2 .5 .4 .3  F e r m e n t e r  S t e r il is a t io n  a n d  S e t -U p
Sterilisation and set-up was performed one day prior to inoculation. The fermenter 
vessel, containing 790 ml M9 salt solution (42 mM Na2 HP0 4 .1 2 H2 0 , 22 mM KH2 P 04) 9 
mM NaCI, 19 mM NH4 CI) and fitted with pH and dissolved oxygen (DOT) electrodes, was 
sterilised by autoclaving at 121°C, 15 psi for a minimum of 20 min. Ancillary vessels for 
addition of acid, base, media components and inoculum were autoclaved along with the 
fermentor. The fermenter was set-up as follows. pH and DOT probes were connected 
and a temperature probe and heating element inserted into ports in the fermenter head 
plate. Ancillary vessels were connected aseptically to addition ports, before priming the 
acid and base lines. Cold water was connected to the condenser and to cooling coils 
running through the fermenter vessel. Compressed air was connected to the fermenter 
sparge line, via a 0.2 pm filter. The motor was attached to the turbine by a connection on 
the fermenter head plate. Following set-up of the fermenter, the remaining sterile media 
components and antibiotics were added aseptically, via an addition port.
2 .5 .4 .4  In o c u l u m  P r e p a r a t io n  a n d  C u l tu r e  C o n d it io n s
Inoculum cultures were prepared from a single colony on a fresh, selective nutrient agar 
plate. Typically, biomass from a colony was used to inoculate 10 ml selective glucose 
minimal media (refer to section 2.5.2) in a 50 ml falcon tube and grown for ~5 h in an 
orbital shaker (37°C, 200 rpm). This culture was used to inoculate 90 ml fresh selective 
glucose minimal media in a 250 ml flask and incubated overnight in an orbital shaker 
(37°C, 200 rpm). The A6oo of the resulting 100 ml pre-culture was determined and the 
culture diluted in fresh media to give 100 ml of culture with an A6oo of -2.0. This was used 
to inoculate 900 ml fresh media in the 2 L fermenter. Fermentation was performed at 
temperature 37°C, pH 7.0, airflow rate 1 wm , agitation rate 800 rpm, for a total of 24 h.
2 .5 .4 .5  S a m p l in g  P r o c e d u r e , A n t is e n s e  R N A  Ex p r e s s io n  a n d  A n a l y s is  o f  P l a s m id
S t a b il it y
Aseptic sampling was carried out via a sample port and line controlled by a 20 ml 
syringe. A 5 ml discard sample was taken before each 5 ml sample taken for analysis. 
Samples were taken from the fermenter at 1 h intervals and placed on ice prior to 
analysis. Duplicate A6oo readings of culture broth were performed immediately. The 
remaining broth was pipetted into 3 x 1 ml aliquots and microfuged (5 min, 14,000 rpm). 
Supernatant was transferred into clean eppendorf tubes and stored at -20°C for 
subsequent analysis of residual glucose and organic acid concentrations. Cell pellets 
were stored at -80°C for enzyme activity analysis.
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Expression of antisense RNA was induced in early/mid exponential growth phase (A6oo
1.0 -  1.5) by addition of IPTG to a final concentration of 1 mM. Polypropylene glycol 
(PPG) was added manually when required, using a needle and syringe, to prevent 
excess foaming in the fermentor.
Plasmid stability was evaluated after 24 h growth by preparing two-fold serial dilutions of 
culture broth in saline, and plating 1 0 0  pl on selective and non-selective nutrient agar. 
Following overnight growth at 37°C, cell counts from selective and non-selective plates 
were determined.
Figure 2.1 Adaptive 2 L fermenter used for bioreactor experiments. The vessel consisted of 
a glass tank with a stainless steel head-plate containing ports for probes and additions, and a 
top-driven turbine. Control of temperature, pH and impeller speed was achieved via digital 
computer control. pH was maintained at 7.0 by automatic addition of 2M NaOH or 2M H3P04 
using a peristaltic pump. Temperature was maintained at 37°C by a heating element and 
cooling coils in the fermenter vessel.
5 9
Chapter 2: Materials and Methods
2.6 F e r m enta tio n  A n alysis
2.6.1 B io m a ss
Cell growth was monitored by A6oo of culture broth, against a blank of sterile culture 
medium. A correlation between A6oo and dry cell weight (dew) was determined as follows. 
Duplicate 20 ml samples of culture broth were taken at mid- log ( 6  h) and stationary 
phase (24 h) and pelleted by centrifugation (15 min, 3,000 rpm) in pre-weighed, pre-dried 
centrifuge tubes. The supernatant was discarded, before drying the pellets at 90°C until a 
stable dry weight was established. Duplicates showed less than 5% variation. The 
following correlation was generated for E. coli MG1655 grown in glucose minimal media:
1 Unit A6oo = 0.3 g L' 1 dew
2.6.2 G luco se
Residual glucose in clarified fermentation broth was measured using a previously 
described method (Dubois et al., 1956). The assay involves oxidation of the aldehyde 
functional group present in glucose and simultaneous reduction of 3,5-dinitrosalicylic acid 
(DNS) to 3-amino,5-nitrosalicylic acid, under alkaline conditions. Assay reagent was 
prepared by dissolving 16 g NaOH and 10 g dinitrosalicylic acid in -300 ml dH2 0. Then 
300 g sodium potassium tartrate was dissolved in -300 dH2 0 , the two solutions were 
combined, and dH20  was added to a final volume of 1 L.
50pl of filtered sample or standard was added to 100pl of assay reagent (16 g L' 1 sodium 
hydroxide, 10g L' 1 dinitro-salicylic acid and 300 g L' 1 sodium potassium tartrate prepared 
in dH2 0). The mixture was incubated at 100°C for 5 min, cooled on ice, and quenched 
with 1 ml water. The A5 4 0  of each sample or standard was then measured against a 
blank, which was generated with dH20  in place of sample or standard. The standard 
curve is shown in Figure 2.2.
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0.5
y = 0 .0497x-0.0328 
R2 = 0.9985
0.4
2  0.3Nin
0.2
Glucose Concentration, mM
Figure 2.2 Glucose standard curve, generated with 2-fold serial dilutions of 10 mM glucose.
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2 .6 .3  P h o s p h a t e
Phosphate concentration in clarified fermentation broth was measured using a previously 
described method (Baykov et al., 1988). Assay reagent was prepared by adding 60 ml 
conc. sulphuric acid to 300 ml dh^O and cooling to room temperature, before 
supplementing with 0.44 g malachite green. On the day of use 2.5 ml of 7.5% ammonium 
molybdate and 0.2 ml of 11% Tween-20 was added to 10 ml of the dye solution. The 
assay was performed by mixing one volume of the assay reagent with four volumes of 
filtered sample or standard and incubating at room temperature for 10 min.
The A63o of each sample or standard was then measured against a blank, which was 
generated with dH20 in place of sample or standard. The standard curve is shown in 
Figure 2.3.
y = 0 .07 89 x -0.0291 
R2 = 0.9999
o
CO
co
0.6
0.4
Phosphate Concentration, uM
Figure 2.3 Phosphate standard curve, generated with 2-fold serial dilutions of 20 pM 
sodium phosphate.
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2 .6 .4  O r g a n ic  A c id
Organic acids in clarified fermentation broth were measured by high performance liquid 
chromatography (Dionex, www.dionex.com). The Chromeleon software package 
(Dionex) was used for peak integration and quantitation.
20 pl of filtered sample or standard was analyzed on an Aminex HPX-87H organic acids 
column with 5 mM sulphuric acid at a flow rate of 0.6 ml min'1 and a column temperature 
of 60°C. The organic acids were detected at 215 nm using a UV detector. Standards of a- 
ketoglutarate, pyruvate, succinate, lactate, formate and acetate were used to quantify 
sample peaks. Figure 2.4 shows the relative elution times of the standard compounds. 
Standard curves are shown in Figure 2.5, A-C.
A sample of sterile culture media identified that uracil, thymidine and IPTG were the only 
media components and supplements detectable by this method.
1.000-
Figure 2.4 A typical chromatogram showing the relative elution times of a-ketoglutarate, 
pyruvate, succinate, lactate, fumarate, formate and acetate. The peaks represent 10 mM 
concentrations of aketoglutarate and pyruvate, and 100 mM concentrations of succinate, 
lactate, formate and acetate.
63
Chapter 2: Materials and Methods
B
y = 25.436X + 2.8389 
R2 = 0.9987
S 200
CL 100
<D 100
y = 22.525x + 2.7436 
R2 = 0.9985
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y = 1.4444X + 2.2552 
R2 = 0.9993
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R2 = 0.9999
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c
Figure 2.5 Organic acid standard curves generated by 2-fold serial dilutions of 10 mM a- 
ketoglutarate and pyruvate (A), 100 mM succinate and lactate (B), and 100 mM formate and 
acetate (C).
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2.6.4.1 Id e n t if ic a t io n  o f  F u m a r a t e  P ea k
To identify an unknown peak on sample chromatograms a range of compounds, 
including malate, citrate, fumarate and acetoin were tested. The elution time of fumarate 
closely matched that of the unidentified peak. To confirm that the identity of the sample 
peak was fumarate, 5 units of fumarase, which converts fumarate to malate, was added 
to 500 pl supernatant and analysed by HPLC. The putative fumarate peak was reduced 
by approx. 50%, shown in Figure 2.6, which positively confirmed its identity. A fumarate 
standard curve, shown in Figure 2.7 was used for quantification.
12.0 15.0 16.0 17.0
Figure 2.6 Chromatogram showing fumarate peak in clarified fermentation broth. The peak 
is reduced by approx. 50% after the addition of fumarase, which converts fumarate to malate.
500
y = 381.22x + 0.4119 
R2 = 0.999
400 |
100 I
0.2 0.6 0.80.4
Fumarate Concentration, mM
4  Fumarate
Figure 2.7 Fumarate standard curve generated with 2-fold serial dilutions of 1 mM fumarate.
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2.6 .5  T o ta l  P ro te in
Total cellular protein was measured using a previously described method (Bradford, 
1976). The principle of the assay is based on the absorbance shift from 465 -  595 nm 
that occurs when coomassie blue binds to proteins in acidic solution.
2.6.5.1 S a m p l e  P r e p a r a t io n
Crude cell extracts for analysis were prepared as follows. Cell pellets, harvested from 1 
ml fermentation broth, were washed twice with 0.5 ml washing buffer (10 mM sodium 
phosphate, pH 7.5; 10 mM magnesium chloride, 1 mM EDTA) before resuspending in 0.5 
ml of the same buffer. Subsequently, the cells were disrupted by sonication (5 cycles of 
10 s on, 10 s off, 6 microns) whilst immersed in an ice bath. Cell debris was pelleted by 
centrifugation (10 min, 14,000 rpm, 4°C) and the extracts recovered into clean 1.5 ml 
tubes. Extracts were placed on ice prior to analysis.
2.6.5 .2  A s s a y  P r o c e d u r e
The assay was performed by mixing 20 pl sample/standard with 1 ml Bio-Rad solution 
(diluted 1 in 5 with dH20), and incubating at room temperature for 5 min. The absorbance 
at 595 nm was measured and used to calculate total protein from the standard curve.
A standard curve, shown in Figure 2.8, was generated with 2-fold serial dilutions of 
bovine serum albumin (BSA).
0.4
0.35 y = 1.4111x -0.0077 
R2 = 0.9989
in 0.25
05in _ „
0.05 I 0.15 
Protein, mg ml'
0.2 0.25 0.3
Figure 2.8 Total protein standard curve, generated with 2-fold serial dilutions of bovine 
serum albumin.
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2.6.6 P h o sph o tr a n sa c etyla se  & A ceta te  K in a se  En zym e  A c tivity
The activity of phosphotransacetylase and acetate kinase were measured in the forward 
direction (towards acetyl CoA) using a previously described method (Brown et al., 1977). 
The coupled reactions for each assay are shown below. p-NADH formation was 
measured at 340 nm in a Biomate 3 spectrophotometer (Thermospectronic).
Phosphotransacetylase:
Phosphotransacetylase
Acetyl + Co A M— ► Acetyl Co A + P
phosphate
Malate dehydrogenase 
Malate + NAD M— ► Oxaloacetate + NADH
Citrate synthase
Oxaloacetate + Acetyl Co A — ► Citrate + Co A
Acetate Kinase:
Acetate Kinase
Acetate ATP Acetyl ADP
— ► phosphate +
Phosphotransacetylase
Acetyl + Co A M — ► Acetyl Co A + P
phosphate
Malate dehydrogenase 
Malate + NAD ^ — ► Oxaloacetate + NADH
Citrate synthase
Oxaloacetate + Acetyl Co A A — ► Citrate + Co A
2.6.6.1 A s s a y  R e a g e n t s
The reagents for phosphotransacetylase and acetate kinase enzyme activity assays are 
detailed in table 2.5 and table 2.6. A 10X assay buffer was prepared with Tris-HCI pH
8.0, MgCb and malate, and stored at 4°C. Coupling enzymes were purchased as 
ammonium sulphate suspensions and stored at 4°C. The remaining components were 
prepared as concentrated stocks and stored in aliquots at -20°C. The reagents were 
thawed and combined immediately prior to sample analysis as several of the reagents 
degrade rapidly.
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Table 2.5 Reagents for phosphotransacetylase enzyme activity assays
Reagent Stock Cone., mM 
(unless otherwise stated)
Working Cone., mM 
(unless otherwise stated)
Buffer
Tris-HCI pH 8.0 500 50
Magnesium Chloride 50 5
L-Malate 100 10
Intermediates
Co Enzyme A 50 1
Nicotinamide Adenine 100 10
Dinucleotide (NAD)
Coupling Enzymes
Citrate Synthase 1.5 Units pl'1 10 Units ml'1
(porcine heart)
Malate Dehydrogenase 5 Units pl'1 10 Units ml'1
(porcine heart)
Substrate
Acetyl Phosphate 1000 10
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Table 2.6 Reagents for acetate kinase enzyme activity assays
Reagent Stock Cone., mM 
(unless otherwise stated)
Working Cone., mM 
(unless otherwise stated)
Buffer
Tris-HCI pH 8.3 500 50
Magnesium Chloride 50 5
L-Malate 100 10
Intermediates
Co Enzyme A 50 1
Nicotinamide Adenine 100 10
Dinucleotide (NAD)
Adenosine triphosphate (ATP) 600 1
Coupling Enzymes
Citrate Synthase 1.5 Units pl'1 10 Units ml'1
(porcine heart)
Malate Dehydrogenase 5 Units pl'1 10 Units ml'1
(porcine heart)
Phosphotransacetylase 1 Unit pl'1 1 Unit ml'1
(Methanosarcina thermophila)
Substrate
Sodium Acetate 1000 300
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2.6 .6 .2  S a m p l e  P r e p a r a t io n
Crude cell extracts were prepared as described in section 2.6.5.1 and assayed 
immediately for enzyme activity.
2.6 .6 .3  E n z y m e  A c t iv it y  M e a s u r e m e n t  a n d  A n a l y s is
Enzyme activity assays were performed at room temperature, in quartz cuvettes with a 1 
ml volume and 1 cm path length. Total assay volume was 1 ml, consisting of 100 pl cell 
extract and 900 pl assay mix.
For each sample, assay reagents were mixed gently in the cuvette and incubated at 
room temperature for 2 min to allow the NADH-forming reaction to reach equilibrium. 100 
pl cell extract was then added and mixed by gentle inversion, before placing the cuvette 
in the spectrophotometer and measuring the change in A 3 4 0 as a function of time. The 
maximum slope was recorded. A control of purified enzyme was run with each assay. 
Samples were assayed in duplicate.
To determine enzyme activity from the maximum slope the following equation was used: 
Units of Enzyme Activity = (Maximum slope/ 6.22)*10
where 6.22 is the molar extinction coefficient of NADH at 340 nm.
One unit of enzyme activity is defined as that amount of enzyme which catalyses the 
formation of 1 pmole of NADH per min, per ml of cell extract. Specific activity is 
expressed as units per mg of protein.
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2.7 C a lc u la tio n s
2.7.1 Specific G rowth Rate
The specific growth rate for batch cultures was calculated by plotting a scatter graph of 
time vs. ln(OD6oo), and using Microsoft Excel to draw a line of best fit through the data 
points corresponding to exponential growth phase. The gradient of the line was 
calculated by Excel, and quoted as the specific growth rate of the culture. Standard error 
of the growth rate was calculated using the ‘LINEST’ function in Excel.
2.7.2  S u b s tra te  Uptake I P roduct Formation R ates
The substrate uptake and product formation rates were calculated by plotting a scatter 
graph of time vs. substrate concentration and using Excel to draw a line of best fit 
through the data points. The gradient of the line, which corresponded to the substrate 
uptake or product formation rate, was calculated by Excel. Standard error of the line was 
calculated using the ‘LINEST’ function in Excel.
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Chapter 3: E. coli MG1655 Growth Studies
3.1 S u m m a r y
This chapter describes growth studies that were conducted with E. coli MG1655 prior to 
the main body of experimentation. E. coli MG1655 was selected for use in this research 
due to availability of the complete genome sequence for the strain (Blattner et al., 1997), 
which was useful for antisense RNA design and metabolic modelling.
The objective of the growth studies was to optimise media composition and inoculation 
regime for shake flask experiments. Several studies were performed, however four time- 
course analyses form the basis of this chapter. The first study compared growth of E. coli 
MG1655 in M9 minimal media, a well-established defined media, with growth in nutrient 
broth. The second study examined the effect of plasmid pTrc99A on growth rate of the 
host cell. The third study aimed to determine the effect of uracil and thymidine 
supplements on growth of E. coli MG1655 in minimal media. The fourth study optimised 
the inoculum regime for shake flask fermentations and analysed glucose uptake and 
acetate excretion from the strain.
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3.2 Ba c k g r o u n d
3.2.1 E. c o l i  P hysiology
E. coli is a member of the family Enterobacteriaceae (Neidhardt et a i, 1987). It is a 
Gram-negative bacteria, whose cells are rod-shaped and approximately 2 pm long and 1 
pm in diameter (Voet and Voet, 1995). In nature E. coli can be found colonising the lower 
gut of animals and as a facultative anaerobe, survives when released into the 
environment, allowing widespread dissemination to new hosts. Pathogenic strains are 
responsible for infections of the enteric, urinary, pulmonary and nervous systems. For 
many years now this small microbe has been the preferred model organism in 
biochemical genetics, molecular biology and biotechnology (Blattner et a!., 1997). It is 
widely used for microbiological research because it is easily accessible, not highly 
virulent and grows readily on defined media (Neidhardt et a/., 1987).
E. coli can synthesise their constituents from a single organic compound and a few 
minerals. They exhibit very efficient energy expenditure, only synthesising what they 
require. The richer array of nutrients available the faster they grow (Neidhardt et al., 
1987). E. coli have evolved a complex set of control mechanisms that sense the external 
and internal milieu, which operates very fast and allows them to adapt to a constantly 
changing environment. This is expected from organisms that must compete with others 
for their food source. Demands from selective pressure for efficiency and adaptability 
have resulted in a complex regulatory network. Many proteins have not only an 
enzymatic or controlling function but also regulate their own synthesis (Neidhardt et al., 
1987).
3.2.2 In d u s tr ia l E. c o l i  Ferm entation
E. coli is extensively used in the biotechnology industry as a host for recombinant protein 
production. There are several advantages of using E. coli for this purpose. Firstly, it has a 
rapid growth rate, which results in efficient production of biomass. Secondly, there is 
extensive understanding of its genetics and physiology, which allows for directed 
pathway modification. In addition, there are more genetic engineering tools and 
procedures available for E. coli than for any other organism (Blanch and Clark, 1996). 
However, there are also disadvantages of using E. coli. These are largely involved with 
the expression of eukaryotic proteins. E. coli does not readily glycosylate proteins or form 
disulphide bonds, which are post-translational modifications performed by eukaryotic 
cells. Also, eukaryotic proteins overproduced in E. coli typically form inclusion bodies
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which require solubilization and subsequent refolding of the resultant protein. This is a 
complicated procedure, and in most cases the recover of biologically active proteins is 
incomplete (Blanch and Clark, 1996). Another problems is that E. coli does not normally 
secrete proteins, although new strategies have been developed to achieve secretion, 
which will ease product isolation. Another factor to be considered is the removal of 
endotoxins, which need to be removed from food and health-care products (Blanch and 
Clark, 1996).
3.2.3 E.cou MG1655
E. coli was the first organism to be selected as a candidate for whole-genome 
sequencing (Blattner et al., 1997). MG1655 was chosen as the strain to sequence 
because it has been maintained as a wild-type strain with minimal genetic manipulation 
(Blattner et al., 1997). The genome of E. coli consists of 4,639,221 bp of circular duplex 
DNA. Protein-coding genes account for 87.8% of the genome, 0.8% encodes stable 
RNAs and 0.7% consists of non-coding repeats, leaving -11%  for regulatory and other 
functions (Blattner et al., 1997). The annotated genome sequence (accession number 
U00096) is available at the National Centre for Biotechnology Information (NCBI) through 
Entrez Genomes division, and GenBank (Blattner et al., 1997).
E. coli MG 1655 is a derivative of the Lederberg strain W1485, which arose from the 
original E. coli K-12 strain after treatment with UV light (Jensen, 1993). It has been used 
as a genetic background for characterising the phenotypes of several RNA polymerase 
mutations, for studies on the control of ribosome synthesis, as the host for a collection of 
Tn10 insertions to facilitate genetic mapping, for total genome sequencing, and as a 
control strain in many experiments involving DNA replication of E. coli growing without 
thymidine (Molina eta!., 1998).
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3.3 C o m pa r iso n  o f C ell G row th  in M9 M in im a l  M edia  a n d
N u tr ien t  B roth
3.3.1 O b je c t iv e
The objective of this study was to compare the growth kinetics of E. coli MG1655 in M9 
minimal media and nutrient broth.
3.3.2 Expe r im e n ta l  Co n d itio ns
The experimental conditions for this study are shown in Table 3.1.
Table 3.1 Experimental conditions for comparing cell growth in M9 minimal media and
nutrient broth.
Strain E. coli MG1655
Media a) M9 minimal media, 4 g L'1 glucose
b) Nutrient broth
Growth mode Batch, 2 L shake flask (250 ml working volume)
Inoculum 1 ml glycerol cell stock
Temperature 37°C
Shaker rpm 200
Sampling times, hours 0, 1, 2, 3, 4, 5, 6, 7, 8 and 24.
Experimental duplication Each media was tested independently two times
3.3.3 Results  a nd  D iscussio n
The growth of E. coli MG 1655 in M9 minimal media and nutrient broth was compared in 
shake-flask cultures over a 24 h time-course. The profiles of OD6oo are shown in Figure
3.1. Maximum specific growth rates and maximum OD6oo are shown in Table 3.2. The 
results show that maximum specific growth rate is more than two-fold higher in cultures 
grown in nutrient media compared to M9 minimal media. This difference was expected 
due to the presence of complex ready-made nutrients such as amino acids in nutrient 
broth, which the cells can quickly utilise. In contrast, when cultured in M9 minimal media 
the cells must synthesise all their constituents from glucose, ammonia and a few 
minerals, resulting in a slower growth rate.
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Figure 3.1 Time-course profiles of cell growth for E. coli MG1655 cultured in a) glucose 
minimal media, and b) nutrient broth. Recombinant cells were grown in 2 L baffled flasks 
containing 250 ml medium at 37°C, 200 rpm. Duplicate analyses were performed for each 
sample; average values of the duplicates are reported.
Table 3.2 Maximum specific growth rates and maximum OD6oo from growth studies of E. 
coli MG 1655 in M9 minimal media and nutrient broth
Media M m a x ( h  ) Maximum ODeoo
M9 Minimal Media 0.43 3.2
Nutrient broth 1 .1 4.5
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3.4 E f fe c t  o f  Plasm id p T rc9 9 A  on G ro w th  o f  E. co li 
MG1655
3.4.1 O b je c t iv e
The objective of this study was to determine if plasmid pTrc99A, to be used for antisense 
RNA expression, caused a reduction in growth of E. coli MG1655 cultured in M9 minimal 
media.
3.4.2  E x p e r im e n ta l C o n d itio n s
The experimental conditions for this study are shown in Table 3.3.
Table 3.3 Experimental conditions for testing the effect of plasmid pTrc99A on the growth
of E. coli MG1655.
Strains E. coli MG 1655,
E. coli MG 1655(pTrc99A)
Media M9 minimal media, 4 g L'1 glucose, 100 pg ml'1 ampicillin*
Growth mode Batch, 2 L shake flask (250 ml working volume)
Inoculum 10 ml overnight culture, constructed from 10-4 dilution of glycerol 
cell stock.
Temperature 37°C
Shaker rpm 200
Sampling times, hours 0, 2, 4, 6, 8 and 24.
Experimental duplication Each media was tested independently two times
* For plasmid-harbouring strain
3.4.3 R e s u lts  and  D iscuss ion
The effect of plasmid pTrc99A on growth of E. coli MG 1655 in M9 minimal media was 
studied in 2 L shake-flasks. The profiles of O D 6oo are shown in Figure 3.2. Maximum 
specific growth rates and maximum O D 6oo are shown in Table 3.4. Results show that 
maximum specific growth rate of the host cell is not impaired by the presence of plasmid 
pTrc99A. Colony counts from selective and non-selective nutrient agar plates indicated 
that the plasmid was stably maintained in the host cell over 24 h (data not shown).
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Figure 3.2 Time-course profiles of cell growth for E. coli MG1655 and E. coli MG1655 
(pTrc99A). Recombinant cells were cultured in 2 L baffled flasks containing 250 ml M9 
medium with 0.4% (wt/vol) glucose at 37°C, 200 rpm. Duplicate analyses were performed for 
each sample; average values of the duplicates are reported.
Table 3.4 Maximum specific growth rates and maximum OD60o from growth studies of E. 
coli MG 1655 and E. coli MG1655(pTrc99A) in 2 L shake flasks.
Strain M m a x (h  ) Maximum ODeoo
E. coli MG 1655 0.56 2.1
E. coli MG 1655(pTc99A) 0.57 2.0
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3.5 E f fe c t  o f  U r a c il  and Thymidine Supplem ents on 
G ro w th  o f  E. c o li M G 1655 in M 9 Minim al M edia
3.5.1 O b jec tive
The objective of this study was to determine if uracil and thymidine supplements increase 
the growth rate of E. coli MG1655 in M9 minimal media. Uracil is a pyrimidine base that is 
incorporated into RNA and thymidine is a nucleoside that is incorporated into DNA. Both 
are essential for cell growth and replication. It has previously been reported that E. coli 
MG1655 may require uracil and thymidine supplements in minimal media for optimal 
growth (Jensen, 1993; Molina etal., 1998).
3.5.2 Ex per im en ta l  C o n d itio ns
The experimental conditions for this study are shown in Table 3.5.
Table 3.5 Experimental conditions for testing the effect of uracil and thymidine 
supplements on growth of E. coli MG1655 in M9 minimal media.
Strain E. coli MG1655(pTrc99A)
Media M9 minimal media, 5 g L'1 glucose, trace element mix, 100 pg ml'1 
ampicillin.
Uracil was added at 20 pg ml'1 and thymidine at 5 pg ml'1.
Growth mode Batch, 2 L shake flask (250 ml working volume)
Inoculum 10 ml starter culture, constructed from 10"4 dilution of glycerol cell 
stock.
Temperature 37°C
Shaker rpm 200
Sampling times, hours 0, 1,2, 3, 4, 5, 6, 7, 8, 9, 10 and 24.
3.5.3 R e s u lts  and  D iscuss ion
The results of Jensen (1993) showed that the growth of E. coli MG 1655 in minimal media 
was 10 to 15% higher in the presence of uracil than in the absence of exogenous 
pyrimidines. Their investigation concluded that E. coli K-12 strains MG1655 and W3110 
starve for pyrimidine in minimal media due to a suboptimal content of the pyrimidine 
biosynthetic enzyme orotate phosphoribosyltransferase (pyrE). This defect is caused by
8 0
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a frameshift mutation in the rph-pyrE operon (Jensen, 1993).
Molina et al. (1998) reported that E. coli MG 1655 has a partial Thy- phenotype and 
requires 5 pg ml"1 thymidine for optimal cell growth. Thy- strains do not have impaired 
growth rates, but chromosome replication time is affected resulting in changes in DNA-to- 
mass ratio and cell composition.
The effect of uracil (20 pg ml "1) and/or thymidine (5 pg ml "1) on growth of E. coli 
MG1655 in M9 minimal media was studied in 2 L shake-flasks. Time-course profiles of 
O D 6oo are shown in Figure 3.3 and maximum specific growth rates are compared in 
Table 3.6. The results show a 15% increase in maximum specific growth rate of E. coli 
MG1655 cultured in M9 minimal media supplemented with 20 pg ml "1 uracil, compared to 
the same strain grown without uracil addition. As expected, thymidine addition to M9 
minimal media does not result in a noticeable increase in maximum specific growth rate, 
but will be included in M9 minimal media for future experiments to ensure optimal cell 
growth. Our results agree with the findings of Jensen (1993) and Molina etal. (1998).
Increasing the supplement concentrations two-fold (40 pg ml"1 uracil, 10 pg ml"1 
thymidine) resulted in no further increase in growth rate (data not shown).
Table 3.6 Maximum growth rates of E. coli MG1655 grown in M9 minimal media with uracil
and/or thymidine supplements.
Supplement(s) M max (h )
No supplements 0.71
20 pg ml"1 uracil 0.82
5 pg ml'1 thymidine 0.73
20 pg ml'1 uracil + 5 pg ml"1 thymidine 0.81
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Figure 3.3 Time-course profiles of cell growth for E. coli MG1655 harbouring pTrc99A. 
Recombinant cells were cultures in 2 L baffled flasks containing 250 ml M9 medium with 0.5% 
(wt/vol) glucose at 37°C, 200 rpm. The effect of uracil and thymidine on cell growth was 
tested by supplementing individual E. coli cultures with a) 20 pg ml'1 uracil, b) 5 pg ml'1 
thymidine and c) 20 pg ml'1 uracil and 5 pg ml'1 thymidine. The growth of these cultures was 
compared with the growth of E. coli without uracil or thymidine supplements.
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3.6 O ptim isa tio n  of S h a k e -F la sk  Fer m en ta tio n
P ro c edu r es
3.6.1 O bjec tive
The objective of this study was to optimise the procedures for shake flask fermentation 
with respect to media composition and an inoculation regime.
3.6.2 Exper im e n ta l  C o n d itio ns
The experimental conditions for this study are shown in Table 3.7.
Table 3.7 Experimental conditions for optimising shake-flask fermentations
Strain E. coli MG1655(pTrc99A)
Media M9 minimal media, 10 g L'1 glucose, trace element mix, 20 pg ml'1 
uracil, 5 pg ml'1 thymidine, 100 pg ml'1 ampicillin..
Growth mode Batch, 2 L shake flask (250 ml total working volume)
Inoculum 10% (v/v) overnight culture, inoculated from a colony on a fresh 
selective nutrient agar plate.
Temperature 37°C
Shaker rpm 200
Sampling times, hours 0, 1,2, 3, 4, 5, 6, 7, 8, and 24.
3.6.3 R e s u lts  and  D iscuss ion
The results presented here show an ‘optimised’ shake-flask fermentation of E. coli 
MG1655(pTrc99A) cultured in M9 minimal media. Figure 3.4 shows a profile of growth, 
glucose uptake and acetate excretion under the above conditions. These conditions were 
formulated by a series of experiments to shorten the lag phase, capture the exponential 
phase within the working day and ensure glucose was not limiting for the duration of the 
fermentation.
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Figure 3.4 Time-course profile of cell growth, residual glucose concentration and acetate 
concentration in E. coli MG1655 harbouring pTrc99A. Recombinant cells were cultured in a 2 
L baffled flask containing 250 ml of M9 medium with 1% (wt/vol) glucose at 37°C, 200 rpm. 
Duplicate analyses were performed for each sample; average values of the duplicates are 
reported.
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3.7 D isc u ssio n  a n d  C o n c lu sio n s
This chapter described the shake flask studies that were performed in order to optimise 
growth of E. coli MG1655 in glucose minimal media. Four experiments were performed, 
which investigated: A) the maximum specific growth rate and biomass levels that were 
achieved in nutrient broth compared with glucose minimal media; B) the impact of empty 
expression vector pTrc99A on cell growth rate; C) the effect of strain-specific 
supplements uracil and thymidine on maximum specific growth rate; and D) optimisation 
of general shake-flask fermentation procedures.
The results from these studies showed that the presence of expression vector pTrc99A 
did not impair cell growth. Furthermore, the addition of 20 pg ml'1 uracil to M9 minimal 
media increased the maximum cell growth rate by 15%. In addition, it was established 
that inoculating shake flask cultures with a 10% (v/v) overnight culture, instead of directly 
from a glycerol cell stock, shortened the lag phase and enabled the exponential growth 
phase to be analysed during the working day. Finally, the concentration of glucose added 
to M9 minimal media was increased from 5 g L'1 to 10 g L'1 to ensure that glucose was 
not limiting throughout the fermentation. It was important to ensure that glucose in the 
culture medium was not depleted during the course of a 24 h fermentation, because in 
the absence of another carbon source it is likely that E. coli would re-consume excreted 
acetate from the culture medium. Under these conditions, it would be difficult to establish 
the total amount of acetate that was produced by E. coli in each experiment. 
Reconsumption of acetate would also alter the flow of carbon through central metabolism 
and lower the cell growth rate.
The minimal media used in this research comprised 10 g L 1 glucose as a carbon source 
and 1 g L'1 ammonium chloride as a nitrogen source. Due to the composition of E. coli 
cells, and the ratio of carbon to nitrogen in the minimal media, it was established that 
ammonium chloride would be depleted before glucose. Therefore, nitrogen availability 
would limit the maximum cell density that could be achieved by E. coli cultures in this 
study. It would be possible to increase the concentration of ammonium chloride, along 
with the concentration of calcium and magnesium salts if it was required to grow E. coli to 
a high cell density, however for the purposes of this study that was not necessary.
Subsequent physiological studies in this research, which are presented in Chapter 5, 
were conducted using the media composition and cultivation procedures that were 
determined by the experiments described in this chapter.
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4.1 S u m m a r y
In E. coli, the majority of acetate is produced via the ackA-pta pathway. It is comprised of 
two enzyme-catalysed reactions, which convert acetyl CoA into acetate. In the first step, 
acetyl CoA is converted to acetyl phosphate by phosphotransacetylase (pta) and in the 
second step, acetyl phosphate is converted to acetate by acetate kinase (ackA). 
Inactivating the ackA-pta pathway in E. coli abolishes production of the intermediary 
compound acetyl phosphate, which has been implicated in a range of important cellular 
functions (refer to section 1.1.1). Furthermore, ackA-pta deletion mutant’s exhibit reduced 
growth rates in glucose-supplemented media. Therefore, this research proposed to use 
antisense RNA as a flexible metabolic engineering tool to partially downregulate 
expression of the pta and ackA genes, and study the effects on E. coli central 
metabolism before and after induction of antisense RNA.
This chapter describes the development of E. coli strains to express antisense RNA 
targeted against phosphotransacetylase and acetate kinase. The expression vector 
pTrc99A was used to develop two plasmids, one with inducible expression of pta 
antisense RNA and one with inducible expression of ackA antisense RNA. In addition, 
the expression vector pMMB66EH, which is compatible with pTrc99A-derived plasmids, 
was used to construct a second plasmid with inducible expression of ackA antisense 
RNA. The plasmids were designed to facilitate individual expression of pta and ackA 
antisense RNA, and co-expression of antisense RNA targeted against both the pta and 
ackA genes simultaneously.
Antisense RNA oligonucleotides were designed to basepair with a short region (-200 
nucleotides) of the target mRNA, encompassing the ribosome binding site and translation 
initiation site. This strategy aims to block ribosome binding and prevent translation of the 
target mRNA, and is generally thought to be the most effective in suppressing expression 
of target genes. Gene fragments for antisense RNA expression were placed under the 
control of the inducible trc and tac promoters on the pTrc99A and pMMB66EH plasmids 
respectively. This allowed conditional expression of antisense RNA during E. coli 
fermentation by addition of IPTG to the culture medium.
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4.2 B a c k g r o u n d
The acetate kinase (ackA) and phosphotransacetylase (pta) genes from E. coli have 
been cloned and sequenced, and were found to encode proteins of 400 and 714 amino 
acids respectively (Kakuda et al., 1994; Matsuyama et al., 1989; Yamamoto-Otake et al., 
1990). In the following pages the ackA and pta genes, mRNA transcripts and 
corresponding proteins are described, and the targets for antisense RNA binding are 
highlighted.
4.2.1 The a c k A -p ta  O peron  in E. c o l i
In E. coli, the genes ackA and pta are organised in the order ackA-pta in an operon 
(Kakuda et al., 1994), which is illustrated in Figure 4.1. Two mRNA transcripts of different 
sizes are produced from the operon. The largest is a 3,700-nucleotide transcript, which is 
produced from the first promoter (P-i), and encompasses both the acetate kinase and 
phosphotransacetylase genes. The smaller transcript, which is 2,300 nucleotides long, is 
produced from the second promoter (P2). It encodes only the phosphotransacetylase 
gene. The ackA and pta genes are regarded as constitutively expressed, although the 
fine structures and regulation of the two promoters remain largely unknown. Putative 
Shine-Dalgarno sequences have been identified in both genes and are highlighted in 
Figure 4.1.
MG1655 pta
Pi
rbs
<  •
240 base ackA antisense RNAj
P2
1  ■ S ' ------------------------
M  •
200 base pta antisense RNA
rbs
200 base pta antisense RNA
MG1655
3,700 base mRNA
2,300 base mRNA
Figure 4.1 Structure of the ackA-pta operon (not drawn to scale). Two mRNA transcripts of 
different sizes are produced: a 3,700 nt mRNA transcribed from both the ackA and pta genes; 
and a 2,300 nt mRNA transcribed from just the pta gene. Antisense RNA oligonucleotides 
have been designed to basepair with a region encompassing the putative ribosome binding 
site and translation initiation site on the ackA and pta mRNA targets, as illustrated above.
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4.2.2 Phosphotransacetylase (EC 2.3.1.8)
E. coli phosphotransacetylase is a 77 kD enzyme which catalyses the reversible 
conversion of acetyl CoA to acetyl phosphate (Kakuda et al., 1994), (Figure 4.2). It has 
been purified from E. coli B and shown to be an allosteric enzyme which is activated by 
pyruvate and inhibited mainly by NADH (Shimizu et al., 1969; Suzuki, 1969). ADP and 
ATP also inhibit the enzyme, but their inhibitory strengths were found to be only one- 
quarter and one-tenth of NADH, respectively.
Structural analysis of the 714 amino acid E. coli phosphotransacetylase protein revealed 
that it contains a 350 amino acid fragment that is not required for phosphotransacetylase 
activity (Galperin and Grishin, 2000). Phosphotransacetylases from most other 
organisms consist of approximately 350 amino acid residues, corresponding to the C- 
terminal part of the E. coli enzyme. Sequence analysis of the additional N-terminal 
fragment from E. coli phosphotransacetylase revealed its similarity with the enzymes 
dethiobiotin synthetase, cobyrinic acid a,c-diamide synthase CobB, cobyric acid synthase 
CobQ and MinD, an ATPase involved in regulation of bacterial cell division (Galperin and 
Grishin, 2000). However, mutations in a possible ATPase sequence in the N-terminal 
fragment of E. coli phosphotransacetylase mean that it is most likely to be devoid of 
catalytic activity. Therefore, the function of this N-terminal domain was suggested to be 
regulation of phosphotransacetylase activity, possibly in response to the intracellular ATP 
level.
4.2.3 A ce ta te  Kinase (EC 2.7.2.1)
E. coli acetate kinase is a 40 kDa protein, comprising 400 amino acids, which catalyses 
the reversible conversion of acetyl phosphate to acetate (Fox and Roseman, 1986a), 
(Figure 4.2). ackA mutants still excrete acetate, therefore It is likely that acetyl phosphate 
can undergo non-enzymatic hydrolysis, which occurs rapidly at 37°C, and form acetate 
even in the absence of acetate kinase (Brown et al., 1977).
O O
O
pta ackA
*■ h3c
o
Acetyl CoA Acetyl Phosphate Acetate
Figure 4.2 The ackA-pta pathway in E. coli.
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4.3 P lasm id  C o n str u c tio n
In total, seven novel plasmids were constructed in this work. Four intermediary plasmids 
(pQR438, pQR440, pQR444, pQR445) were developed in order to produce a pta 
antisense RNA expression vector (pQR439), and two ackA antisense RNA expression 
vectors (pQR441, pQR446). The component parts of the plasmids are listed and 
described in Table 4.1.
Table 4.1 Plasmid component definitions
Plasmid Component Description
P Ire trc promoter
P lac tac promoter
mcs Multiple cloning site
rrnBT1T2 Transcription termination signal
pBR322 ori Origin of plasmid replication from plasmid pBR322: Includes all genes 
and sites necessary for a plasmid to replicate in E. coli.
RSF 1010 ori Origin of plasmid replication from plasmid RSF 1010: Includes all 
genes and sites necessary for a plasmid to replicate in E. coli.
pUC ori Origin of plasmid replication from plasmid pUC: Includes all genes and 
sites necessary for a plasmid to replicate in E. coli.
lac lq lac lq repressor for strong inhibition of transcription from the trc or tac 
promoters in the absence of inducer, i.e. 1 mM IPTG
antisense pta DNA fragment of the pta gene
antisense ackA DNA fragment of the ackA gene
Ampr Ampicillin resistant
Kanr Kanamycin resistant
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4.3.1 Development o f a C o n s tru c t fo r  p ta  Antisense RNA 
Expression
4.3.1.1 PQR439
Plasmid pQR439 was developed to express antisense RNA targeted against E. coli 
MG1655 pta mRNA. Using E. coli MG1655 chromosomal DNA as a template, a 200 bp 
fragment of the 2,141 bp pta gene, encompassing the putative ribosome binding site and 
extending into the open reading frame, was amplified by PCR (Figure 4.3). The PCR 
primers were designed to introduce restriction sites at the 5’ and 3’ ends of the amplified 
gene fragment, to facilitate cloning of the PCR product into expression vector pTrc99A in 
an antisense orientation. The forward primer (5’-GCAAGCTTCGAAAGAGGATAAACCG- 
3’) introduced a Hind\\\ restriction site onto the 5’ end of the pta gene fragment, and the 
reverse primer (5’-CGCTTAAGTGGAAGAGTTCGCACGC-3’) introduced an EcoRI 
restriction site onto the 3’ end of the pta gene fragment. In total, the PCR product was 
216 bp in length.
To ensure there was no significant chance of pta antisense RNA binding to other mRNAs 
transcribed from the E. coli genome, the antisense strand of the pta gene fragment was 
screened against the complete genome sequence of E. coli MG1655 using the BLASTn 
homology search (available at www.ncbi.nlm.nih.gov/BLAST/). The results showed that 
the pta gene fragment had no significant homology with any other areas of the E. coli 
MG1655 genome.
5’ C T G C C T G A T T  T C A C A C G C C A  G C T C A G C TG T  G T G T T T T G T A  A C C C G C C A A A
T C G G C G T T A A  CGAAAGAGGA TAAACCGTGT CCCG TATTAT TATGCTGATC  
_________rbs____________ ^Translation start site
pta forward primer
CCTACCGGAA CCAGCGTCGG TCTGACCAGC GTAGCTTGGC GTGATCCGTG  
CAATGGAACG CAAAGGCGTT CGTCTGAGCG TTTTCAAA CC TATCGCTCAG  
CCGCGTACCG GTGGCGATGC GCCGATCAGA CTACGACTAT CGTGCGTGCG
M----------
pta reverse primer
A A CTCTTC CA CCACGACGGC CGCTG AACCG  C TG A A A A TG A  G C T A C G TT G A  3’
Figure 4.3 Partial DNA sequence of the E. coli MG1655 pta gene. The 200 bp gene 
fragment amplified by PCR is highlighted in bold, and the location for primer binding is shown, 
in relation to the pta ribosome-binding site and translation start site.
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The PCR-amplified pta gene fragment was ligated into cloning vector pCR2.1-TOPO, 
forming pQR438. E. coli TOP10 was transformed with the ligation mixture. Colonies of E. 
coli TOP10 harbouring pQR438 were identified by antibiotic selection and blue-white 
colour screening, followed by restriction analysis of the purified plasmid. In addition, a 
section of plasmid pQR438, encompassing the DNA insert, was sequenced to ensure 
that the plasmid contained the correct DNA insert i.e. the pta gene fragment.
Subsequently, the pta gene fragment was excised from pQR438 by EcoR\/Hind\\\ double 
digestion and gel purified, prior to ligating in antisense orientation into the multiple cloning 
site of expression vector pTrc99A, forming pQR439 (Figure 4.5). The ligation mixture was 
used to transform E. coli DH5cr. Restriction analysis of isolated pQR439 was performed 
to confirm presence of the pta gene fragment (Figure 4.4). E. coli MG 1655 was 
transformed with pQR439 for pta antisense RNA expression studies.
1 2 3
1000 bp
500 bp
300 bp 
200 bp
100 bp
Figure 4.4 TBE agarose gel (2%) of pQR439 following EcoRI//-//nc/lll digestion. Lane 1, 100 
bp ladder comprising DNA fragments of 100, 200, 300, 400, 500, 517, 600, 700, 800, 900, 
1000, 1200 and 1517 bp; Lane 2, pQR439 undigested; Lane 3, pQR439 digested with EcoRI 
and Hind\\\. Agarose gel electrophoresis was performed at 100 v for approximately 1 h (as 
described in Materials and Methods) and visualised under UV light.
4125 bp plasmid backbone
M  206 bp pta gene fragment
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antisense ptaHincftU EcoRI
lacZa
pUC ori pQR438 
(4147 bp)
Ampr
EcoRI
Hind\ 11
mcs
trc
PTrc99A Amp' 
(4176 bp)/aclq
pBR322 ori
EcoR\/Hind\\\ digestion and EcoRI/H/ndlll digestion and
gel purification of pta gene gel purification of linearised
fragment vector
Ligation of pta gene fragment into mcs of pTrc99A
EcoRI
1
antisense pta Hind\\\
Ptrc rrnBTiT2
PQR439 Amp' 
,ad, (4331 bp)
pBR322 ori
Figure 4.5 Construction of plasmid pQR439, designed to express antisense RNA targeted 
against the E. coli MG1655 pta gene. Relevant restriction sites are shown. Genes and 
plasmids are not drawn to scale.
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4.3.2 D e ve lo p m e n t o f  C o n s t r u c ts  f o r  a c k A  A n tis e n s e  R N A 
E x p re s s io n
4.3.2.1 PQR441
Plasmid pQR441 was developed to express antisense RNA targeted against E. coli 
MG 1655 ackA mRNA. Using E. coli MG 1655 chromosomal DNA as a template, a 240 bp 
fragment of the 1202 bp ackA gene, encompassing the putative ribosome binding site 
and extending into the open reading frame, was amplified by PCR. The PRC primers 
were designed to introduce restriction sites at the 5’ and 3’ ends of the amplified gene 
fragment, to facilitate cloning of the PCR product into expression vector pTrc99A in an 
antisense orientation. The forward primer (5’-GCAAGCTTTATCAATTATAGGTACT-3’) 
introduced a BamHI restriction site onto the 5’ end of the ackA gene fragment, and the 
reverse primer (5’-CGCTTAAGTAGTATTAACGATAAAG-3’) introduced an EcoRI 
restriction site onto the 3’ end of the ackA gene fragment. In total, the PCR product was 
256 bp in length.
To ensure there was no significant chance of ackA antisense RNA binding to other 
mRNAs transcribed from the E. coli genome, the antisense strand of the ackA gene 
fragment was screened against the complete genome sequence of E. coli MG1655 using 
the BLASTn homology search (available at www.ncbi.nlm.nih.gov/BLAST/). The results 
showed that the ackA gene fragment had no significant homology with any other areas of 
the E. coli MG1655 genome.
5’ C G G TG T C A T C  A TG C G C TA C G  C T C T A T G G C T  C C C T G A C G TT  T T T T T A G C C A
C G TA T  C A ATT A T AGGT A C T T  CCATGTCGAG TAAG TTAGTA CTGGTTCTGA
__________________ rbs Translation start site
ackA forward primer
ACTGCGGTAG TTC TTC A C TG  AAATTTGCCA TCATCGATGC AGTAAATGGT  
GAAGAGTACC T TT C T G G T T T  AGCCGAATGT TTCCACCTGC CCGAAGCACG 
TATCAAATGG  AAAATGGACG GCAATAAACA GGAAGCGGCT TTAGGTGCAG  
GCGCCGCTCA CAGCGAAGCG CTCAACTTTA TCG TTAATAC T A T T C T G G C A
M-------------------------------
ackA reverse primer
C A A A A A C C A G  A A C T G T C T G C  G C A G C TG A C T G C T A TC G G T C  A C C G T A TC G T  3’
Figure 4.6 Partial DNA sequence of the E. coli MG1655 ackA gene. The 240 bp gene 
fragment amplified by PCR is highlighted in bold, and the location for primer binding is shown 
in relation to the ackA ribosome-binding site and translation start site.
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The PCR-amplified ackA gene fragment was ligated into cloning vector pCR2.1-TOPO 
forming pQR440. E. coli TOP10 was transformed with the ligation mixture. Colonies of E. 
coli TOP10 harbouring pQR440 were identified by antibiotic selection and blue-white 
colour screening, followed by restriction analysis of the purified plasmid. In addition, a 
section of plasmid pQR440, encompassing the DNA insert, was sequenced to ensure 
that the plasmid contained the correct DNA insert, i.e. the ackA gene fragment.
Subsequently, the ackA gene fragment was excised from pQR440 by EcoRI/BamHI 
double digestion and gel purified, prior to ligating in antisense orientation into the multiple 
cloning site of expression vector pTrc99A, forming pQR441 (Figure 4.8). The ligation 
mixture was used to transform E. coli DH5c. Restriction analysis of isolated pQR441 was 
performed to confirm presence of the ackA gene fragment (Figure 4.7). E. coli MG1655 
was transformed with pQR441 for ackA antisense RNA expression studies.
1000 b p  ►
300 bp --------- ►
200 bp --------- ►
4125 bp plasmid backbone
^ ____ 246 bp ackA gene fragment
Figure 4.7 TBE agarose gel (2%) of pQR441 following EcoRI/BamHI digestion. Lane 1, 100 
bp ladder comprising DNA fragments of 100, 200, 300, 400, 500, 517, 600, 700, 800, 900, 
1000, 1200 and 1517 bp; Lane 2, pQR441 undigested; Lane 3, pQR441 digested with EcoRI 
and BamHI. Agarose gel electrophoresis was performed at 100 v for approximately 1 h (as 
described in Materials and Methods) and visualised under UV light.
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antisense ackA EcoRI BamHI
EcoRI
lacZo
pUC ori pQR440
(4547 bp)
Kanr
Ampr
mcs
trc
PTrc" A Amp,
(4176 bp)/aclq
pBR322 ori
EcoRI/BamHI digestion and EcoRI/BamHI digestion and 
gel purification of ackA gene gel purification of linearised 
fragment vectorX X
Ligation of ackA gene fragment into mcs of pTrc99A
1
antisense ackAEcoRI BamHI
trc
pQR441
(4371 bp)
Ampr
/aclq
pBR322 ori
Figure 4.8 Construction of plasmid pQR441, designed to express antisense RNA targeted 
against the E. coli MG 1655 ackA gene. Relevant restriction sites are shown. Genes and 
plasmids are not drawn to scale.
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4.3.2.2 PQR445
Plasmid pQR445 was developed from pMMB66EH to provide a vector for antisense RNA 
expression, which can stably coexist in E. coli with pTrc99A-derived vectors, and has a 
different antibiotic selection marker. Both pTrc99A and pMMB66EH possess the p- 
lactamase gene which confers resistance to ampicillin, therefore it was decided to clone 
an aminoglycoside 3’-phosphotransferase gene, which confers resistance to kanamycin, 
into a unique Pvu\ restriction site in the p-lactamase gene of pMMB66EH to abolish 
ampicillin resistance and introduce kanamycin resistance (Figure 4.11).
Using plasmid pUC4K as a template, a 1250 bp DNA fragment containing the 815 bp 
aminoglycoside 3’-phosphotransferase gene, which confers resistance to kanamycin, 
was amplified by PCR. PCR primers were designed to introduce Pvu\ restriction sites at 
the 5’ and 3’ ends of the PCR product (PCR primer sequences: forward primer, 5’- 
GCCGATCGGT CGACCT GCAGGGGGGGGGGGGCGCT GA-3’; reverse primer, 5’- 
GCCGATCGGCAGGGGGGGGGGGGAAGCCACGTTGTGT-3’). Altogether, the PCR 
product was 1266 bp in length. The PCR-amplified kanamycin resistance gene was 
ligated into cloning vector pCR2.1-TOPO, forming plasmid pQR444. E. coli TOP10 was 
transformed with the ligation mixture. Colonies of E. coli TOP10 harbouring pQR444 
were identified by antibiotic selection and blue-white colour screening, followed by 
restriction analysis of the purified fragment. In addition, a section of plasmid pQR444, 
encompassing the DNA insert was sequenced to ensure that the plasmid contained the 
correct DNA insert i.e. the kanamycin resistance gene.
Subsequently, the kanamycin resistance gene was excised from pQR444 in two 
fragments of 559 bp and 697 bp (due to an internal Pvu\ site) by Pvu\ digestion (Figure 
4.9). The gene fragments were gel purified and then combined, prior to ligating into a 
unique Pvu\ site located in the open reading frame of the ampicillin resistance gene in 
pMMB66EH, forming pQR445 (Figure 4.11). The ligation mixture was used to transform 
E. coli DH5cz and colonies harbouring pQR445 were selected by plating on 10 pg ml'1 
kanamycin. Plasmid pQR445 was then isolated, and the identity confirmed by restriction 
analysis. It proved difficult to achieve a sufficiently high yield and purity of plasmid 
pQR445 using the Qiagen Mini/Midiprep Kits, so pQR445 was purified on a caesium 
chloride gradient, by Dr John Ward. Restriction analysis of pQR445 confirmed presence 
of the kanamycin resistance gene, excised in two fragments from the 8.8 kb plasmid 
backbone by Pvu\ digestion (Figure 4.10). E. coli MG 1655 was transformed with pQR445 
to generate a control strain for antisense RNA expression studies.
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3.0 k b ------ ►
1.0 k b ------ ►
0.5 kb ------ ►
8.8 kb linearised pMMB66EH
697 bp & 559 bp kanamycin
resistance
gene-fragments
Figure 4.9 TBE agarose gel (1%) of pQR444 and pMMB66EH, following PvuI digestion. 
Lane 1, 1 kb ladder comprising DNA fragments of 0.5, 1, 1.5, 2, 3, 4, 5, 6, 8 and 10 kb; Lane 
2, pQR444 undigested; Lane 3, pQR444 digested with Pvu\\ Lane 4, pMMB66EH undigested; 
Lane 5, pMMB66EH digested with Pvu\. Agarose gel electrophoresis was performed at 100 v, 
for approximately 1 h (as described in Materials and Methods) and visualised under UV light.
10.0 kb
3.0 kb
1.0 kb
0.5 kb
8.8 kb plasmid backbone
697 bp kanamycin resistance 
gene fragment
559 bp kanamycin resistance 
gene fragment
Figure 4.10 TBE agarose gel (1%) of pQR445 following Pvu\ digestion. Lane 1, 1 kb ladder 
comprising DNA fragments of 0.5, 1, 1.5, 2, 3, 4, 5, 6, 8 and 10 kb; Lane 2, pQR445 
undigested; Lane 3, pQR445 digested with Pvu\. Agarose gel electrophoresis was performed 
at 100 v, for approximately 1 h (as described in Materials and Methods) and visualised under 
UV light.
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Kanamycin resistance gene
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Ligation of two kanamycin-resistance gene fragments 
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P  fac
Pvu I
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PQR445 X
(10063 bp)
/aclq
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RSF 1010 ori
Figure 4.11 Construction of plasmid pQR445, developed from pMMB66EH to provide a 
vector for antisense RNA expression, which can stably coexist in E. coli with pTrc99A-derived 
vectors, and has a different selection marker (kanamycin). Relevant restriction sites are 
shown. Genes and plasmids are not drawn to scale.
Pvu\
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4.3.2.3 PQR446
Plasmid pQR446 was designed to express antisense RNA targeted against E. coli 
MG1655 ackA mRNA. It was developed from pQR445 to enable co-expression of pta 
antisense RNA (from pQR439) and ackA antisense RNA (from pQR446) in E. coli 
MG1655. The same ackA gene fragment used to construct pQR441 (for details refer to 
section 4.3.2.1) was incorporated into pQR445 to generate pQR446.
The ackA gene fragment was excised from pQR440 by EcoRI/BamHI double digestion 
and gel purified, prior to ligating in antisense orientation into the multiple cloning site of 
expression vector pQR445, forming pQR446 (Figure 4.13). The ligation mixture was used 
to transform E. coli DH5ar, which resulted in a number of unusually slow growing colonies 
on selective nutrient agar. Five colonies were picked and cultured in nutrient broth, and 
the plasmid DNA was purified for analysis. However, due to the low concentration of the 
resulting plasmid DNA preparations, a restriction analysis was inconclusive. The 
problems with purification of pQR445 and pQR446 are likely to be due to the low copy 
number of the parent plasmid, pMMB66EH. Low copy number plasmids are known to be 
more difficult to work with and are not frequently used for laboratory work. Plasmid 
pMMB66EH was chosen to work with in this research because it is compatible with 
pTrc99A, in contrast to many other expression vectors, which are not.
Instead of restriction analysis, it was decided to use PCR to detect the ackA gene 
fragment in the five individual plasmid preparations of putative pQR446. The original 
primers, used to amplify the ackA gene fragment from E. coli MG 1655 chromosomal 
DNA, were used for these PCR reactions. Negative and positive control PCRs were 
performed, with no template in the reaction, and with E. coli MG1655 chromosomal DNA 
as a template, respectively. The results, shown in Figure 4.12, indicate that the ackA 
gene fragment is present in all five plasmid preparations of putative pQR446. It is 
possible that the plasmid preparations could have been contaminated with chromosomal 
DNA, which would give the same results. However, subsequent analysis of a larger scale 
preparation of putative pQR446 confirmed the presence of a plasmid of the correct size. 
In addition, E. coli MG1655 transformed with pQR446 is resistant to kanamycin, but has 
different physiological properties from E. coli MG1655(pQR445). Specifically, pQR446 
has a much lower growth rate. The physiological characterisation of E. coli 
MG1655(pQR446) is examined in detail in Chapter 6.
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1 2 3 4 5 6 7 8
1000 bp
500 bp 
300 bp 
200 bp 
100 bp
— ►
— ►
— ► 
— ►Ifig il; < ------ 256 bp ackA gene fragments
Figure 4.12 TBE agarose gel (1.5%) of PCR reactions, designed to amplify the ackA gene 
fragment from pQR446. Lane 1, 100 bp ladder comprising DNA fragments of 100, 200, 300, 
400, 500, 517, 600, 700, 800, 900, 1000, 1200 and 1517 bp; Lane 2, negative control using 
no template in the reaction; Lane 3, positive control using MG1655 chromosomal DNA as a 
template for the reaction; Lanes 4-8 PCR reactions using pQR446 as the template and the 
original primers designed to amplify the ackA gene fragment. Agarose gel electrophoresis 
was performed at 100 v for approximately 1 h (as described in Materials and Methods) and 
visualised under UV light.
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antisense ackA
BamH\EcoRI
SamHI EcoRI
lacZa mcs
P  tac
pUC ori pQR440
(4547 bp)
pQR445
(10063 bp)
Kanrlac\'
Ampr RSF 1010 ori
EcoRI/SamHI digestion and EcoRI/SamHI digestion and
gel purification of ackA gene gel purification of linearised 
fragment vector
^  *
Ligation of ackA gene fragment into mcs of pTrc99A
1
antisense ackA
EcoRI fiamHI
P tac
pQR446
(10300 bp)
/aclq
RSF 1010 ori
Figure 4.13 Construction of plasmid pQR446, designed to express antisense RNA targeted 
against the ackA gene. Relevant restriction sites are shown. Genes and plasmids are not 
drawn to scale.
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4.4 Recom binant E. c o li S tra in s
Table 4.2 describes the E. coli strains that were developed and characterised during this 
research. These include control strains, which comprise E. coli MG1655 containing just 
the empty expression vectors, and antisense RNA-expressing strains, which comprise E. 
coli MG1655 harbouring the antisense RNA constructs previously described in this 
chapter.
Table 4.2 Recombinant E. coli Strains
Strain Name Plasmid(s) Description
E. coli MG 1655(pTrc99A) pT rc99A Control for E. coli strains harbouring a plasmid derived 
from pTrc99A.
E. coli MG1655(pQR439) pQR439 E. coli with pTrc99A-derived plasmid that expresses 
antisense RNA targeted against phosphotransacetylase
E. coli MG1655(pQR441) pQR441 E. coli with pTrc99A-derived plasmid that expresses 
antisense RNA targeted against acetate kinase
E. coli MG1655(pQR445) pQR445 Control for E. coli strains harbouring a plasmid derived 
from pQR445
E. coli MG 1655(pQR446) pQR446 E. coli with pQR445-derived plasmid that expresses 
antisense RNA targeted against acetate kinase
E. coli
MG1655(pTrc99A/pQR445)
pT rc99A 
&
pQR445
Control for E. coli strain harbouring two plasmids, one 
derived from pTrc99A and one from pQR445
E. coli
MG1655(pQR439/pQR446)
pQR439
&
pQR446
E. coli with a pTrc99A-derived plasmid that expresses 
antisense RNA targeted against phosphotransacetylase 
and pQR445-derived plasmid that expresses antisense 
RNA targeted against acetate kinase
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4.4.1 D u a l -P la s m id  H a r b o u r in g  S t r a in s
4.4.1.1 E. COLI MG1 655(pTrc99A/pQ R445)
E. coli MG1655(pTrc99A/pQR445) was developed as a plasmid control strain for E. coli 
MG1655(pQR439/pQR446) (see section 4.4.1.2). E. coli MG1655 was transformed with 
pTrc99A and pQR445 simultaneously, and plated on selective nutrient agar plates 
containing 10 pg ml'1 kanamycin and 500 pg ml'1 ampicillin to select for double 
transformants. Figure 4.14 shows plasmids pTrc99A and pQR445 isolated from 
MG1655(pTrc99A/pQR445) and linearised by EcoRI digestion. The observed difference 
in the band intensities of pQR445 and pTrc99A is due to the difference in copy number 
between these two plasmids. pTrc99A, which is a derivative of pBR322, has an average 
copy number of -50-80 plasmids/cell, depending on the media and cell growth phase 
(Lin-Chao and Bremer, 1986). In contrast, pMMB66EH, which is a derivative of 
RSF1010, has a lower average copy number of -10-15 plasmids/cell (Morales et al., 
1990).
1 2 3
10.0 kb------ ► A------ 10063 bp linearised pQR445
4.0 kb------ ► A------ 4176 bp linearised pTrc99A
3.0 kb------ ►
0.5 kb------ ►
Figure 4 .14 TBE Agarose gel (1%) of pTrc99A and pQR445, isolated from a culture of E. coli 
MG1655(pTrc99A/pQR445) and linearised by EcoRI digestion. Lane 1, 1 kb ladder 
comprising DNA fragments of 0.5, 1, 1.5, 2, 3, 4, 5. 6. 8. 10 kb; Lane 2, pTrc99A and pQR445 
undigested; Lane 3, pTrc99A and pQR445 digested with EcoRI. Agarose gel electrophoresis 
was performed at 100 v for approximately 1 h (as described in Materials and Methods) and 
visualised under UV light.
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4.4.1.2 E. c o l i MG1 655(pQR439/pQR446)
E. coli MG1655(pQR439/pQR446) was developed to express antisense RNA targeted 
against both the pta and ackA genes. Competent E. coli MG 1655 transformed with 
pQR439 and pQR446 simultaneously did not result in any colonies on selective nutrient 
agar, therefore E. coli MG1655(pQR439/pQR446) was developed by preparing 
competent E. coli MG1655(pQR439), and transforming an aliquot of these with pQR446. 
Cell counts of MG1655(pQR439/pQR446) grown on selective and non-selective nutrient 
agar revealed that 10 pg ml"1 kanamycin and 500 pg ml'1 ampicillin stably maintained 
both plasmids in E. coli MG1655.
Plasmids pQR439 and pQR446 isolated from MG1655(pQR439/pQR446) and linearised 
by EcoRI digestion, are shown in Figure 4.15. As mentioned in the previous section, the 
observed difference in band intensities for pQR439 and pQR446 is due to the difference 
in the copy numbers of these two plasmids. It is possible that the discrepancy in copy 
number will affect the level of antisense RNA expressed from these plasmids. This is 
discussed further in the following section (section 4.5).
10.0 kb-
5.0 kb------ ►
4.0 kb-------►
jam
<■ *
\<4------- 10300 bp linearised pQR446
N  4331 bp linearised pQR439
3.0 kb-
1.5 kb-
Figure 4.15 TBE Agarose gel (1%) of pQR439 and pQR446, isolated from a culture of E. coli 
MG1655(pQR439/pQR446) and linearised by EcoRI digestion. Lane 1, 1 kb ladder 
comprising DNA fragments of 0.5, 1, 1.5, 2, 3, 4, 5. 6. 8. 10 kb; Lane 2, pQR439 and pQR446 
undigested; Lane 3, pQR439 and pQR446 digested with EcoRI. Agarose gel electrophoresis 
was performed at 100 v for approximately 1 h (as described in Materials and Methods) and 
visualised under UV light.
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4 .5  D isc u ssio n  an d  C o n c lu sio n s
This chapter described the construction of seven novel plasmids, which were generated 
using molecular biology techniques for DNA recombination. Four intermediary plasmids 
(pQR438, pQR440, pQR444, pQR445) were constructed in order to produce a pta 
antisense RNA expression vector (pQR439), and two ackA antisense RNA expression 
vectors (pQR441, pQR446). E. coli MG1655 was transformed with the individual 
plasmids, and with combinations of compatible plasmids, to generate seven recombinant 
strains for antisense RNA expression studies.
The novel plasmids that were constructed in this research were derived from the 
expression vectors pTrc99A and pMMB66EH. pTrc99A is a relatively high copy number 
plasmid, with an average copy number of -50-80 plasmids/cell (Lin-Chao and Bremer, 
1986). In contrast, pMMB66EH is a relatively low copy number plasmid, with an average 
copy number of -10-15 plasmids/cell (Morales et al., 1990). The difference in plasmid 
copy number may potentially affect the relative amount of antisense RNA produced from 
the constructs derived from each plasmid-type. However, the promoters used for 
antisense RNA expression are the strong trc and tac promoters (Amann et al., 1988; Lin- 
Chao and Bremer, 1986). Therefore, the amount of antisense RNA produced from both 
plasmid types should still greatly out-number the amount of pta and ackA mRNA that is 
produced from the single copy of each gene on the E. coli MG 1655 chromosome. The 
choice of expression vectors for metabolic engineering strategies and particularly 
antisense RNA expression is discussed further in the general discussion in Chapter 7.
In E. coli, the genes coding for acetate kinase and phosphotransacetylase are organised 
in the order ackA-pta in an operon (Kakuda et al., 1994). Two mRNA transcripts of 
different sizes are produced, one which encompasses both the ackA and pta genes, and 
one which encompasses just the pta gene. The mechanism of antisense RNA-mediated 
gene downregulation is thought to involve suppression of mRNA translation and/or 
destabilisation of the message, therefore binding of either ackA or pta antisense RNA to 
the dual message could potentially affect the expression of both genes. This was 
evaluated by examining the enzyme levels of both phosphotransacetylase and acetate 
kinase in all the strains that were characterised in this study. The results are discussed in 
the following chapter (Chapter 5).
Factors to consider, which might affect the suppression of pta and ackA gene expression 
by antisense RNA are: 1) the stability of the antisense RNA products in E. coli; 2) the rate 
of antisense RNA binding to the target mRNA; and 3) the half-life of
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phosphotransacetylase and acetate kinase proteins. This information is not known, 
however it may be possible to gain some insight into the half-life of 
phosphotransacetylase and acetate kinase by the experiments that were performed in 
this study.
Analysis of the recombinant E. coli strains involved physiological characterisation, which 
is described in the following chapter (Chapter 5), and metabolic flux analysis, which is 
described in Chapter 6.
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5.1 S ummary
The objective of this study was to determine the impact of putative pta and ackA 
antisense RNA on growth, enzyme levels and organic acid production by E. coli MG1655. 
Four novel E. coli strains were constructed to express antisense RNA targeted against 
phosphotransacetylase mRNA and/or acetate kinase mRNA, as described in the 
previous chapter (Chapter 4). This chapter describes the physiological effect of putative 
antisense RNA expression, as determined by shake flask and bioreactor experiments. 
Growth, enzyme levels and organic acid production were evaluated in the antisense 
RNA-expressing cultures and compared with those of the control cultures, which 
harboured the parent plasmids.
It was hypothesised that putative pta/ackA antisense RNA would partially suppress 
expression of phosphotransacetylase and acetate kinase, and result in reduced acetate 
production by E. coli MG1655. Previous studies with mutant E. coli strains have indicated 
that in the absence of the ackA-pta pathway, excess carbon flux in central metabolism is 
re-directed towards lactate production (Chang et al., 1999; Diaz-Ricci et al., 1991). The 
aim of this study was to determine the effectiveness of antisense RNA in suppressing 
expression of phosphotransacetylase and acetate kinase, and re-directing carbon flow in 
E. coli central metabolism.
Shake flask and bioreactor experiments showed that expression of putative pta antisense 
RNA from plasmid pQR439 resulted in -40% reduction in phosphotransacetylase levels 
in E. coli MG1655 compared to the control culture, and a -10-15% decrease in total 
acetate accumulation. Furthermore, E. coli MG1655(pQR439) showed ~2-fold increase in 
lactate production compared to the control. Expression of putative ackA antisense RNA 
from plasmid pQR441 resulted in -40% reduction in acetate kinase and -50-60% 
reduction in phosphotransacetylase levels in E. coli MG1655. However, acetate 
accumulation was still only reduced by -12-20% in the antisense RNA-regulated cultures, 
compared to the control culture. In contrast, expression of putative ackA antisense RNA 
from plasmid pQR446 led to severe growth retardation, reduced acetate production and 
dramatically increased lactate production in E. coli MG 1655. However, the control culture 
harbouring the parent plasmid for this set of experiments had lower enzyme levels and 
acetate production than the control culture for the previous sets of experiments, which 
suggested that some component of the parent plasmid, pQR445, might interfere with 
acetate production by E. coli MG1655.
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Simultaneous expression of pta & ackA antisense RNA from plasmids pQR439 and 
pQR446 respectively, achieved -40%  reduction in phosphotransacetylase levels 
compared to the control culture harbouring the parent plasmids. The levels of acetate 
kinase were also reduced in this culture, compared to the parent strain, and no growth 
retardation was observed. Furthermore, total acetate accumulation was reduced by up to 
-28%, compared to the control culture. However the control culture, E. coli 
MG1655(pTrc99A/pQR445) exhibited -40% lower levels of acetate accumulation 
compared to the original control culture E. coli MG1655(pTrc99A). This again suggested 
that the presence of plasmid pQR445 lead to reduced acetate production by E. coli 
MG1655. In conclusion, the fermentation results indicated that pta and/ or ackA 
antisense RNA partially suppressed expression of phosphotransacetylase and acetate 
kinase in E. coli MG1655, resulting in decreased levels of acetate formation and 
redirection of carbon flux to lactate production.
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5.2 Impact o f  Putative pta Antisense R N A  on G ro w th  and 
Production Form ation
5.2.1 C o n s tru c t io n  o f  E. c o l i  MG1 655(pQR439)
Plasmid pQR439 was constructed to express a 200-nucleotide pta antisense RNA 
molecule, complementary to the 5’ region of pta mRNA encompassing the ribosome- 
binding site and translation initiation site. E. coli K-12 strain MG1655 was transformed 
with plasmid pQR439, as described in Materials and Methods, and the identities of 
ampicillin-resistant transformants as E. coli MG1655(pQR439) were verified by plasmid 
isolation and restriction analysis (see section 4.3.1.1). E. coli MG1655(pQR439) cultured 
on selective nutrient agar exhibited growth characteristics that were typical of E. coli 
MG1655.
In the following pages, shake flask and bioreactor experiments to evaluate the impact of 
putative pta antisense RNA on growth and product formation are described. E. coli 
MG1655 harbouring the parent plasmid, pTrc99A, was used as a control strain for these 
studies. E. coli MG1655(pQR439) was studied under ‘uninduced’ conditions, i.e. no IPTG 
was added to the culture medium, and under ‘induced’ conditions, in which IPTG (1mM) 
was added to the culture medium at early-mid log phase (after 3 hours growth). All the 
plasmids were stably maintained throughout the 24 hour study.
Under uninduced conditions, expression of pta antisense RNA from the trc promoter on 
plasmid pQR439 should be repressed. However, there may be ‘leaky’ expression of pta 
antisense RNA from the uninduced plasmid. Therefore, comparing the profiles of the 
uninduced culture of E. coli MG1655(pQR439) with the plasmid control culture should 
indicate how well expression of antisense RNA from this construct is regulated.
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5.2.2 S h a ke  F la s k  A n a ly s is  o f  E. c o l i  MG1 655(pQR439)
The objective of this study was to determine the effect of pta antisense RNA expression 
on growth and acetate production by E. coli MG1655 in shake flask culture, prior to a 
more detailed study in controlled bioreactors. Two E. coli strains were used in this study: 
E. coli MG1655(pQR439), generated to express antisense RNA targeted against 
phosphotransacetylase; and E. coli MG1655(pTrc99A), a control strain harbouring the 
parent plasmid. Experimental conditions for the shake flask experiments are detailed in 
Table 5.1, and the results are presented and discussed in the following pages.
Table 5.1 Experimental conditions for testing the effect of putative pta antisense RNA in
shake flask experiments
Strains E. coli MG1655(pQR439) 
(see Table 2.1)
E. coli MG 1655(pTrc99A) 
(see Table 2.1)
Media M9 minimal media, 10 g L'1 glucose, trace element mix, 20 
pg ml'1 uracil, 5 pg ml'1 thymidine, 100 pg ml'1 ampicillin.
(see Table 2.4)
Growth Mode Batch, 2 L shake flask (250 ml total working volume)
Temperature 37°C
Shaker Speed 200 rpm
Sampling Times 0, 1,2 ,3 , 4, 5, 6, 7, 8, and 24 h
IPTG Addition Time 3 h
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5.2.2.1 G r o w t h  and G l u c o s e  U p t a k e  by E. c o l i  M G 1 6 5 5 (pQ R 4 3 9 )
The impact of putatively produced pta antisense RNA on maximum biomass 
concentration (expressed as OD6oo). growth rate and glucose uptake rate is summarised 
in Table 5.2. Time course profiles of cell density and residual glucose concentration are 
shown in Figure 5.1. Overall, the results indicated that growth and glucose uptake were 
comparable in all three cultures. During the exponential growth phase, the cell densities 
in the induced and uninduced cultures of E. coli MG1655(pQR439) were lower than in the 
control culture. However, all the cultures achieved a similar final biomass concentration 
after 24 h growth. Glucose was depleted at similar rates for all three cultures.
Table 5.2 Summary of substrate uptake and biomass formation in shake flask experiments
Fermentation
characteristic
MG1655(pTrc99A) MG1655(pQR439)
uninduced
MG1655(pQR439) 
induced
(control) (antisense pta) (antisense pta)
Max. OD6ooa 5.5 ±0.1 5.3 ± 0.02 5.4 ± 0.02
Growth Rate (h'1)b 0.51 ±0.08 0.55 ± 0.03 0.54 ± 0.03
Glucose Uptake Rate 
(mM h'1)b
6.1 ±0.5 4.7 ±0.2 5.3 ±0.5
a Mean ± standard error of the mean.
b Rate established over the range 2-6 hours after inoculation (± standard error).
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Figure 5.1 Time-course profiles of (A) cell growth and (B) residual glucose concentration in 
E. coli MG1655 harbouring pTrc99A (■), pQR439 uninduced (•), and pQR439 induced (o ) .  
Recombinant cells were cultured in 2 L baffled shake flasks containing 250 ml of M9 medium 
with 1% (wt/vol) glucose at 37°C and shaken at 200 rpm. The arrow indicates the point of 
induction with 1 mM IPTG. Duplicate analyses were performed for each sample; average 
values of the duplicates are shown.
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5 .2 .2 .2  O rg a n ic  A c id  P ro d u c tio n  by E. c o li M G1 6 5 5 (p Q R 4 3 9 )
As previously discussed in Chapter 1 (section 1.2.3.2), E. coli grown with glucose under 
aerobic conditions produces acetate as the main by-product of fermentation. However, 
under anaerobic conditions, ethanol, formate, succinate and lactate are often produced, 
in addition to acetate (Clark, 1989). The fermentative pathways leading to succinate, 
lactate and ethanol formation play an important role in regenerating NAD+ in the absence 
of oxidative phosphorylation, as shown in Figure 1.2. In this study, it was hypothesised 
that reducing the carbon flow to acetate might result in re-channelling of carbon to some 
of these other by-products, even under aerobic conditions. Furthermore, although 
pyruvate is not typically excreted by E. coli, some previous studies have observed 
pyruvate excretion in pta mutant strains (Chang et al., 1999; Diaz-Ricci et al., 1991; 
Kakuda et al., 1994). Therefore, the concentrations of acetate, pyruvate, succinate, 
lactate and ethanol in the culture medium were examined in all the physiological studies 
that are presented in this chapter. Formate was not produced by any of the E. coli 
cultures that were studied. This was expected because pyruvate formate lyase, which 
converts pyruvate to formate, is only expressed under anaerobic conditions. It is 
extremely sensitive to molecular oxygen, which causes irreversible inactivation due to 
peptide bond cleavage of one of the protein subunits (Becker et al., 1999; Knappe and 
Sawers, 1990).
The impact of putatively produced pta antisense RNA on organic acid production by E. 
coli MG1655 in shake flask culture is summarised in the following pages. Results showed 
that there was negligible difference in the production of pyruvate, lactate, succinate or 
ethanol by E. coli MG1655(pQR439) compared to the control culture (Table 5.3 A). 
However, acetate production was reduced in both the induced and uninduced cultures of 
E. coli MG1655(pQR439), compared to the control culture.
The peak acetate concentration was reduced by -30%  in the induced culture of E. coli 
MG1655(pQR439), and by -23%  in the uninduced culture of E. coli MG1655(pQR439), 
compared to the control culture (Table 5.3 A). Furthermore, the acetate production rates 
were also lower in these cultures during exponential growth phase (Table 5.3 B), and the 
total amount of acetate produced (mmoles) per 100 mmoles of glucose consumed 
followed the same trend (Table 5.3 C). These initial results are promising and suggest 
that production of acetate in E. coli MG1655 is reduced by expression of putative pta 
antisense RNA.
115
Chapter 5: Fermentation of E. coli M G1655 Expressing Putative Antisense RNA
Time course profiles of acetate accumulation are shown in Figure 5.2. All the cultures 
exhibited peak acetate levels after 24 hours growth. The peak acetate levels were more 
than 2-fold higher than the acetate levels after 8 hours growth, which suggests that 
during stationary phase all the cultures continued to metabolise glucose and produce 
acetate.
During mid-late exponential growth phase, the acetate levels are slightly lower in both the 
induced and uninduced cultures of E. coli MG1655(pQR439), compared to the control 
culture. This may have been due to lower biomass levels during this time. However, after 
24 hours growth, the biomass levels were comparable in all three cultures, but there was 
lower levels of acetate in both the induced and uninduced cultures of E. coli 
MG1655(pQR439). The similarity in profiles of the induced and uninduced cultures of E. 
coli MG1655(pQR439) suggests that putative pta antisense RNA was expressed from 
pQR439 even under repressed conditions. This will be discussed further in light of the 
bioreactor experiments.
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Figure 5.2 Time course profiles of acetate concentration in E. coli MG1655 harbouring 
pTrc99A (■), pQR439 uninduced (•), and pQR439 induced (o). Recombinant cells were 
cultured in 2 L baffled shake flasks containing 250 ml of M9 medium with 1% (wt/vol) glucose 
at 37°C and shaken at 200 rpm. The arrow indicates the point of induction with 1 mM IPTG.
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Table 5.3
Summary of organic acid production in shake flask experiments: (A) Peak Product 
Concentration, (B) Production Rate, and (C) mmoles produced per 100 mmoles of glucose 
consumed.
A
Peak Product Concentration 
(mM)
MG1655(pT rc99A) MG1655(pQR439) 
uninduced
MG1655(pQR439) 
induced
(control) (antisense pta) (antisense pta)
Acetate 30 23 21
Pyruvate 2 < 1 1
Lactate 1 2 < 1
Succinate 3 3 2
Ethanol <1 < 1 < 1
B
Production Rate 
(mM h’1)a
MG1655(pTrc99A) MG1655(pQR439)
uninduced
MG1655(pQR439)
induced
(control) (antisense pta) (antisense pta)
Acetate 1.9 ±0.1 1.2 ±0.05 1.3 ±0.05
a Rate established over the range 2-6 hours after inoculation (± standard error).
C
mmoles produced /1 0 0  mmoles 
glucose consumed
MG1655(pTrc99A) MG1655(pQR439)
uninduced
MG1655(pQR439)
induced
(control) (antisense pta) (antisense pta)
Acetate 50 42 39
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5.2.3 A n a ly s is  o f  E. c o l i  MG1 655(pQR439) in a  C o n t r o l l e d  
B i o r e a c t o r
The objective of this study was to determine the effect of pta antisense RNA expression 
on growth, enzyme levels and organic acid production by E. coli MG1655, cultured in a 
controlled bioreactor. Two E. coli strains were used in this study: E. coli 
MG1655(pQR439), generated to express antisense RNA targeted against 
phosphotransacetylase; and E. coli MG1655(pTrc99A), a control strain harbouring the 
parent plasmid. Experimental conditions for the bioreactor experiments are detailed in 
Table 5.4, and the results are presented and discussed in the following pages.
Table 5.4 Experimental conditions for testing the effect of putative pta antisense RNA in
bioreactor experiments
Strains E. coli MG1655(pQR439) 
(see Table 2.1)
E. coli MG 1655(pTrc99A) 
(see Table 2.1)
Media M9 minimal media, 10 g L'1 glucose, trace element mix, 20 
pg ml'1 uracil, 5 pg ml'1 thymidine, 100 pg ml'1 ampicillin.
(see Table 2.4)
Growth M ode Batch, 2 L bioreactor (1 L working volume), pH control
Tem perature 37°C
Agitation Speed 800 rpm
A ir Flow Rate 1 vvm
Sam pling T im es 0, 1,2, 3,4, 5, 6, 7, 8, and 24 h
IPTG A ddition  T im e 3 h
1 1 8
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5.2.3.1 O p t im is a t io n  o f  A e r a t io n  C o n d it io n s  f o r  B io r e a c t o r  E x p e r im e n t s
Prior to the first bioreactor experiment, the airflow rate and rate of agitation in the 
fermentor vessel were optimised to ensure that the E. coli cultures would remain fully 
aerated during the course of a 24-hour long fermentation. A culture of the control strain, 
E. coli MG1655(pTrc99A), was used to establish the optimum conditions.
Initially the airflow rate was set at 0.5 vvm, and the agitation rate at 500 rpm. By 
monitoring the %DOT (dissolved oxygen tension) in the culture, it was apparent that the 
available oxygen in the culture was depleted rapidly. Therefore, the airflow rate and 
agitation rate were increased in a step-wise fashion up to 1 vvm and 800 rpm 
respectively. At these levels, the %DOT in a culture of E. coli MG1655(pTrc99A) 
remained above 60% for the duration of a 24 hour fermentation (Figure 5.3 A). These 
parameters were kept constant for all of the bioreactor experiments that are presented in 
this chapter.
Time course profiles of %DOT, carbon dioxide production rate (CPR) and oxygen uptake 
rate (OUR), for a culture of E. coli MG1655(pTrc99A), are shown in Figure 5.3. Oxygen 
was utilised and carbon dioxide was produced rapidly, and at the same rate, for the first 6 
hours of the fermentation, which corresponded to exponential growth phase on glucose. 
The subsequent sharp peak at ~6h corresponded to depletion of ammonium chloride, 
which is the nitrogen source in M9 minimal media. Hence, nitrogen depletion coincides 
with the onset of stationary phase in the culture (data not shown). The effect of nitrogen 
depletion on the levels of acetate produced by E. coli will be discussed at the end of this 
chapter in section 5.5. Off-gas profiles for all bioreactor experiments in this chapter were 
recorded, and showed little variation from these profiles.
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Figure 5.3 Time course profiles of (A) % DOT (■), and (B) OUR (o) and CPR (•), in E. coli 
MG 1655 harbouring pTrc99A. Recombinant cells were cultured in a 2 L baffled fermenter 
containing 1 L of M9 medium with 1% (wt/vol) glucose at 37°C. The airflow rate was set at 1 
vvm and the rate of agitation was set at 800 rpm, to ensure the culture was fully aerated. The 
sharp peak that can be seen on both graphs at -6  h corresponds to depletion of ammonium 
chloride, the nitrogen source in M9 minimal media. This was determined experimentally (data 
not shown).
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5 .2 .3 .2  G r o w t h  and G l u c o s e  U p t a k e  by E. c o l i  MG 1 6 5 5 (pQ R 4 3 9 )
The impact of putatively produced pta antisense RNA on maximum biomass 
concentration (expressed as O D6oo), growth rate and glucose uptake rate is summarised 
in Table 5.5. Time-course profiles of cell density and residual glucose concentration are 
shown in Figure 5.4. Overall, the results indicated that growth and glucose uptake were 
comparable in all three cultures, which agrees with previous observations of these strains 
in shake flask culture (see section 5.2.2.1). However, the maximum O D 6oo of both the 
induced and uninduced cultures of E. coli MG1655(pQR439) were slightly higher than the 
control culture. This may have been due to small variations in the media composition, 
which allowed these cultures to accumulate slightly more biomass. Glucose was depleted 
at similar rates for all three cultures.
T ab le  5 .5  Summary of substrate uptake and biomass formation in bioreactor experiments
Fermentation
characteristic
MG1655(pTrc99A) MG1655(pQR439) 
uninduced
MG1655(pQR439) 
induced
(control) (antisense pta) (antisense pta)
Max. OD6ooa 5.5 ±0.1 6.6 ± 0.09 5.8 ± 0.09
Growth Rate (h'1)b 0.49 ± 0.03 0.54 ± 0.007 0.55 ± 0.02
Glucose Uptake Rate 5.0 ±0 .5 5.2 ± 0.9 4.5 ±0.6
(mM h'1)b
3 Mean ± standard error of the mean.
b Rate established over the range 2-6 hours after inoculation (± standard error).
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Figure 5.4 Time-course profiles of (A) cell growth and (B) residual glucose concentration in 
E  coli MG1655 harbouring pTrc99A (■), pQR439 uninduced (•), and pQR439 induced (o). 
Recombinant cells were cultured in a 2 L baffled fermenter containing 1 L of M9 medium with 
1% (wt/vol) glucose at 37°C. The arrow indicates the point of induction with 1 mM IPTG. 
Duplicate analyses were performed for each sample; average values of the duplicates are 
reported.
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5.2.3.3 Enzyme A c tiv ity  Leve ls  in E. c o l i MG1 655(pQR439)
The impact of putatively produced pta antisense RNA on the levels of 
phosphotransacetylase and acetate kinase in E. coli MG1655 was evaluated by 
examining the specific enzyme activities (Figure 5.5). Time course profiles of 
phosphotransacetylase specific activity showed that both the induced and uninduced 
cultures of E. coli MG1655(pQR439) had reduced levels of phosphotransacetylase 
compared to the control culture. After 24h growth, the level of phosphotransacetylase in 
the induced culture of E. coli MG1655(pQR439) was ~40% lower than the control culture. 
These results indicate that putative pta antisense RNA partially suppressed expression of 
phosphotransacetylase in E. coli MG1655. In addition, the results confirmed that 
phosphotransacetylase levels were reduced in the uninduced culture of E. coli 
MG1655(pQR439), which suggests that putative pta antisense RNA was expressed even 
under repressed conditions. This will be discussed further in section 5.5 at the end of this 
chapter, and in Chapter 7.
The levels of acetate kinase in both the induced and uninduced cultures of E. coli 
MG1655 were comparable with the control culture. This indicates that putative pta 
antisense RNA does not affect expression of acetate kinase in E. coli MG1655.
It is notable that the error margin was highest in the enzyme activity assays from the 
earliest fermentation samples, due to a low cell density in the samples of culture broth. 
This explains the variation in specific activities immediately after fermenter inoculation.
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Figure 5.5 Time-course profiles of specific enzyme activity for (A) phosphotransacetylase 
and (B) acetate kinase in E. coli MG1655 harbouring pTrc99A (■), pQR439 uninduced (•), 
and pQR439 induced (o). Recombinant cells were cultured in a 2 L baffled fermenter 
containing 1 L of M9 medium with 1 % (wt/vol) glucose at 37°C. The arrow indicates the point 
of induction with 1 mM IPTG. Duplicate analyses were performed for each sample; average 
values of the duplicates are reported.
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5.2.3.4 O rg a n ic  Acid P ro d u c tio n  by E. c o l i MG1 655(pQR439)
The impact of putatively expressed pta antisense RNA on organic acid production by E. 
coli MG1655 cultured under controlled conditions is summarised in the following pages. 
Results showed that there was negligible difference in the production of pyruvate, 
succinate or ethanol by E. coli MG1655(pQR439) compared to the control culture (Table
5.6 A). However, differences in the production of acetate and lactate were observed.
The peak acetate concentration in the induced culture of E. coli MG1655(pQR439) was 
reduced by ~15% compared to the control culture. This is not as big a reduction in peak 
acetate levels as was observed in the shake flask study. However, the control culture 
accumulated less acetate in the bioreactor experiments compared to the shake flask 
experiments, which may account for the difference. The induced cultures of E. coli 
MG1655(pQR439) actually produced equivalent amounts of acetate in shake flask 
culture and under controlled conditions in a bioreactor.
Time course profiles of acetate concentration (Figure 5.6 A) showed that both the 
induced and uninduced cultures of E. coli MG1655(pQR439) accumulated lower levels of 
acetate during exponential growth phase, compared to the control culture. This trend 
closely resembles the biomass profiles of the cultures, and is consistent with the results 
obtained from the shake flask studies (see section 5.2.2.2). The total amounts of acetate 
produced (mmoles) per 100 mmoles of glucose consumed (Table 5.6 C) confirmed that 
the control culture produced the most acetate, followed by the uninduced culture of E. 
coli MG1655(pQR439), and then the induced culture of E. coli MG1655(pQR439). Taken 
together, these results indicate that putative pta antisense RNA results in partial 
suppression of phosphotransacetylase, which leads to reduced carbon flow to acetate in 
E. coli MG1655.
Surprisingly, all the bioreactor cultures accumulated lactate after 24 h growth. This was 
unexpected in the control culture, as lactate is not typically produced by E. coli under 
aerobic conditions. The fermentative lactate dehydrogenase (IdhA), which coverts 
pyruvate to lactate, is usually induced by low pH under anaerobic conditions (Bunch et 
al., 1997; Ruijun et al., 2001). However, lactate dehydrogenase is present in substantial 
basal levels under all conditions, and is allosterically activated by its substrate, pyruvate. 
Therefore, Ruijun et al. (2001) proposed that increased sugar metabolism indirectly 
induces expression of lactate dehydrogenase. In this study, lactate may have been 
produced in the control culture as a consequence of the excess glucose that was present 
in the media after depletion of the nitrogen source. Under these conditions, glucose was
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taken up and metabolised by E. coli, but not used for biomass generation. Therefore, it is 
feasible that metabolites at the end of the glycolytic pathway, such as pyruvate, may 
have accumulated, causing increased expression of lactate dehydrogenase and 
subsequent production of lactate. Time course profiles of lactate concentration (Figure
5.6 B) confirmed that lactate was produced during stationary phase.
The timing of lactate production by the induced and uninduced cultures of E. coli 
MG1655(pQR439) was similar to the control culture. However, the peak lactate levels 
were ~2-fold higher than the control culture. The amounts of lactate produced (mmoles) 
per 100 mmoles of glucose consumed (Table 5.6 C) confirmed that the induced culture of 
E. coli MG1655(pQR439) produced the most lactate, followed by the uninduced culture of 
E. coli MG1655(pQR439), and then the control culture. These results suggest that 
expression of putative pta antisense RNA leads to reduced carbon flow to acetate and 
increased carbon flow to lactate.
Re-direction of carbon flow from acetate production to lactate production has previously 
been observed in mutant E. coli strains defective in phosphotransacetylase (Chang et al., 
1999; Diaz-Ricci et al., 1991). The probable mechanism for the alteration in carbon flux 
involves the build up of acetyl CoA, which is the substrate for phosphotransacetylase. 
Increased levels of acetyl CoA inhibit activity of the pyruvate dehydrogenase enzyme, 
which leads to a build up of pyruvate in the cell, and as previously described, pyruvate 
has been shown to increase expression of the lactate dehydrogenase enzyme (Bunch et 
al., 1997). Hence, excess pyruvate is converted to lactate, which accumulates in the 
culture medium. Studies have shown that reducing the level of acetyl CoA in pta mutant 
strains effectively diminishes lactate production by the culture (Chang et al., 1999; Diaz- 
Ricci et al., 1991).
In this study, it is notable that the greatest differences in lactate production occur during 
stationary phase. Therefore, it would be interesting to analyse the pattern of lactate and 
acetate accumulation in more detail during this period, to determine whether they 
accumulate rapidly during early stationary phase, or more gradually. It would also be 
interesting to see whether reduced carbon flow to acetate in cultures of E. coli expressing 
putative pta antisense RNA, occurs at the same time as increased carbon flow to lactate.
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Figure 5.6 Time-course profiles of (A) acetate concentration and (B) lactate concentration in 
E. coli MG1655 harbouring pTrc99A (■), pQR439 uninduced (•), and pQR439 induced (o). 
Recombinant cells were cultured in a 2 L baffled fermenter containing 1 L of M9 medium with 
1% (wt/vol) glucose at 37°C. The arrows indicate the point of induction with 1 mM IPTG.
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Table 5.6
Summary of organic acid production in bioreactor experiments: (A) Peak Product 
Concentration, (B) Production Rate, and (C) mmoles produced per 100 mmoles of glucose 
consumed.
A
Peak Product Concentration 
(mM)
MG1655(pT rc99A) MG1655(pQR439) 
uninduced
MG1655(pQR439) 
induced
(control) (antisense pta) (antisense pta)
Acetate 25 26 21
Pyruvate 2 < 1 < 1
Lactate 6 12 13
Succinate 1 1 2
Ethanol < 1 < 1 < 1
B
Production Rate 
(mM h 'V
MG1655(pT rc99 A) MG1655(pQR439) 
uninduced
MG1655(pQR439) 
induced
(control) (antisense pta) (antisense pta)
Acetate 2.0 ±0.1 2.1 ±0 .3 2.1 ±0.3
Lactate 0.0 0.0 0.3 ± 0.08
a Rate established over the range 2-6 hours after inoculation (± standard error).
C
mmoles produced /1 00  mmoles 
glucose consumed
MG1655(pT rc99A) MG1655(pQR439) 
uninduced
MG1655(pQR439) 
induced
(control) (antisense pta) (antisense pta)
Acetate 49 46 44
Lactate 12 23 30
1 2 8
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5.3 Im pact o f  P u ta tiv e  ackA A n tisense R N A  on G ro w th
a n d  P r o d u c t  Fo r m a tio n
5.3.1 C o n s t r u c t io n  o f  E. c o u  MG1 655(pQR441 )
Plasmid pQR441 was constructed to express a 240-nucleotide ackA antisense RNA 
molecule, complementary to the 5’ region of ackA mRNA encompassing the ribosome- 
binding site and translation initiation site. E. coli K-12 strain MG1655 was transformed 
with plasmid pQR441, as described in Materials and Methods, and the identities of 
ampicillin-resistant transformants as E. coli MG1655(pQR441) were verified by plasmid 
isolation and restriction analysis (see section 4.3.2.1).
Due to the fact that E. coli MG1655(pQR441) exhibited normal growth characteristics on 
nutrient agar and in nutrient broth, it was decided not to perform shake flask studies of 
the strain, and proceed directly to cultivation under controlled conditions in a fermenter. 
In the following pages, bioreactor experiments to evaluate the impact of putative ackA 
antisense RNA are described. E. coli MG1655 harbouring the parent plasmid, pTrc99A, 
was used as a control strain for these studies. E. coli MG1655(pQR441) was studied 
under ‘uninduced’ conditions, i.e. no IPTG was added to the culture medium, and under 
induced conditions, in which IPTG (1mM) was added to the culture medium at early-mid 
log phase (after 3 hours growth). All the plasmids were stably maintained throughout the 
24 hour study.
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5.3.2 A n a ly s is  o f  E. c o l i  MG1 655(pQR441 ) in a  C o n tr o l le d  
B io r e a c to r
The objective of this study was to determine the effect of ackA antisense RNA expression 
on growth, enzyme levels and organic acid production by E. coli MG1655, cultured in a 
controlled bioreactor. Two E. coli strains were used in this study: E. coli 
MG1655(pQR441), constructed to express antisense RNA targeted against acetate 
kinase; and E. coli MG1655(pTrc99A), a control strain harbouring the parent plasmid. 
Experimental conditions for the bioreactor experiments are detailed in Table 5.7, and the 
results are presented and discussed in the following pages.
Table 5.7 Experimental conditions for testing the effect of putative ackA antisense RNA in
bioreactor experiments
Strains E. coli MG1655(pTrc99A) 
(see Table 2.1)
E. coli MG1655(pQR441) 
(see Table 2.1)
Media M9 minimal media, 10 g L'1 glucose, trace element mix, 20 
pg ml'1 uracil, 5 pg ml'1 thymidine, 100 pg ml'1 ampicillin.
(see Table 2.4)
Growth Mode Batch, 2 L bioreactor (1 L working volume)
Temperature 37°C
Agitation Speed 800 rpm
Air Flow Rate 1 w m
Sampling Times, hours 0, 1,2, 3,4, 5,6, 7, 8, and 24.
IPTG Addition Time, hours 3
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5.3 .2 .1  G r o w t h  a n d  G l u c o s e  U p t a k e  b y  E. c o l i  MG 1 6 5 5 (pQ R 441 )
The impact of putatively produced ackA antisense RNA on maximum biomass 
concentration (expressed as ODeoo), growth rate and glucose uptake rate is summarised 
in Table 5.8. Overall, the results indicated that the growth and glucose uptake were 
comparable in all three cultures. The maximum OD6 0 0  of the induced culture of E. coli 
MG1655(pQR441) was slightly higher than the control culture. This may have been due 
to a small variation in the media composition. Time course profiles of cell density and 
residual glucose concentration (Figure 5.7) show that the biomass production and 
depletion of glucose are comparable in all three cultures for the duration of the 24 hour 
fermentation.
T a b le  5 .8  Summary of substrate uptake and biomass formation in bioreactor experiments
Fermentation
characteristic
MG 1655(pT rc99A) MG1655(pQR441)
uninduced
MG1655(pQR441)
induced
(control) (antisense ackA) (antisense ackA)
Max. OD6ooa 5.5 ±0.1 5.5 ± 0.005 6.0 ±0.1
Growth Rate (h'1)b 0.49 ± 0.03 0.53 ±0.01 0.53 ± 0.03
Glucose Uptake Rate 5.3 ± 0.6 3.8 ±0 .9 5.2 ± 0.4
(mM h‘1)b
a Mean ± standard error of the mean
b Rate established over the range 2-6 hours after inoculation (± standard error).
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Figure 5.7 Time-course profiles of (A) cell growth and (B) residual glucose concentration in 
E. coli MG1655 harbouring pTrc99A (■), pQR441 uninduced (•), and pQR441 induced (o). 
Recombinant cells were cultured in a 2 L baffled fermenter containing 1 L of M9 medium with 
1% (wt/vol) glucose at 37°C. The arrow indicates the point of induction with 1 mM IPTG. 
Duplicate analyses were performed for each sample; average values of the duplicates are 
shown.
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5.3.2.2 Enzyme A c tiv ity  L e v e ls  in E. c o u  MG1 655(pQR441 )
The impact of putatively produced ackA antisense RNA on phosphotransacetylase and 
acetate kinase specific enzyme activity is shown in Figure 5.8. Time course profiles of 
acetate kinase specific activity indicated that both the induced and uninduced cultures of 
E. coli MG1655(pQR441) had reduced levels of acetate kinase compared to the control 
culture. After 24 hours of growth, the level of acetate kinase in the induced culture of E. 
coli MG1655(pQR441) was ~40% lower than the control culture. These results indicated 
that putative ackA antisense RNA partially suppressed expression of acetate kinase in E. 
coli MG1655. Furthermore, the results indicated that putative ackA antisense RNA was 
expressed from the uninduced culture of E. coli MG1655(pQR441). This was expected 
due to the fact that plasmid pQR441 was derived from the same parent plasmid as 
pQR439 (i.e. pTrc99A), which also showed probable leaky expression of antisense RNA 
from the trc promoter.
Time course profiles of phosphotransacetylase activity indicated that both the induced 
and uninduced cultures of E. coli MG1655(pQR441) had reduced levels of 
phosphotransacetylase compared to the control culture. After 24 hours of growth, the 
levels of phosphotransacetylase in the induced and uninduced cultures of E. coli 
MG1655(pQR441) were -50-60%  lower than the control culture. These results suggest 
that putative ackA antisense RNA indirectly suppressed the expression of 
phosphotransacetylase in E. coli MG1655. This effect was anticipated because the genes 
for phosphotransacetylase and acetate kinase are co-transcribed (see section 4.2.1).
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Figure 5.8 Time-course profiles of specific enzyme activity for (A) phosphotransacetylase 
and (B) acetate kinase in E. coli MG1655 harbouring pTrc99A (■), pQR441 uninduced (•), 
and pQR441 induced (o). Recombinant cells were cultured in a 2 L baffled fermenter 
containing 1 L of M9 medium with 1% (wt/vol) glucose at 37°C. The arrow indicates the point 
of induction with 1 mM IPTG. Duplicate analyses were performed for each sample; average 
values of the duplicates are shown.
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5.3.2.3 O rg a n ic  A cid  P ro d u c tio n  by E. c o l i MG1 655(pQR441 )
The impact of putatively expressed ackA antisense RNA on organic acid production is 
summarised in the following pages. Results showed that there was negligible difference 
in the production of pyruvate, succinate or ethanol by the induced or uninduced cultures 
of E. coli MG1655(pQR441) compared to the control culture (Table 5.9 A). However, 
differences in the production of acetate and lactate were observed.
The peak acetate concentration was reduced by -12-20% in the induced and uninduced 
cultures of E. coli MG1655(pQR441), compared to the control culture. Furthermore, the 
peak level of acetate in the induced culture of E. coli MG1655(pQR441) was comparable 
to the peak level in the induced culture of E. coli MG1655(pQR439) (as shown in section 
5.2.3.4). These results indicate that no additional reduction in carbon flow to acetate was 
achieved by suppressing expression of acetate kinase in addition to 
phosphotransacetylase. This was expected due to the fact that the reaction that is 
catalysed by acetate kinase (i.e. conversion of acetyl phosphate to acetate) can occur 
rapidly by non-enzyme hydrolysis at 37°C (Brown et al., 1977).
Time course profiles of acetate concentration (Figure 5.9 A) showed that both the 
induced and uninduced cultures of E. coli MG1655(pQR441) accumulated slightly higher 
levels of acetate during mid-late exponential phase and early stationary phase, compared 
to the control culture. However, the final acetate levels in both the induced and 
uninduced cultures of E. coli MG1655(pQR441) were slightly lower than the control 
culture. Total amounts of acetate produced (mmoles) per 100 mmoles of glucose 
consumed (Table 5.9 C) revealed that both the induced and uninduced cultures of E. coli 
MG1655(pQR441) produced equivalent amounts of acetate as the control culture. These 
results are unexpected and do not reflect the reduced levels of phosphotransacetylase 
and acetate kinase observed in the cultures expressing putative ackA antisense RNA.
The peak lactate level in the uninduced culture of E. coli MG1655(pQR441) was -2-fold 
higher than the control culture (Table 5.9 A). This increase in lactate production was also 
observed in the uninduced culture of E. coli MG1655(pQR439) (as shown in section 
5.2.3.4.). However, the peak lactate concentration in the induced culture of E. coli 
MG1655(pQR441) was ~2-fold lower than the control culture, which was unexpected. 
Time course profiles of lactate concentration (Figure 5.9 B) showed that the levels of 
lactate were low in all three cultures up until stationary phase, which was expected due to 
the results of the previous study with E. coli MG1655(pQR439). However, after 24 hours 
of growth the induced culture of E. coli MG1655(pQR441) exhibited a reduced level of
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lactate compared to the control culture, whereas the uninduced culture of E. coli 
MG1655(pQR441) exhibited an increased level of lactate, compared to the control 
culture. The amounts of lactate produced (mmoles) per 100 mmoles of glucose 
consumed (Table 5.9 C) reflected this trend.
In conclusion, the results of this study indicate that expression of putative ackA antisense 
RNA in E. coli MG1655 suppresses expression of phosphotransacetylase and acetate 
kinase, but does not greatly reduce carbon flow to acetate. The impact of putative 
expression of ackA antisense RNA from plasmid pQR441 (derived from pTrc99A) is 
compared with expression of putative ackA antisense RNA from plasmid pQR446 
(derived from pMMB66EH), in the following section (section 5.3.6).
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Figure 5.9 Time-course profiles of (A) acetate concentration and (B) lactate concentration in 
E. coli MG1655 harbouring pTrc99A (■), pQR441 uninduced (•), and pQR441 induced (o ). 
Recombinant cells were cultured in a 2 L baffled fermenter containing 1 L of M9 medium with 
1% (wt/vol) glucose at 37°C. The arrows indicate the point of induction with 1 mM IPTG.
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Table 5.9
Summary of organic acid production in bioreactor experiments: (A) Peak Product 
Concentration, (B) Production Rate, and (C) mmoles produced per 100 mmoles of glucose 
consumed.
A
Peak Product Concentration 
(mM)
MG1655(pTrc99A) MG1655(pQR441) 
uninduced
MG1655(pQR441)
induced
(control) (antisense ackA) (antisense ackA)
Acetate 25 20 22
Pyruvate 2 < 1 <1
Lactate 6 13 3
Succinate 1 1 < 1
Ethanol < 1 < 1 < 1
B
Production Rate MG1655(pTrc99A) MG1655(pQR441) MG1655(pQR441)
(mM h 'V uninduced induced
(control) (antisense ackA) (antisense ackA)
Acetate 2.1 ±0.1 2.6 ±0.3 2.7 ±0.2
Lactate 0.0 0.0 0.2 ± 0.07
a Rate established over the range 2-6 hours after inoculation (± standard error).
C
mmoles produced /1 0 0  mmoles MG1655(pTrc99A) MG1655(pQR441) MG1655(pQR441)
glucose consumed uninduced induced
(control) (antisense ackA) (antisense ackA)
Acetate 47 47 46
Lactate 11 31 7
1 3 8
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5.3.3 C o n s t r u c t io n  o f  E. c o l i  MG1 655(pQR445)
Plasmid pQR445 was constructed from pMMB66EH to provide a vector for antisense 
RNA expression, which can stably coexist in E. coli with pTrc99A-derived vectors, and 
has a different antibiotic selection marker. Both pTrc99A and pMMB66EH possess the (3- 
lactamase gene, which confers resistance to ampicillin. Therefore, an aminoglycoside 3’- 
phosphotransferase gene, which confers resistance to kanamycin, was cloned into the 
open reading frame of the (3-lactamase gene, abolishing ampicillin resistance and 
introducing kanamycin resistance (see section 4.3.2.2). E. coli K-12 strain MG1655 was 
transformed with plasmid pQR445, as described in Materials and Methods, and the 
identities of kanamycin-resistant transformants as E. coli MG1655(pQR445) were verified 
by plasmid isolation and restriction analysis. E. coli MG1655(pQR445) cultured on 
selective nutrient agar exhibited growth characteristics that were typical of E. coli 
MG1655.
5.3.4 C o n s t r u c t io n  o f  E. c o l i  MG1 655(pQR446)
Plasmid pQR446 was constructed from pQR445 to express a 240-nucleotide ackA 
antisense RNA molecule, complementary to the 5’ region of ackA mRNA encompassing 
the ribosome-binding site and translation initiation site. The ackA gene fragment in 
plasmid pQR446 is identical to the ackA gene fragment in plasmid pQR441. The purpose 
of developing pQR446 was to create a plasmid that expresses putative ackA antisense 
RNA, which can stably coexist in E. coli MG1655 with pQR439 (putative pta antisense 
RNA expression vector). E. coli K-12 strain MG1655 was transformed with plasmid 
pQR446, as described in Materials and Methods. The identities of the kanamycin- 
resistant transformants as E. coli MG1655(pQR446) were verified by plasmid isolation 
and PCR-amplification of the ackA gene fragment (see section 4.3.2.3).
E. coli MG1655(pQR446) exhibited growth patterns that were uncharacteristic of the 
parent strain. Colonies of E. coli MG1655(pQR446) cultured on selective nutrient agar 
were unusually small, indicating a slow growth rate. In addition, the segretational stability 
of plasmid pQR446 in the host cell was initially low. However, passaging the strain 
several times on selective nutrient agar led to increased stability of pQR446 in E. coli 
MG1655(pQR446). Plasmid maintenance was monitored as described in Materials and 
Methods (Chapter 2).
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In the following pages, shake flask experiments to determine the growth and plasmid 
stability of E. coli MG1655(pQR445) and E. coli MG1655(pQR446) are described. In 
addition, bioreactor experiments to evaluate the impact of putative ackA antisense RNA 
from pQR446 are discussed. E. coli MG1655 harbouring the parent plasmid, pQR445, 
was used as a control strain for the studies. E. coli MG1655(pQR446) was studied under 
‘uninduced’ conditions, i.e. no IPTG was added to the culture medium, and under 
induced conditions, in which IPTG (1mM) was added to the culture medium at early-mid 
log phase (after 3 hours growth). Under uninduced conditions, expression of ackA 
antisense RNA from the tac promoter on plasmid pQR446 should be repressed. 
However, the reduced growth rate of uninduced E. coli MG1655(pQR446) on selective 
nutrient agar indicated that there was basal expression of ackA antisense RNA from the 
plasmid.
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5.3.5 G ro w th  and P lasm id -S tab ility  Studies o f  E. c o li  
MG1 655(pQR445) & E. COLI MG1 655(pQR446)
5.3.5.1 S h a k e -F la s k  G ro w th  S tu d y  o f  E. c o l i MG1 655(pQR445)
E. coli MG1655(pQR445) is a plasmid control strain for experiments involving putative 
ackA antisense RNA expression from plasmid pQR446. E. coli MG1655 harbouring 
plasmid pQR445 exhibited typical growth characteristics of the host strain when cultured 
on selective nutrient agar. However, it was decided to perform a shake flask study of E. 
coli MG1655(pQR445) to examine the growth profile and to evaluate plasmid stability 
after 24 hours growth, prior to cultivation of the strain in a controlled bioreactor. 
Experimental conditions for the shake flask study are shown in Table 5.10, and the 
results are presented and discussed below.
Table 5.10 Experimental conditions for examining the growth and plasmid stability of E. coli
MG1655(pQR445)
Strain E. coli MG1655(pQR445) 
(see Table 2.1)
Media M9 minimal media, 10 g L'1 glucose, trace element mix, 20 
pg ml'1 uracil, 5 pg ml'1 thymidine, 10 pg ml'1 kanamycin.
(see Table 2.4)
Growth Mode Batch, 2 L shake flask (250 ml total working volume)
Temperature 37°C
Shaker Speed 200 rpm
Sampling Times 0, 1,2, 3,4, 5,6, 7, 8, and 24 h
A time course profile of cell density for E. coli MG1655(pQR445) is shown in Figure 5.10. 
Results show that the growth characteristics of E. coli MG1655(pQR445) are comparable 
with E. coli MG 1655(pTrc99A), which was the original control strain used in this study 
(see section 5.2.2.1). Analysis of the plasmid stability of E. coli MG1655(pQR445) after 
24 h growth indicated that there was no decrease in plasmid-harbouring cells in the 
population.
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Figure 5.10 A time-course profile of cell growth for E. coli MG1655(pQR445). Recombinant 
cells were cultured in 2 L baffled shake flasks containing 250 ml of M9 medium with 1% 
(wt/vol) glucose at 37°C and shaken at 200 rpm. Duplicate analyses were performed for each 
sample; average values of the duplicates are shown.
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5 .3 .5 .2  P la s m id  S t a b i l i t y  S tu d y  o f  E. c o u  M G 1 6 5 5 (p Q R 4 4 6 ) in N u t r ie n t  B r o th  and
M 9  M in im a l  M e d ia
Due to the initial instability of plasmid pQR446 in host cell E. coli MG1655, it was decided 
to examine the proportion of plasmid-containing cells at several time-points throughout 
the course of a 24 h shake flask fermentation. The study was conducted in both nutrient 
broth and M9 minimal media, to determine whether the media composition affected 
plasmid stability. Experimental conditions for the shake flask study are shown in Table 
5.11.
Table 5.11 Experimental conditions for examining the plasmid stability of E. coli 
MG1655(pQR446) in nutrient broth and M9 minimal media
Strain E. coli MG 1655(pQR446) 
(see Table 2.1)
Media Nutrient agar, 10 pg ml'1 kanamycin.
M9 minimal media agar, 10 pg ml'1 kanamycin 
(see Table 2.4)
Growth Mode Batch, 250 ml shake flask (50 ml total working volume)
Temperature 37°C
Shaker Speed 200 rpm
Sampling Times 0, 2, 4, 6, and 24 h
The results showed plasmid stability was high at all points tested during the 24 h culture, 
and no discernible difference was detected between cultures grown in nutrient broth or 
M9 minimal media (data not shown).
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5.3.5.3 S h ake  F la s k  G ro w th  S tu d y  o f  E. c o u  MG1 655(pQR446)
Following the observation that plasmid pQR446 was stably maintained in a population of 
E. coli MG1655(pQR446) for 24 h, it was decided to study the growth kinetics in shake 
flask culture, prior to fermentation in a controlled bioreactor. Experimental conditions for 
the shake flask study are shown in Table 5.12, and the results are presented and 
discussed below.
Table 5.12 Experimental conditions for examining the growth and plasmid stability of E. coli
MG1655(pQR446)
Strain E. coli MG1655(pQR446) 
(see Table 2.1)
Media M9 minimal media, 10 g L'1 glucose, trace element mix, 20 
pg ml'1 uracil, 5 pg ml'1 thymidine, 10 pg ml'1 kanamycin.
(see Table 2.4)
Growth Mode Batch, 500 ml shake flask (100 ml total working volume)
Temperature 37°C
Shaker Speed 200 rpm
Sampling Times 0, 1,2, 3,4, 5,6, 7, 8, 9, 10, 11, 12 and 24 h
A time course profile of cell density for E. coli MG1655(pQR446) grown in shake flask 
culture is shown in Figure 5.11. The growth rate and maximum cell density of the culture 
were reduced by -45%  and -60%  respectively, compared to the plasmid control strain 
grown in shake flask culture (see section 5.3.5.1). These results indicate that a dramatic 
alteration in the physiology of E. coli MG 1655 was brought about by the presence of 
plasmid pQR446. This is discussed further in light of the bioreactor experiments in the 
following section (5.3.6).
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Figure 5.11 A time-course profile of cell growth for E. coli MG1655(pQR446). Recombinant 
cells were cultured in a 500 ml shake flasks containing 100 ml of M9 medium with 1% (wt/vol) 
glucose at 37°C and shaken at 200 rpm. Duplicate analyses were performed for each sample; 
average values of the duplicates are shown.
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5.3.6 A n alys is  o f  E. c o l i  MG1 655(pQR446) in a  C o n tro lle d  
B io re a c to r
The objective of this study was to determine the impact of putative ackA antisense RNA, 
expressed from plasmid pQR446, on growth, enzyme levels and organic acid production 
by E. coli MG1655 cultured in a controlled bioreactor. Two E. coli strains were used in 
this study: E. coli MG1655(pQR446), generated to express antisense RNA targeted 
against acetate kinase; and E. coli MG1655(pQR445), a control strain harbouring the 
parent plasmid. Experimental conditions for the bioreactor experiments are detailed in 
Table 5.13, and the results are presented and discussed in the following pages.
Table 5.13 Experimental conditions for testing the effect of putative ackA antisense RNA in
bioreactor experiments
Strains E. coli MG 1655(pQR445) 
(see Table 2.1)
E. coli MG 1655(pQR446) 
(see Table 2.1)
Media M9 minimal media, 10 g L'1 glucose, trace element mix, 20 
pg ml*1 uracil, 5 pg ml'1 thymidine, 10 pg ml*1 kanamycin.
(see Table 2.4)
Growth Mode Batch, 2 L bioreactor (1 L working volume)
Temperature 37°C
Agitation Speed 800 rpm
Air Flow Rate 1 vvm
Sampling Times 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 and 24 h
IPTG Addition Time 3 h
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5.3.6.1 G ro w th  and G lu c o s e  U p ta k e  by E. c o l i MG1 655(pQR446)
The impact of putatively produced ackA antisense RNA from plasmid pQR446 on 
maximum biomass concentration (expressed as ODeoo). growth rate and glucose uptake 
rate is summarised in Table 5.14. The maximum ODeoo of the induced and uninduced 
cultures of E. coli MG1655(pQR446) were reduced by -48%  and -38%  respectively, 
compared to the control culture. Furthermore, growth rates of the induced and uninduced 
cultures of E. coli MG1655(pQR446) were reduced by -65%  and -  54% respectively, 
compared to the control culture. These results are dramatically different to those obtained 
from the study of putative ackA antisense RNA expression from plasmid pQR441 (see 
section 5.3.2.1).
Time course profiles of cell density and residual glucose concentration are shown in 
Figure 5.12. The cell densities of both the induced and uninduced cultures of E. coli 
MG1655(pQR446) were much lower than the control culture for the duration of the 24 h 
fermentation. However, the results show that glucose is depleted at a comparable rate in 
all three cultures for the first eight hours of growth, and is almost competed depleted in 
both the induced and uninduced culture of E. coli MG1655(pQR446) after 10 hours 
growth. These observations suggest that E. coli MG1655(pQR446) is metabolising 
glucose rapidly and utilising it for production of another compound rather than converting 
it to biomass, as in the control culture.
Table 5.14 Summary of substrate uptake and biomass formation in bioreactor experiments
Fermentation
characteristic
MG1655(pQR445) MG1655(pQR446) 
uninduced
MG1655(pQR446)
induced
(control) (antisense ackA) (antisense ackA)
Max. ODeoo3 6.5 ± 0.05 4.0 ± 0.01 3.4 ± 0.02
Growth Rate (h'1)b 0.63 ± 0.03 0.28 ±0.01 0.22 ±0.01
Glucose Uptake Rate 5.2 ± 0 .7 2.3 ±0 .3 1.1 ±0 .7
(mM h 1)b
3 Mean ± standard error of the mean.
b Rate established over the range 0-4 hours after inoculation (± standard error).
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Figure 5.12 Time-course profiles of (A) cell growth and (B) residual glucose concentration in 
E. coli MG1655 harbouring pQR445 (■), pQR446 uninduced (•), and pQR446 induced (o). 
Recombinant cells were cultured in a 2 L baffled fermenter containing 1 L of M9 medium with 
1% (wt/vol) glucose at 37°C. The arrow indicates the point of induction with 1 mM IPTG. 
Duplicate analyses were performed for each sample; average values of the duplicates are 
shown.
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5.3.6.2 Enzyme A c tiv ity  L e v e ls  in E . c o l i MG1 655(pQR446)
The impact of putatively produced ackA antisense RNA from plasmid pQR446 on 
phosphotransacetylase and acetate kinase specific enzyme activity is shown in Figure 
5.13. The time course profiles of acetate kinase activity indicated that both the induced 
and uninduced cultures of E. coli MG1655(pQR446) had elevated levels of acetate 
kinase compared to the control culture. After 24 h growth, the level of acetate kinase in 
the induced and uninduced cultures of E. coli MG1655(pQR446) was ~3-fold higher than 
the control culture. However, it is notable that the levels of acetate kinase in this control 
culture were -60%  lower than the acetate kinase levels in the original plasmid control 
culture, E. coli MG1655(pTrc99A) (see section 5.3.2.2). Furthermore, the time course 
profiles of phosphotransacetylase activity indicated that both the induced and uninduced 
cultures of E. coli MG1655(pQR446) also had elevated levels of phosphotransacetylase 
compared to the control culture. Again, the levels of phosphotransacetylase in this control 
culture were -80%  lower than the phosphotransacetylase levels in the original plasmid 
control culture, E. coli MG1655(pTrc99A) (see section 5.3.2.2).
These results were unexpected and are difficult to explain. The presence of plasmid 
pQR445 in E. coli MG1655 seems to result in reduced levels of both acetate kinase and 
phosphotransacetylase. This may be due to the interaction of a component that is 
encoded by plasmid pQR445 with the E. coli MG 1655 chromosomal DNA. It would be 
interesting to compare the enzyme activities in the host cell with this control strain. In 
addition, microarray analysis could be used to investigate the effect of pQR445 presence 
on global gene expression in E  coli MG 1655.
149
Chapter 5: Fermentation of E. coli MG1655 Expressing Putative Antisense RNA
0 .0 6 -
0.05 -
o> IPTG
zd. 0 .0 4 -
9  0 .0 3 -
<U 0 . 0 2 -  Q.
SI o.oi -
0.00
0 2 4 6 8 24
Time (h)
0 .0 4 -
IPTGo>
zL  0 .0 3 -
o  0 . 0 2 -
Q.
0.00
2486420
Time (h)
Figure 5.13 Time-course profiles of specific enzyme activity for (A) phosphotransacetylase 
and (B) acetate kinase in E. coli MG 1655 harbouring pQR445 (■), pQR446 uninduced (•), 
and pQR446 induced (o). Recombinant cells were cultured in a 2 L baffled fermenter 
containing 1 L of M9 medium with 1% (wt/vol) glucose at 37°C. The arrow indicates the point 
of induction with 1 mM IPTG. Duplicate analyses were performed for each sample; average 
values of the duplicates are shown.
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5.3.6.3 O rg a n ic  A cid  P ro d u c tio n  by E. c o l i MG1 655(pQR446)
The impact of putatively produced ackA antisense RNA on organic acid production is 
summarised in the following pages. Results showed that there was negligible difference 
in the production of pyruvate, succinate or ethanol by the induced or uninduced cultures 
of E. coli MG1655(pQR446) compared to the control culture. However, dramatic 
differences in the production of acetate and lactate were observed.
Time course profiles of acetate concentration (Figure 5.14) showed that during 
exponential growth phase and early stationary phase, acetate accumulation in both the 
induced and uninduced cultures of E. coli MG1655(pQR446) was greatly reduced 
compared to the control culture. This trend is reflected in the initial acetate production 
rates (Table 5.15 B). However, the final acetate levels were comparable in all three 
cultures. The peak acetate concentration exhibited by the control culture, E. coli 
MG1655(pQR445), was -45%  lower than the peak acetate concentration in the original 
control culture, E. coli MG1655(pTrc99A) (see section 5.3.2.3). This observation is 
consistent with the lower levels of phosphotransacetylase and acetate kinase in E. coli 
MG1655(pQR445) compared to E. coli MG1655(pTrc99A). Overall, these results are very 
interesting, and suggest that putative expression of ackA antisense RNA from pQR446 
greatly reduced acetate production by E. coli MG 1655. However, it is difficult to separate 
the probable effects of the parent plasmid with the effects of putative ackA antisense 
RNA. Further investigation is required to determine how the presence of control plasmid 
pQR445 affects acetate production by E. coli MG1655.
Cultures of E. coli MG1655(pQR446) exhibited peak lactate levels that were ~6-7-fold 
higher than the control culture. The amounts of lactate produced (mmoles) per 100 
mmoles of glucose consumed agree with this trend (Table 5.15 C). Time course profiles 
of lactate accumulation (Figure 5.14) showed that lactate was produced by both the 
induced and uninduced cultures of E. coli MG1655(pQR446) right from the start of growth 
in the fermenter, which is strikingly different from the lactate production pattern that has 
been observed in all the other cultures studied during this research. The timing of lactate 
production by the control culture E. coli MG1655(pQR445) followed the same trend as all 
the previous cultures studied i.e. lactate was only produced during stationary phase 
(Figure 5.14).
The high levels of lactate that were produced by the slow-growing E. coli 
MG1655(pQR446) indicate that lactate dehydrogenase was expressed at high levels in 
these cultures. This would agree with a study by Bunch et al. (1997), which showed that
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E. coli cultures expressing high levels of lactate dehydrogenase grew very poorly, 
especially in minimal medium. Growth inhibition was thought to be due to depletion of the 
intracellular pyruvate pool. The cause of probable increased levels of lactate 
dehydrogenase in E. coli MG1655(pQR446) may have been accumulation of intracellular 
pyruvate due to inhibition of the pyruvate dehydrogenase complex by elevated levels of 
acetyl CoA, as previously discussed in section 5.2.3.4. However, the 
phosphotransacetylase and acetate kinase levels in E. coli MG1655(pQR446) were not 
reduced to such an extent that high levels of acetyl CoA would have been expected to 
accumulate. Therefore, it is likely that additional, more complex factors are involved. The 
results of this study are discussed further in section 5.5 at the end of the chapter.
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F ig u re  5 .1 4  Time-course profiles of (A) acetate concentration and (B) lactate concentration in 
E  coli MG 1655 harbouring pQR445 (■), pQR446 uninduced (•), and pQR446 induced (o). 
Recombinant cells were cultured in a 2 L baffled fermenter containing 1 L of M9 medium with 
1% (wt/vol) glucose at 37°C. The arrow indicates the point of induction with 1 mM IPTG.
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Table 5.15
Summary of organic acid production in bioreactor experiments: (A) Peak Product 
Concentration, (B) Production Rate, and (C) mmoles produced per 100 mmoles of glucose 
consumed.
A
Peak Product Concentration 
(mM)
MG 1655(pQR445) MG1655(pQR446)
uninduced
MG1655(pQR446)
induced
(control) (antisense ackA) (antisense ackA)
Acetate 14 14 14
Pyruvate < 1 < 1 < 1
Lactate 9 54 63
Succinate < 1 < 1 < 1
Ethanol < 1 < 1 < 1
B
Production Rate MG1655(pQR445) MG1655(pQR446) MG1655(pQR446)
(mM h 'V uninduced induced
(control) (antisense ackA) (antisense ackA)
Acetate 1.8 ±0 .3 0.5 ±0 .05 0.0
Lactate 0.0 2.8 ±0 .3 2.4 ± 0.6
3 Rate established over the range 0-4 hours after inoculation (± standard error).
C
mmoles produced / 100 mmoles MG1655(pQR445) MG1655(pQR446) MG1655(pQR446)
glucose consumed uninduced induced
(control) (antisense ackA) (antisense ackA)
Acetate 32 31 27
Lactate 24 117 130
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5 .4  Im p act o f  P u ta t iv e  pta &  ackA  A n tisense R N A  on
G r o w t h  a n d  P r o d u c t  F o r m a t io n
5.4.1 C o n s t r u c t io n  o f  E. c o l i  MG1655(pQR439/pQR446)
E. coli MG1655(pQR439/pQR446) was constructed to co-express putative pta and ackA 
antisense RNA in E. coli. Construction of plasmids pQR439 and pQR446 have previously 
been summarised in sections 5.2.1 and 5.3.4 respectively.
Simultaneous transformation of E. coli MG 1655 with pQR439 and pQR446 resulted in no 
ampicillin-kanamycin resistant transformants. Therefore, plasmids pRQ439 and pQR446 
were transformed into E. coli MG1655 in several stages. First, E. coli MG1655 was 
transformed with pQR439, and competent E. coli MG1655(pQR439) cells were prepared. 
Then, E  coli MG1655(pQR439) was transformed with pQR446. Initially, many colonies 
grew on nutrient agar supplemented with 15 pg ml"1 kanamycin and 100 pg ml'1 
ampicillin. However, re-streaking of individual colonies from the transformation plate on to 
selective nutrient agar resulted in an unexpectedly small number of colonies, which were 
short lived and could not easily be sub-cultured if the plate was more than a few days old. 
Subsequent analysis of the cells by plating on nutrient agar containing either ampicillin or 
kanamycin, and by analysis of isolated plasmid DNA, revealed that pQR439 was being 
‘lost’ from the strain. Therefore, it was decided to increase the concentration of ampicillin 
from 100 pg m l'1 to 500 pg m l'1 to increase the selection pressure for maintenance of 
pQR439 in E. coli MG1655(pQR439/pQR446). This higher level of ampicillin was 
successful in maintaining pQR439 in E. coli MG1655(pQR439/pQR446), without 
inhibiting growth of the strain (data not shown). The identities of ampicillin-kanamycin 
resistant colonies were confirmed by plasmid isolation and restriction analysis (see 
section 4.4.1.2). All experiments with E. coli MG1655(pQR439/pQR446) were initiated by 
culturing cells, from a glycerol stock stored at -80°C, on selective nutrient agar as 
individual colonies, and then immediately sub-culturing them in selective liquid media.
E. coli MG1655(pQR439/pQR446) cultured on selective nutrient agar exhibited growth 
characteristics that were typical of the host strain. In the following pages, bioreactor 
experiments to determine the impact of putative pta and ackA antisense RNA are 
described. E. coli MG 1655 harbouring the parent plasmids, pTrc99A & pQR445, was 
used as a control strain for these studies. E. coli MG1655(pQR439/pQR446) was studied 
under ‘uninduced’ conditions, i.e. no IPTG was added to the culture medium, and under 
induced condition, in which IPTG (1 mM) was added to the culture medium. Two time 
points were selected for IPTG addition: immediately after fermenter inoculation (0 h); and
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early-mid log phase (after 3 hours growth). Under uninduced conditions, expression of 
pta & ackA antisense RNA should be repressed. However, previous studies of E. coli 
MG1655(pQR439) (section 5.2) and E. coli MG1655(pQR446) (section 5.3) indicated that 
high levels of antisense RNA were expressed even under repressed conditions.
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5.4.2 A n a ly s is  o f  E. c o l i MG1 655(pQR439/pQR446) in a  C o n tr o l le d  
B io r e a c to r
The objectives of this study were to determine (A) the effect of co-expression of pta & 
ackA antisense RNA on growth, enzyme levels and organic acid production by E. coli 
MG 1655, and (B) whether induction of antisense RNA at the start of fermentation results 
in greater suppression of the target enzymes, compared to induction in early-mid log 
phase. Two E. coli strains were used in this study: E. coli MG1655(pQR439/pQR446), 
developed to co-express antisense RNA targeted against phosphotransacetylase and 
acetate kinase: and E. coli MG1655(pTrc99A/pQR445), a control strain harbouring the 
parent plasmids. All the plasmids were stably maintained throughout the 24 hour study. 
Experimental conditions for the bioreactor experiments are detailed in Table 5.16, and 
the results are presented and discussed in the following pages.
Table 5.16 Experimental conditions for testing the effect of putative ackA & pta antisense
RNA in bioreactor experiments
Strains E. coli MG1655(pQR439/pQR446) 
(see Table 2.1)
E. coli MG1655(pTrc99A/pQR445) 
(see Table 2.1)
Media M9 minimal media, 10 g L'1 glucose, trace element mix, 20 
pg ml’1 uracil, 5 pg ml'1 thymidine, 10 pg ml'1 kanamycin, 
500 pg ml'1 ampicillin.
(see Table 2.4)
Growth Mode Batch, 2 L bioreactor (1 L working volume)
Temperature 37°C
Agitation Speed 800 rpm
Air Flow Rate 1 vvm
Sampling Times 0, 1, 2, 3, 4, 5, 6, 7, 8, and 24 h
IPTG Addition Time 3 h
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5.4.2.1 G ro w th  and G lu c o s e  U p ta k e  by E. c o l i MG1 655(pQR439/pQR446)
The impact of putatively expressed pta and ackA antisense RNA on maximum biomass 
concentration (expressed as OD6 0 0 ), growth rate and glucose uptake rate is summarised 
in Table 5.17. Time course profiles of cell density and residual glucose concentration are 
shown in Figure 5.15. Overall, the results indicated that growth and glucose uptake were 
comparable in all three cultures, and were typical of the host cell. These results were 
unexpected due to the impaired growth rate and reduced biomass levels that were 
observed in cultures of E. coli MG1655 harbouring the single plasmid pQR446 (see 
section 5.3.4.1).
Table 5.17 Summary of substrate uptake and biomass formation in bioreactor experiments
Fermentation
characteristic
MG1655
(pTrc99A/pQR445)
MG1655
(pQR439/pQR446)
uninduced
MG1655 
(pQR439/pQR446) 
induced at 0 h
MG1655 
(pQR439/pQR446) 
induced at 3 h
(control) (antisense pta  & ackA) (antisense pta & ackA) (antisense pta & ackA)
Max. ODijoo8 5 .1  ± 0 . 0 3 5 .1  ±  0 .0 3 5 .7  ±  0 .0 9 4 .7  ±  0 .0 7
Growth Rate (h 1)b 0 . 4 8  ±  0 .0 4 0 . 4 7  ±  0 .0 4 0 . 4 9  ±  0 .0 6 0 .4 5  ±  0 .0 4
Glucose Uptake 
Rate (mM h 1)b
6 .1  ± 0 . 5 5 . 9  ± 0 . 9 4 . 9  ± 0 . 7 6 .0  ±  0 .8
a Mean ± standard error of the mean.
b Rate established over the range 2-6 hours after inoculation (± standard error).
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Figure 5.15 Time-course profiles of (A) cell growth and (B) residual glucose concentration in 
E. coli MG1655 harbouring pTrc99A & pQR445 (■), pQR439 & pQR446 uninduced (•), 
pQR439 & pQR446 induced at the point of fermenter inoculation (A), and pQR439 & pQR446 
induced 3 h after inoculation (o). Recombinant cells were cultured in a 2 L baffled fermenter 
containing 1 L of M9 medium with 1% (wt/vol) glucose at 37°C. Arrows indicate the points of 
induction with 1 mM IPTG. Duplicate analyses were performed for each sample; average 
values of the duplicates are shown.
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5.4.2.2 Enzyme A c tiv ity  L eve ls  in E. c o l i MG1 655(pQR439/pQR446)
The impact of putatively produced pta and ackA antisense RNA on 
phosphotransacetylase and acetate kinase specific enzyme activity is shown in Figure 
5.16.
Time course profiles of phosphotransacetylase activity revealed that the control culture, 
E. coli MG1655(pTrc99A/pQR445) exhibited comparable levels with E. coli MG 1655 
harbouring the single plasmid pTrc99A, which were higher than the levels in E. coli 
MG1655 harbouring only plasmid pQR445. Furthermore, the profiles of acetate kinase 
activity also reflected this trend, i.e. E. coli MG1655(pTrc99A/pQR445) exhibited 
comparable acetate kinase levels with E. coli MG1655 harbouring the single plasmid 
pTrc99A, which were higher than E. coli MG 1655 harbouring only plasmid pQR445.
Results showed that the culture of E. coli MG1655(pQR439/pQR446) that was induced 
immediately after fermenter inoculation had reduced levels of both 
phosphotransacetylase and acetate kinase, compared to the control culture. E. coli 
MG1655(pQR439/pQR446) that was induced after 3 hours growth also had slightly 
reduced levels of phosphotransacetylase compared to the control culture, and exhibited 
levels of both phosphotransacetylase and acetate kinase that were similar to the culture 
of E. coli MG1655 harbouring only the single pQR439 plasmid.
In this study, the levels of phosphotransacetylase and acetate kinase in the uninduced 
culture of E. coli MG1655(pQR439/pQR446) were comparable with the control culture. 
These results suggest that putative expression of pta & ackA antisense RNA in E. coli 
MG1655 leads to partial suppression of phosphotransacetylase and acetate kinase. 
Whilst the effect was more pronounced in E. coli MG1655(pQR439/pQR446) induced at 
the start of fermentation, the overall enzyme suppression achieved did not exceed the 
enzyme suppression achieved with individual expression of putative pta (see section 5.2) 
or ackA (see section 5.3) antisense RNA.
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Figure 5.16 Time-course profiles of specific enzyme activity for (A) phosphotransacetylase 
and (B) acetate kinase in E. coli MG 1655 harbouring pTrc99A & pQR445 (■), pQR439 & 
pQR446 uninduced (•), pQR439 & pQR446 induced at the point of fermenter inoculation (A), 
and pQR439 & pQR446 induced 3 h after inoculation (o). Recombinant cells were cultured in 
a 2 L baffled fermenter containing 1 L of M9 medium with 1% (wt/vol) glucose at 37°C. The 
arrow indicates the point of induction with 1 mM IPTG. Duplicate analyses were performed for 
each sample; average values of the duplicates are shown.
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5.4.2.3 O rg a n ic  A cid  P ro d u c tio n  by E. c o l i MG1 655(pQR439/pQR446)
The impact of putatively produced pta and ackA antisense RNA on organic acid 
production is summarised in the following pages. Results showed that there was 
negligible difference in the production of pyruvate, succinate or ethanol in any of the 
cultures studied. However, differences in the production of acetate and lactate were 
observed.
The peak acetate levels in all the cultures of E. coli MG1655(pQR439/pQR446) and in 
the control culture, E. coli MG1655(pTrc99A/pQR445), were reduced by -40%  compared 
to E. coli MG 1655 harbouring the single control plasmid, pTrc99A (as shown in section 
5.2.3.4). However, these lower peak acetate levels were comparable with the peak 
acetate levels in E. coli MG1655 harbouring either pQR445 or pQR446 (as shown in 
section 5.3.6.3). Therefore, these results suggest that the presence of plasmid pQR445 
or pQR446 in the dual plasmid-harbouring strains is having an impact on acetate 
production by the cultures.
Time course profiles of acetate accumulation (Figure 5.17 A) show that the acetate levels 
in all the cultures were roughly the same up until early-mid log phase. After this point 
there is some variation between the cultures, with E. coli MG1655(pQR439/pQR446) 
induced at 0 h accumulating the highest levels of acetate during mid-late exponential 
growth phase and into early stationary phase. After 24 hours growth, all the cultures 
exhibited comparable levels of acetate, apart from the culture of E. coli 
MG1655(pQR439/pQR446) induced at 3 h, which exhibited a slightly lower level. The 
total amounts of acetate produced (mmoles) per 100 mmoles of glucose consumed 
reflected this trend (Table 5.18 C).
The peak level of lactate in the control culture, E. coli MG1655(pTrc99A/pQR445), was 
comparable with the culture of coli MG1655 harbouring the single plasmid pQR445. In 
fact, the amounts of lactate produced per 100 mmoles of glucose consumed were 
identical in E. coli MG1655(pTrc99A/pQR445) and E. coli MG1655(pQR445). The peak 
lactate levels in all the cultures of E. coli MG1655(pQR439/pQR446) were comparable, 
and were -50%  lower than the control culture. This trend was also reflected by the 
amounts of lactate produced per 100 mmoles of glucose consumed, (Table 5.18 C). Time 
course profiles of lactate production (Figure 5.17 B) showed that lactate levels were low 
in all the cultures during exponential growth phase, increasing into early stationary phase 
and peaking after 24 h in late stationary phase. This pattern was typical of E. coli 
MG1655 harbouring pTrc99A, pQR439 or pR445, but was not typical of pQR446.
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In conclusion, the results of this study show that the dual plasmid-harbouring strains 
possess some characteristics of both of the strains harbouring the individual plasmids. 
Cultures of E. coli MG1655(pTrc99A/pQR445) resembled E. coli MG1655(pTrc99A) in 
biomass production and enzyme levels, however the acetate and lactate levels were 
more similar to E. coli MG1655(pQR445). Cultures of E. coli MG1655(pQR439/pQR446) 
resembled E. coli MG1655(pQR439) in biomass production, enzyme levels, and lactate 
accumulation, however the levels of acetate accumulation were more similar to E. coli 
MG1655(pQR446).
It is difficult to separate the effects of putative antisense RNA expression from the 
probable effects of the pMMB66EH-derived constructs (i.e. pQR445 and pQR446) on E. 
coli MG1655 metabolism. However, it would be interesting to study these constructs 
further and determine the mechanism of acetate reduction in E. coli MG 1655 harbouring 
the pMMB66EH-derived constructs.
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Figure 5.17 Time-course profiles of (A) acetate concentration and (B) lactate concentration in 
E. coli MG 1655 harbouring pTrc99A & pQR445 (■), pQR439 & pQR446 uninduced (•), 
pQR439 & pQR446 induced at the point of fermenter inoculation (A), and pQR439 & pQR446 
induced 3 h after inoculation (o). Recombinant cells were cultured in a 2 L baffled fermenter 
containing 1 L of M9 medium with 1% (wt/vol) glucose at 37°C. The arrows indicate the points 
of induction with 1 mM IPTG.
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T a b le  5 .1 8
Summary of organic acid production in bioreactor experiments: (A) Peak Product 
Concentration, (B) Production Rate, and (C) mmoles produced per 100 mmoles of glucose 
consumed.
A
Peak Product 
Concentration 
(mM)
MG1655 
(pT rc99A/pQR445)
MG1655
(pQR439/pQR446)
uninduced
MG1655 
(pQR439/pQR446) 
induced at 0 h
MG1655 
(pQR439/pQR446) 
induced at 3 h
(control) (antisense pta & ackA) (antisense pta & ackA) (antisense pta & ackA)
Acetate 16 15 15 11
Pyruvate < 1 < 1 < 1 < 1
Lactate 12 7 6 6
Succinate < 1 < 1 < 1 < 1
Ethanol < 1 < 1 < 1 < 1
B
Production MG1655 MG1655 MG1655 MG1655
Rate (mM h'1) (pT rc99A/pQR445) (pQR439/pQR446) (pQR439/pQR446) (pQR439/pQR446)
uninduced induced at 0 h induced at 3 h
(control) (antisense pta & ackA) (antisense pta & ackA) (antisense pta & ackA)
Acetate 1.3 ±0.1 1.0 ±0 .2 2.8 ± 0.3 1.5 ±0.1
Lactate 0.0 0.1 ±0 .05 0.1 ± 0.04 0.0
a Rate established over the range 2-6 hours after inoculation (± standard error).
C
mmoles produced / MG1655 MG1655 MG1655 MG1655
100 mmoles (pT rc99A/pQR445) (pQR439/pQR446) (pQR439/pQR446) (pQR439/pQR446)
glucose consumed uninduced induced at 0 h induced at 3 h
(control) (antisense pta & ackA) (antisense pta & ackA) (antisense pta & ackA)
Acetate 29 24 31 21
Lactate 24 13 11 13
165
Chapter 5: Fermentation of E. coli M G1655 Expressing Putative Antisense RNA
5 .5  D is c u s s io n  a n d  C o n c l u s io n s
This chapter discussed the physiological characterisation of four recombinant E. coli 
strains that were constructed to express putative antisense RNA targeted against 
phosphotransacetylase and acetate kinase in E. coli MG1655. It was hypothesised that 
expression of these putative antisense RNA molecules would suppress expression of 
their target enzymes and reduce acetate accumulation in the culture medium. 
Recombinant E. coli strains were cultured in shake flasks and 2 L controlled bioreactors 
to evaluate the impact of putative antisense RNA expression on growth kinetics, enzyme 
levels and organic acid production. Some of the interesting aspects of these studies are 
discussed further in this section.
Results of the bioreactor experiments showed that expression of putative pta antisense 
RNA from a pTrc99A-derived construct (pQR439) was able to reduce the total acetate 
accumulation by -15% , compared to the control culture. Lactate accumulation was 
increased by -50%  in this culture (as shown in section 5.2.3.4). Putative expression of 
ackA antisense RNA from a pTrc99A-derived construct (pQR441) also resulted in 
reduced total acetate accumulation compared to the control culture. However, the 
proportion of acetate that was produced from the metabolised glucose was not reduced 
in this culture. Lactate accumulation was not increased in this culture either (as shown in 
section 5.3.2.3).
Putative expression of ackA antisense RNA from a pMMB66EH-derived construct 
(pQR446) resulted in dramatically altered growth and product formation by E. coli 
MG1655 (as shown in section 5.3.6). However as previously discussed, the reduced 
levels of acetate in cultures of E. coli MG 1655 harbouring plasmid pQR446 may have 
been due to a plasmid-mediated affect. This conclusion was based on the fact that 
cultures of E. coli MG1655 harbouring the parent plasmid (pQR445) exhibited reduced 
levels of acetate compared to the original control culture, E. coli MG1655(pTrc99A), and 
the other cultures studied in this research. The possible mechanism that caused reduced 
acetate production by pQR445 might involve the interaction of a plasmid-encoded 
molecule with the E. coli MG 1655 chromosomal DNA. Such a molecule may have directly 
inhibited expression of phosphotransacetylase and/or acetate kinase at the level of 
transcription or translation, or may have inhibited activity of the phosphotransacetylase 
and/or acetate kinase enzymes by binding to them and either altering their conformation 
or blocking access to their active site. This would agree with the reduced enzyme activity 
levels that were exhibited by E. coli MG1655(pQR445). To examine this further, it would
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be necessary to compare the enzyme activity levels and acetate accumulation in cultures 
of E. coli MG1655(pQR445) with cultures of E. coli MG1655 harbouring the parent 
plasmid pMMB66EH, and with the empty host cell.
Surprisingly, the enzyme activity levels of phosphotransacetylase and acetate kinase 
were higher in cultures of E. coli MG1655 harbouring plasmid pQR446, compared to E. 
coli MG 1655 harbouring the parent plasmid, pQR445. This suggests that the region of 
plasmid pQR445 that was disrupted in constructing pQR446 (i.e. the multiple cloning site) 
may have been responsible for mediating the reduction in acetate production by the host 
cell. However, this seems unlikely due to the nature of the region. It consists of a series 
of restriction sites for cloning in heterologous gene fragments. Analysis of the sequence 
similarity of this region with E. coli MG1655 chromosomal DNA may give an indication of 
the likelihood of this possibility. Furthermore, results suggest that the impaired growth 
rate, reduced levels of acetate production and very high levels of lactate production by E. 
coli MG 1655 harbouring pQR446 (described in section 5.3.6.3) may have been due to a 
combination of putative ackA antisense RNA and plasmid-mediated effects.
Kim and Cha (2003) also attempted to reduce acetate production by E. coli using 
antisense RNA (see section 1.3.2.2.3). The key difference in their study was the E. coli 
strain they investigated, which was the low-acetate producer BL21. As previously 
discussed in Chapter 1, a recent study has shown that the glyoxylate shunt and acetyl 
CoA synthetase (Figure 1.1) are active when E. coli BL21 is grown on glucose (Phue and 
Shiloach, 2004). This allows the cells to utilise carbon in the central pathways more 
efficiently, and excrete less as acetate. In contrast, the glyoxylate shunt and acetyl CoA 
synthetase are inactive in high-acetate producing K-12 strains, when grown on glucose. 
Kim and Cha (2003) found that in shake flask culture, E. coli BL21 expressing a) pta 
antisense RNA, b) ackA antisense RNA, and c) pta and ackA antisense RNA all 
accumulated slightly higher levels of acetate compared to the control culture. However, 
when recombinant protein (GFP: green fluorescent protein) was co-expressed with the 
antisense RNA molecules in E. coli BL21, -15-20%  reduction in peak acetate levels was 
achieved. Lactate accumulation was not reported in this study. Overall, the study 
achieved a similar reduction in acetate production using antisense RNA as was found in 
this research, despite the probable differences in acetate metabolism in the two strains.
In glucose minimal media, mutant E. coli strains defective in phosphotransacetylase and 
acetate kinase typically exhibit reduced growth rates (15-30%) and very low levels of 
acetate production. In the absence of phosphotransacetylase, it is assumed that acetate 
is produced by pyruvate oxidase, which converts pyruvate directly to acetate (as
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described in Chapter 1). The reduced acetate excretion is compensated for by increased 
excretion of pyruvate and/or lactate in these cultures, during the exponential growth 
phase (Chang et al., 1999; Contiero et al., 2000; Diaz-Ricci et al., 1991; Hahm et al., 
1994; Kakuda et al., 1994). The antisense-regulated strains that were constructed in this 
study have similar phenotypes as the mutant E. coli strains with defective 
phosphotransacetylase and acetate kinase. However, to examine the effects of putative 
pta and ackA antisense RNA in E. coli MG1655 further, it would be necessary to isolate 
and quantify the levels of antisense RNA and target mRNA that are present in the 
recombinant E. coli strains. Although, studies have shown that the level of a specific 
mRNA does not always correlate with the level of its corresponding protein (Lee et al., 
2003; Mehra et al., 2003). Therefore, measurement of enzyme activity levels and product 
formation provides a better gauge of the impact of antisense RNA on metabolism.
In the majority of cultures in this study, ammonium chloride was depleted after -6  hours 
growth. However, glucose was still present in excess amounts after this time. Therefore, 
it is likely that the high levels of acetate that accumulated after 24 hours growth were a 
consequence of the excess glucose that was present after biomass production had 
ceased. It would be interesting to study the effect of increasing the initial concentration of 
ammonium chloride on the final acetate levels in these cultures. Alternatively, the effect 
of using ammonium hydroxide as an alkali in the pH buffering system for the 
fermentations could be investigated. This would provide a secondary nitrogen source, 
which may lead to increased carbon flow to biomass production and lower carbon flow to 
acetate.
In order to investigate the effects of pta and ackA antisense RNA expression further, the 
fermentation results presented in this chapter have been used for metabolic flux analysis 
of the recombinant E. coli strains. This approach used the specific growth rate, specific 
glucose uptake rate and specific product formation rates to calculate the intracellular flux 
distribution for each E. coli strain. The results are presented in the following chapter 
(Chapter 6).
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6.1 S u m m a r y
A quantitative description of metabolism is of fundamental importance for analysing the 
impact of genetic or environmental perturbations on carbon flow through the E. coli 
metabolic network. This chapter describes the use of metabolic flux analysis to 
investigate the impact of reduced acetate production on carbon flow through the central 
metabolic pathways of E. coli MG 1655. Metabolic flux analysis was the approach chosen 
for this study due to its simplicity. It requires only information about metabolic reaction 
stoichiometry, metabolic requirements for growth, and the measurement of a few strain- 
specific parameters. Enzyme kinetic data, which is difficult to obtain, is not required for 
metabolic flux analysis.
In this study, the computer software FluxAnalyzerVAA  was used in conjunction with a 
pre-determined metabolic reaction network of E. coli central metabolism, to perform 
metabolic flux analysis. The aim of the study was to provide a more detailed insight into 
the effect of pta and ackA antisense RNA on E. coli MG1655 metabolism and 
complement the results from physiological studies presented in the previous chapter 
(Chapter 5). Substrate uptake and product formation profiles, from the physiological 
studies in Chapter 5, were used to calculate specific substrate uptake and product 
formation fluxes for each strain. These external measured fluxes were used to determine 
the intracellular flux distribution of each strain at steady state. A pseudo-steady state was 
assumed during the different phases of fermentation where all the measured variables 
were changing at a constant rate (Stephanopoulos et al., 1998).
Results from metabolic flux analysis revealed that putative ackA antisense RNA, 
expressed from plasmid pQR446 had the greatest impact on carbon flux through E. coli 
MG1655 central metabolism. These results were not surprising as the physiological 
characteristics of this strain were dramatically altered compared to the control strain. 
Specifically, the induced culture of E. coli MG1655(pQR446) exhibited reduced fluxes 
through the pentose phosphate pathway and the TCA cycle, and a reduced specific 
growth rate compared to the control culture.
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6.2 Ba c k g r o u n d
A quantitative description of metabolism and the ability to engineer metabolic change are 
important for achieving specific bioprocessing goals, and for developing our fundamental 
understanding of cell biology. For example, analysing the metabolism in an organism can 
provide useful information to help optimise strains for the production of metabolites and 
therapeutics, and to assess the metabolic consequences of genetic alterations. Hence, 
quantitative analysis of metabolism is of fundamental and practical importance (Edwards 
et al., 1999).
There are four main approaches to modelling metabolic pathways, which are 1) kinetic 
modelling, 2) biochemical systems theory, 3) metabolic control analysis, and 4) metabolic 
flux analysis. Attempts at kinetic modelling of metabolism have been hampered by the 
requirement for extensive and explicit enzyme kinetics. Furthermore, enzyme analysis is 
usually performed in vitro, which may not be representative of the conditions existing 
inside the cell. The human red blood cell is the only system for which sufficient enzyme 
kinetics are available, and a full dynamic model has been developed (Lee and Palsson, 
1991). In general, comprehensive kinetic information is not available for some pathways 
in microbial cells. However, a small kinetic model of E. coli central carbon metabolism 
has been developed, which is capable of describing the dynamic behaviour of 
metabolites in the central pathways with regard to amino acid synthesis (Chassagnole et 
al., 2002). Biochemical systems theory identifies the enzymes in a metabolic pathway 
that have a significant influence on the overall pathway flux (Savageau, 1970). However, 
this approach is quite complicated mathematically because it incorporates non-linear 
elements into the model. Metabolic control analysis has been used for investigating 
metabolic regulation at steady state (Heinrich and Rapoport, 1974; Kacser and Burns, 
1973). This analysis can be useful for small systems, but tends not to be predictive for 
environments that differ largely from the original operating point. Metabolic flux analysis 
is the most user-friendly approach for modelling metabolism. This is the approach chosen 
for this thesis and is described in more detail in the following section.
6.2.1 M e t a b o l ic  F l u x  A n a l y s is
Metabolic flux analysis (MFA) is a mathematical method, which is used to evaluate the 
flow of carbon through a steady-state metabolic network. It is based on the fundamental 
law of mass conservation, and only requires information about metabolic reaction 
stoichiometry, metabolic requirements for growth, and the measurement of a few strain- 
specific parameters (Edwards et al., 2002; Edwards et al., 1999; Varma and Palsson,
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1994). Kinetic information, which is difficult to obtain, is not necessary for metabolic flux 
analysis.
MFA is performed by using a stoichiometric model to represent the reactions in a 
metabolic network. A pseudo-steady state can be assumed because metabolic transients 
are typically rapid compared to cellular growth rates and environmental changes. The 
consequence of this assumption is that all the metabolic fluxes leading to formation and 
degradation of any given metabolite must balance, represented by the flux balance 
equation
S . v = b (1)
where S is a matrix containing the stoichiometry of the metabolic reactions, v is a vector 
of the ‘n’ reaction rates, and b is a vector containing the net metabolite uptake by the cell 
(Stephanopoulos et al., 1998). Equation (1) is typically underdetermined as the number 
of reactions in a given metabolic network normally exceeds the number of metabolites. 
The number of reactions minus the number of metabolites in a network specifies the 
number of degrees of freedom. If for example, there were 10 degrees of freedom in a 
network, then 10 measured fluxes would be required in order to determine a unique 
solution for the intracellular flux distribution. If, in this example, 10 measured fluxes could 
not be determined experimentally, a linear optimisation algorithm could be used to 
optimise the intracellular flux distribution for a certain objective (e.g. maximising biomass 
production) (Varma and Palsson, 1994).
The outcome of MFA is a metabolic flux map, which shows the biochemical reactions 
included in the model along with an estimation of the steady state rate (i.e. the flux) at 
which each reaction in the diagram occurs. Such maps contain useful information about 
the contribution of specific pathways to the overall processes of substrate utilisation and 
product formation. However, the real value lies in the differences that are observed when 
flux maps obtained from different strains or under different conditions are compared with 
one another. Through these comparisons, the impact of genetic and environmental 
perturbations can be examined, and the importance of specific pathways accurately 
described. In addition to quantification of pathway fluxes, MFA can also be used for: 1) 
identification of branch point control, 2) identification of alternative pathways, and 3) 
calculation of maximum theoretical yields (Holms, 1999; Stephanopoulos et al., 1998).
The reliance of metabolic flux analysis on reaction stoichiometry is its greatest strength 
but can also be its greatest weakness. This is because flux distributions within the cell
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are ultimately determined by the kinetics properties of cellular enzymes, expression of 
these enzymes, and regulatory mechanisms within the cell. MFA does not incorporate 
this additional information, which limits its ability to describe cellular metabolism 
accurately.
6.2 .1 .1  M e ta b o lic  F lu x  A n a ly s is  o f  E. c o l i
Metabolic flux analysis has been widely used to study E. coli metabolism. Therefore, four 
examples from the literature have been selected and are discussed below in 
chronological order. The first example used MFA to study the central metabolic pathways 
of E. coli, grown under a range of different conditions in batch culture. Specifically, the 
efficiency of carbon conversion to biomass, and the excretion of acetate by E. coli ML308 
were examined. Results showed that carbon compounds that feed into phosphorylated 
parts of the central pathways are converted to biomass more efficiently than carbon 
compounds that feed into non-phosphorylated pathways. In addition, MFA indicated that 
acetate excretion by E. coli is a consequence of the uptake rate of the primary carbon 
source, and is used by the cell to balance the flux to CO2 and energy generation with the 
fluxes to biosynthesis and growth (Holms, 1986).
The second example used MFA to predict cell growth and by-product secretion in 
chemostat cultures of E. coli W3110. Strain-specific parameters, such as the maximum 
oxygen uptake rate and maximum glucose uptake rate for E. coli W3110 were 
experimentally determined and used to constrain the stoichiometric model of central 
metabolism. The internal flux distributions were then calculated by using linear 
optimisation, with the objective of maximising biomass production. Linear optimisation is 
a mathematical method, which calculates the unknown fluxes by determining the 
optimum flux distribution that would achieve a certain objective. Results from the study 
showed that by specifying a glucose uptake rate, the model was capable of quantitatively 
predicting the optimal growth rate, oxygen uptake rate and by-product secretion rates in 
chemostat experiments (Varma and Palsson, 1994). These results indicate that the 
objective set for linear optimisation (i.e. to maximise biomass production) is valid, and 
gives a good approximation of carbon flow through the E. coli metabolic network.
The third example is a theoretical study, which was based on a comprehensive flux 
model of E. coli metabolism. The model aimed to include all known reactions in the E. 
coli metabolic network, including those compiled in the Kyoto Encyclopaedia of Genes 
and Genomes (KEGG, 1999, website http://www.genome.ad.jp/kegg/). Due to the size of 
the model, linear optimisation, with the objective of maximising biomass, was used to
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calculate the flux distributions. The aim of the study was to determine the smallest gene 
set capable of maximising biomass production on glucose, and then investigate the 
maximum number of gene deletions from this gene set that still maintains a specified 
level of biomass production. The model predicted that 202 intracellular reactions (out of 
400 reactions in the model) were required to sustain maximum biomass production. 
These included glycolytic reactions, the pentose phosphate pathway, the TCA cycle, the 
respiratory reactions and other anabolic and catabolic routes necessary for optimal 
growth. From this set of reactions, the model predicted that only 18 gene deletions would 
render the network incapable of growth (Burgard and Maranas, 2001). This study is 
interesting and contributes to our understanding of the crucial reactions and pathways 
that are necessary to support growth.
The final example is a recent theoretical study of a comprehensive flux model of the E. 
coli metabolic network, which was originally developed by the group of Palsson (Edwards 
et al., 2001; Edwards and Palsson, 2000). The flux model was generated by 
‘reconstructing’ the metabolic network of E. coli MG1655 from the annotated genome 
sequence. In the recent study using this model, the overall organisation of flux in the E. 
coli metabolic network was investigated under different growth conditions. Results 
showed that flux distribution in the E. coli metabolic network is highly uneven. 
Furthermore, the study indicated that most metabolic reactions have low fluxes, and the 
overall activity of metabolism is dominated by several reactions with very high fluxes i.e. 
the reactions in central metabolism. Fluxes, mainly within the high-flux backbone, are 
reorganised by E. coli in response to changes in growth conditions (Almaas et al., 2004).
Evident in these examples of metabolic flux analysis is the trend towards developing 
larger and more comprehensive flux models. This is desirable in terms of the overall goal 
of simulating cellular activity in silico, however comprehensive models of metabolism are 
not always required. As the final example demonstrated, the majority of carbon flux is 
concentrated in a high-flux backbone, in the central metabolic pathways. Therefore, a 
smaller flux model of central metabolism can be effectively used for many investigative 
studies. In the work presented here, a small model of E. coli central metabolism was 
used to study the flow of carbon to acetate and other organic acids in E. coli MG 1655 
expressing antisense RNA targeted against phosphotransacetylase and acetate kinase. 
The aim of the study was to determine the effectiveness of antisense RNA in redirecting 
carbon flux in E. coli central metabolism.
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6.3 M a te r ia ls  a n d  M eth o d s
6.3.1 E. cou F e r m en ta tio n s
The fermentation data used for metabolic flux analysis in this study was obtained from 
bioreactor experiments described in Chapter 5. Materials and methods for fermentation 
procedures are detailed in Chapter 2.
Briefly, batch fermentations of E. coli MG1655 harbouring recombinant plasmids were 
performed in a 2 L bioreactor (1 L working volume). Cultures were grown in selective M9 
minimal media supplemented with 10 g L'1 glucose and a trace element solution (see 
section 2.5.2). Fermentations were maintained at 37°C, pH 7.0, airflow rate of 1 vvm, and 
impeller agitation rate of 800 rpm. These aeration conditions maintained a DOT of >60% 
throughout the 24 h fermentation. Two molar phosphoric acid and two molar sodium 
hydroxide were used to control pH.
Each fermentation was prepared in the same manner and run under the same conditions. 
A 10 ml culture was inoculated using a colony from a fresh selective nutrient agar plate, 
and incubated at 37°C, 200 rpm for -6  hours. The entire 10 ml culture was then used to 
inoculate 90 ml sterile media, and incubated at 37°C, 200 rpm overnight. The resulting 
100 ml pre-culture was then used to inoculate 900 ml sterile media in the fermenter to 
bring the working volume to 1 L. Ten samples were aseptically removed from the 
fermenter over the course of the 24 h fermentation. The cell density (OD6oo) was 
determined, then the sample was immediately centrifuged and the supernatant was 
removed from the solids, and stored at -20°C for analysis. The cell pellet was stored at - 
80°C for analysis. The concentrations of residual glucose and organic acids in the 
supernatant samples were determined by colorimetric assay and HPLC, as described in 
section 2.6.
6.3.2 Da t a  P r e p a r a tio n  fo r  M eta b o lic  F lux  A n alysis
After the fermentation data was collected and analysed, the external fluxes (i.e. growth 
rate, specific glucose uptake rate and specific organic acid production rates) were 
calculated in order to perform metabolic flux analysis. Three steps were used to calculate 
the external fluxes: 1) partitioning of the fermentation data into phases of linear change, 
2) calculation of the slope for each measured variable in each phase, and 3) conversion 
into specific flux units (mM h'1 g DCW‘1) to account for biomass variations. There are 
different ways of calculating the external fluxes for metabolic flux analysis, however this
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method suited the data that was obtained in this study, and was also used to examine the 
impact of antisense RNA expression in the study of Desai and Papoutsakis (1999).
The first step was to plot the fermentation data (biomass, residual glucose concentration 
and organic acid concentration) on a single graph, and partition the data into phases 
where all variables are changing linearly. The plotted data helped to determine where to 
partition the data into phases. For example, one phase boundary would be at the change 
from exponential growth into stationary phase. The slope of the biomass changes at this 
point, therefore the biomass variable is not changing linearly. Examples of how data was 
partitioned into phases are shown in the following sections. The phases are indicated in 
roman numerals above the graphs. The second step was to calculate the slope of the line 
(mM h'1) for each variable in each phase. Finally, to account for variations in biomass, the 
specific flux for each variable at the mid-point of each phase was calculated. The 
resulting specific flux units were millimolar per hour per gram of dry cell weight (mM h'1 g 
DCW"1). Metabolic flux analysis was performed for each phase, using the measured 
extracellular fluxes as inputs for the calculation. Comparisons were then made between 
the internal flux distributions of different phases in a fermentation, and comparable 
phases in different fermentations.
6.3.3  M e ta b o lic  F lu x  A n a lysis
In this study, MFA was performed using the computer programme FluxAnalyzer V. 4.1, 
which was developed specifically for flux and pathway analysis in metabolic networks by 
Steffen Klamt (Max-Planck-lnstitute for Dynamics of Complex Technical Systems, 
Magdeburg, Germany; http://www.mpi-magdeburg.mpg.de/projects/fluxanalyzer; E-mail: 
Klamt@mpi-magdeburg.mpg.de). This software is freely available for scientific purposes, 
and requires Mathwork’s MATLAB software for operation.
A metabolic model of E. coli central metabolism, that was developed by Steffen Klamt 
(see contact details above) and provided with the FluxAnalyzer software, was used for 
metabolic flux analysis in this study. Figure 6.1 shows a diagram of the E. coli metabolic 
network as it appears in the Flux Analyzer programme. The grey boxes beside each 
reaction arrow are for the display of flux values. The model is composed of 106 reactions, 
(see Appendix 1) including glycolysis, the TCA cycle, pentose phosphate cycle, oxidative 
phosphorylation and pathways for amino acid biosynthesis. There are 89 internal 
(balanced) metabolites (abbreviations and full names of each metabolite are listed in 
Appendix 2). Consequently, the model has 17 degrees of freedom, which means that 17 
fluxes must be specified in order to determine the intracellular flux distribution.
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The 17 fluxes that were used as inputs to calculate the intracellular flux distributions in 
this study include measured extracellular fluxes and fluxes that can be set to 0.00, to 
constrain the model (see Table 6.1). The fluxes set to 0.00 include uptake fluxes of 
carbon compounds that are not present in the media and cannot therefore be taken up 
into the cell, reactions that we can assume are not occurring under the fermentation 
conditions, and some reverse reactions. Futile cycles and linearly dependent reactions 
(i.e. coupled reactions such as the interconversion of cofactors, or reversible reactions in 
central metabolism) cannot be included in flux balance models as the linear algebra used 
to calculate the intracellular flux distributions cannot resolve these reactions. Such 
reactions will simply cancel each other out (Stephanopoulos et al., 1998). Due to 
technical problems with the measurement of carbon dioxide evolution and oxygen uptake 
in some of the bioreactor experiments, the CPR and OUR have not been used as inputs 
for metabolic flux analysis. Instead they are left as ‘unknown’ and are calculated by MFA, 
along with the intracellular flux distribution.
Table 6.1 Set of fluxes used to constrain the stoichiometric model and calculate
intracellular flux distributions.
Measured extracellular fluxes Fluxes set to 0.00 to constrain the model
1. M (specific growth rate) 1. Glucose uptake (non-PTS)
2. Glucose uptake rate 2. Gluconate uptake
3. Acetate production rate 3. Glycerol uptake
4. Lactate production rate 4. 6-phosphogluconate: 2 keto-3-desoxy-6-phosphogluconate
5. Formate production rate 5. Isocitrate: glyoxylate
6. Ethanol production rate 6. N A DH : NADPH
7. Succinate production rate 7. Fructose-1,6-bisphosphate: Fructose-6-phosphate
8. Oxaloacetate: Phosphoenolpyruvate
9. Pyruvate: Phosphoenolpyruvate
10. Fumarate : Succinate
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Figure 6.1 E. coli metabolic reaction network. External metabolites are shown in boxes. The 
grey boxes are used to display fluxes. Measured extracellular fluxes are inputted into the 
appropriate boxes, and used to calculate the unknown internal fluxes.
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6 .4  S e n s itiv ity  A n a ly s is  o f  th e  E. c o li M e ta b o lic  N e tw o rk
The results of metabolic flux analysis are only as accurate as the experimentally 
measured rates that are used as inputs for the flux calculation. To analyse the effect of 
variability in the measured input fluxes on the calculated output fluxes, a sensitivity 
analysis was performed. The input data-set used for the sensitivity analysis was from the 
control culture E. coli MG1655(pTrc99A), Phase II (see section 6.5.1). Sensitivity analysis 
was performed by calculating the internal flux distribution for a high and low value of each 
measured input flux, and determining the maximum variability on the output fluxes. The 
high values corresponded to the mean flux value plus standard error, and the low values 
corresponded to the mean flux value minus standard error. Results of the sensitivity 
analysis are reported in Table 6.2.
The results showed that variability in the measured glucose uptake rate leads to the 
greatest variation in the calculated output fluxes in central metabolism. The standard 
error on the measured glucose uptake rate was ± 6 %. However, this small variation led 
to up to 13 % variation in calculated oxygen uptake rates and carbon dioxide production 
rates, up to 16 % variation in calculated fluxes through glycolysis and up to 20 % 
variation in calculated fluxes through the TCA cycle. These variations are quite high and 
should be taken in consideration when comparing metabolic flux distributions and 
extrapolating differences between different flux maps. In contrast, the error margin on the 
specific growth rate and the acetate production rate did not have such a great effect on 
the variability of the calculated output fluxes.
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Table 6.2 Sensitivity analysis of E. coli MG1655(pTrc99A) Phase II.
Reaction 1: p Reaction 6: Reaction 14:
Glc_PTS_up Ac ex
HIGH LOW HIGH LOW HIGH LOW
MEASURED INPUT FLUXES
Reaction 1: p (0.49 ± 0.03) 0.52 0.46 0.49 0.49 0.49 0.49
Reaction 6: Glc PTS up (8.5 ± 0.5) 8.5 8.5 9.0 8.0 8.5 8.5
Reaction 12: Lac ex (0) 0 0 0 0 0 0
Reaction 14: Ac_ ex (3.6 ±0 .1 ) 3.6 3.6 3.6 3.6 3.7 3.5
CALCULATED OUTPUT FLUXES
Reaction 2: 0 2 _ u p :
21.1 23.7 25.4 19.4 22.2 22.6
Reaction 3: N _up:
5.7 5.0 5.3 5.3 5.3 5.3
Reaction 4: C 0 2 _ e x :
22.4 24.9 26.6 20.6 23.4 23.8
Reaction 5: S_up:
0.1 0.1 0.1 0.1 0.1 0.1
Reaction 7: Glc_ATP_up :
0 0 0 0 0 0
Reaction 8: Succ_ex:
0 0 0 0 0 0
Reaction 9: Glyc_up :
0 0 0 0 0 0
Reaction 10: Glyc::Glyc3P :
0 0 0 0 0 0
Reaction 11: DHAP::Glyc3P :
0.07 0.07 0.07 0.07 0.07 0.07
Reaction 13: Eth_ex :
0 0 0 0 0 0
Reaction 15: Glucn_up :
0 0 0 0 0 0
Reaction 16: Form_ex :
0 0 0 0 0 0
Reaction 17: G6P::F6P :
6.3 7.5 8.0 5.8 6.8 7.0
Reaction 18: F16P::F6P :
0 0 0 0 0 0
Reaction 19: F6P::F16P :
7.3 7.8 8.3 6.9 7.5 7.6
Reaction 20: F16P::T3P :
7.3 7.8 8.3 6.9 7.5 7.6
Reaction 21: DHAP::G3P :
7.3 7.7 8.2 6.8 7.5 7.5
Reaction 22: G3P::DPG :
15.1 15.6 16.5 14.1 15.3 15.4
Reaction 23: DPG::3PG :
15.1 15.6 16.5 14.1 15.3 15.4
Reaction 24: 3PG::2PG :
14.1 14.8 15.7 13.3 14.4 14.5
Reaction 25: 2PG::PEP :
14.1 14.8 15.7 13.3 14.4 14.5
Reaction 26: PEP::PYR :
3.7 4.5 4.8 3.4 4.1 4.1
Reaction 27: Pyr::PEP :
0 0 0 0 0 0
Reaction 28: PYR::AcCoA :
10.6 11.6 12.3 9.9 11.1 11.1
Reaction 29: AcCoA::Cit:
5.4 6.6 7.2 4.8 5.9 6.2
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Reaction 30: Cit::ICit:
5.4 6.6 7.2 4.8 5.9 6.2
Reaction 31: ICit::alKG :
5.4 6.6 7.2 4.8 5.9 6.2
Reaction 32: alKG::SuccCoA :
4.8 6.1 6.7 4.3 5.3 5.6
Reaction 33: SuccCoA::Succ:
4.5 5.9 6.4 4.0 5.1 5.3
Reaction 34: Succ::Fum :
4.8 6.1 6.7 4.3 5.3 5.6
Reaction 35: Fum::Succ :
0 0 0 0 0 0
Reaction 36: Fum::Mal:
5.4 6.6 7.2 4.8 5.9 6.1
Reaction 37: Mal::OxA :
5.4 6.6 7.2 4.8 5.9 6.1
Reaction 38: ICit::Glyox :
0 0 0 0 0 0
Reaction 39: Glyox::Mal:
0 0 0 0 0 0
Reaction 40: G6P::PGIac :
2.1 1.0 0.9 2.1 1.6 1.5
Reaction 41: AcCoA::Adh :
0 0 0 0 0 0
Reaction 42: Adh::Eth :
0 0 0 0 0 0
Reaction 43: PGIac::PGIuc :
2.1 1.0 0.9 2.1 1.6 1.5
Reaction 44: Glucn::PGIuc :
0 0 0 0 0 0
Reaction 45: PGIuc::RI5P :
2.1 1.0 0.9 2.1 1.6 1.5
Reaction 46: RI5P::X5P :
1.1 0.3 0.3 1.1 0.7 0.6
Reaction 47: RI5P::R5P :
1.1 0.6 0.7 1.1 0.9 0.8
Reaction 48: Transketl :
0.6 0.3 0.2 0.6 0.5 0.4
Reaction 49: Transaldo :
0.4 0.06 0.04 0.4 0.3 0.2
Reaction 50: Transket2 :
0.6 0.3 0.2 0.6 0.5 0.4
Reaction 51: PGIuc::KetoPGIuc :
0 0 0 0 0 0
Reaction 52: KetoPGIuc::G3P_Pyr:
0 0 0 0 0 0
Reaction 53: OxA::PEP :
0 0 0 0 0 0
Reaction 54: PEP::OxA :
1.5 1.4 1.4 1.4 1.4 1.4
Reaction 55: AcCoA::AcP :
3.3 3.3 3.3 3.3 3.4 3.2
Reaction 56: AcP::Ac :
3.3 3.3 3.3 3.3 3.4 3.2
Reaction 57: Pyr::Form :
0 0 0 0 0 0
Reaction 58: Pyr::Lac :
0 0 0 0 0 0
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6 .5  R e s u lts  o f  M e ta b o lic  F lu x  A nalysis
6.5.1 M e ta b o l ic  F lu x  A n a ly s is  o f  E. c o l i  MG1655(pQR439)
Metabolic flux analysis was performed to examine the impact of reduced acetate 
production on carbon fluxes in E. coli MG1655(pQR439) expressing putative pta 
antisense RNA. The results were compared with the carbon fluxes in the plasmid control 
strain, E. coli MG1655(pTrc99A). The first step was to examine the substrate and product 
concentration profiles for each strain, and partition the data into phases of approximately 
linear change. Profiles for E. coli MG1655(pTrc99A) and E. coli MG1655(pRQ439) 
induced are shown in Figure 6.2. The data was partitioned into four phases, which are 
labelled at the top of each graph in roman numerals. Specific external fluxes were then 
determined at the mid-point of each phase of interest and used to calculate the 
intracellular flux distribution (Table 6.3). In this study, MFA was not performed for phase I 
or phase IV. This was due to the fact that in phase I, which corresponded to early 
exponential growth phase, the biomass levels were low, the cells were adjusting to 
conditions in the fermenter, and there was some variations in the measurements of 
residual glucose concentration during this time. In phase IV, which corresponded to 
stationary phase, there were not enough data points to establish the rates of substrate 
uptake and product formation.
Phase II corresponded to mid-late exponential growth phase in both the control culture, 
E. coli MG1655(pTrc99A), and E. coli MG1655(pQR439) expressing putative pta 
antisense RNA. Metabolic flux analysis showed that the intracellular flux distributions 
were comparable in both cultures during this time. This is not surprising given the similar 
substrate utilisation and product formation patterns for these cultures (as described in 
Chapter 5, section 5.2.3). Phase III corresponded to early stationary phase in both the 
control cultures. Once again, due to similar physiological profiles, MFA revealed very 
similar flux distributions for the control culture and the culture of E. coli MG1655(pQR439) 
expressing putative pta antisense RNA. Therefore, due to the greatest differences 
occurring during stationary phase, this approach was not able to provide additional 
insight into the effect of putative pta antisense RNA on carbon flow through central 
metabolism.
The results from metabolic flux analysis of E. coli MG1655(pQR441) and E. coli 
MG1655(pTrc99A/pQR439) also showed no noticeable differences in the flux 
distributions during the phases were there was sufficient data to perform MFA. Therefore, 
the results of these studies are not described further.
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Figure 6.2 Time course profiles of biomass (•), residual glucose (o), acetate concentration 
(A ) and lactate concentration (A) in (A) E. coli MG1655(pTrc99A) and (B) E. coli 
MG1655(pQR439) induced. The data is partitioned into four phases where the rate of change 
of each variable is approximately linear.
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Table 6.3 Measured input fluxes and calculated output fluxes for E. coli MG1655(pTrc99A) 
and E. coli MG1655(pQR439) induced for phases II and III.
E. coli MG1655(pTrc99A) E. coli MG1655 (pQR439) 
induced
Phase II Phase III Phase II Phase III
INPUTS
Reaction 1: p 0.49 0.02 0.55 0.12
Reaction 6: Glc PTS up 8.5 0.6 9.7 1.5
Reaction 12: Lac ex 0 0.5 0.7 0.2
Reaction 14: Ac ex 3.6 0.2 4.8 0.6
OUTPUTS
Reaction 2: 02_up :
22.4 0.6 22.3 1.8
Reaction 3: N_up :
5.3 0.2 6.0 1.8
Reaction 4: C02_ex :
23.6 0.6 28.7 2.1
Reaction 5: S _u p :
0.1 0.01 0.1 0.08
Reaction 7: Glc_ATP_up :
0 0 0 0
Reaction 8: Succ_ex :
0 0 0 0
Reaction 9: Glyc_up :
0 0 0 0
Reaction 10: Glyc::Glyc3P :
0 0 0 0
Reaction 11: DHAP::Glyc3P :
0.1 0.01 0.1 0.02
Reaction 13: Eth_ex :
0 0 0 0
Reaction 15: Glucn_up :
0 0 0 0
Reaction 16: Form_ex :
0 0 0 0
Reaction 17: G6P::F6P :
6.9 0.4 7.1 0.4
Reaction 18: F16P::F6P :
0 0 0 0
Reaction 19: F6P::F16P :
7.6 0.5 8.4 1.0
Reaction 20: F16P::T3P :
7.6 0.4 8.4 1.0
Reaction 21: DHAP::G3P :
7.5 0.5 8.3 0.9
Reaction 22: G3P::DPG :
15.3 1.0 17.2 2.3
Reaction 23: DPG::3PG :
15.3 1.0 17.2 2.3
Reaction 24: 3PG::2PG :
14.5 1.0 16.3 2.1
Reaction 25: 2PG::PEP :
14.5 1.0 16.3 2.1
Reaction 26: PEP::PYR :
4.1 0.3 4.5 0.1
Reaction 27: Pyr::PEP :
0 0 0 0
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Reaction 28: PYR::AcCoA :
11.1 0.3 11.8 1.1
Reaction 29: AcCoA::Cit :
6.0 0.03 5.4 0.2
Reaction 30: Cit::ICit:
6.0 0.09 5.4 0.2
Reaction 31: ICit::alKG :
6.0 0.09 5.4 0.2
Reaction 32: alKG::SuccCoA :
5.5 0.07 4.7 0.01
Reaction 33: SuccCoA::Succ :
5.2 0.06 4.4 0.06
Reaction 34: Succ::Fum :
5.5 0.07 4.7 0.01
Reaction 35: Fum::Succ :
0 0 0 0
Reaction 36: Fum::Mal:
6.0 0.09 5.3 0.1
Reaction 37: Mal::OxA :
6.0 0.08 5.3 0.1
Reaction 38: ICit::Glyox :
0 0 0 0
Reaction 39: Glyox::Mal:
0 0 0 0
Reaction 40: G6P::PGIac :
1.5 0.1 2.4 1.1
Reaction 41: AcCoA::Adh :
0 0 0 0
Reaction 42: Adh::Eth :
0 0 0 0
Reaction 43: PGIac::PGIuc :
1.5 0.1 2.4 1.1
Reaction 44: Glucn::PGIuc :
0 0 0 0
Reaction 45: PGIuc::RI5P :
1.5 0.1 2.4 1.1
Reaction 46: RI5P::X5P :
0.7 0.08 1.2 0.6
Reaction 47: RI5P::R5P :
0.9 0.06 1.2 0.5
Reaction 48: Transketl :
0.4 0.05 0.8 0.3
Reaction 49: Transaldo :
0.4 0.04 0.7 0.3
Reaction 50: Transket2 :
0.2 0.05 0.5 0.3
Reaction 51: PGIuc::KetoPGIuc :
0 0 0 0
Reaction 52: KetoPGIuc::G3P_Pyr:
0 0 0 0
Reaction 53: OxA::PEP :
0 0 0 0
Reaction 54: PEP::OxA :
1.4 0.06 1.6 0.4
Reaction 55: AcCoA::AcP :
3.3 0.2 4.5 0.5
Reaction 56: AcP::Ac :
3.3 0.2 4.5 0.5
Reaction 57: Pyr::Form :
0 0 0 0
Reaction 58: Pyr.Lac :
0 0.5 0.7 0.2
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6 .5 .2  M e ta b o lic  F lu x  A n a ly s is  o f  E. c o l i  MG1 655(pQ R 446)
Metabolic flux analysis was performed to assess the impact of the dramatically altered 
physiology of E. coli MG1655(pRQ446) expressing putative ackA antisense RNA (see 
Chapter 5, section 5.3.6), on carbon fluxes through the central metabolic pathways. The 
results were compared with the carbon fluxes in the plasmid control strain, E. coli 
MG1655(pQR445). Fluxes were calculated as previously described in section 6.4.1, and 
are displayed in Table 6.4. The partitioned profiles of substrate uptake and product 
formation are shown in Figure 6.3.
The control culture, E. coli MG1655(pQR445), and the induced culture of E. coli 
MG1655(pQR446), exhibited very different substrate uptake and product formation 
patterns, therefore the linear phases in the two cultures are not directly comparable. 
However, comparisons have been made as far as possible and are discussed below. 
Metabolic flux analysis was not performed for phase IV due to the small number of data 
points in this phase.
Phase I corresponded to exponential growth phase in the control culture and early 
exponential growth phase in the induced culture of E. coli MG1655(pQR446). Metabolic 
flux analysis revealed that the specific fluxes through glycolysis were similar for both 
cultures, however E. coli MG1655(pQR446) exhibited lower specific fluxes through the 
pentose phosphate pathway and through the TCA cycle (Figure 6.4), which is 
presumably due to the lower rate of biomass production and therefore the reduced 
requirement for production of NADPH. The most notable difference involves the flow of 
carbon to lactate and acetate in these cultures.
Phase II corresponded to late exponential growth phase/transition phase in the control 
culture E. coli MG1655(pQR445), and mid-exponential growth phase in E. coli 
MG1655(pQR446) induced. Metabolic flux analysis revealed that the specific fluxes 
through glycolysis were ~4-fold higher in the induced culture of E. coli MG1655(pQR446) 
compared to the control culture. In addition, the specific fluxes through the pentose 
phosphate pathway were ~3-fold lower in the induced culture of E. coli MG1655(pQR446) 
compared to the control culture. The specific fluxes through the TCA cycle were similar 
for both cultures. These results confirm that glucose is being utilised primarily for lactate 
production in the induced culture of E. coli MG1655(pQR446) at the expense of biomass 
production. The results are illustrated in Figure 6.5.
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Phase III corresponded to the transition between exponential growth phase and 
stationary phase in the control culture, E. coli MG1655(pQR445), and late exponential 
growth phase in the induced culture of E. coli MG1655(pQR446). Metabolic flux analysis 
revealed low specific fluxes through glycolysis, the pentose phosphate pathway and the 
TCA cycle in the control culture. This was expected, due to the fact that biomass 
production was very low during this time. Specific acetate and lactate production fluxes 
were also low in the control culture in phase III. In contrast, the specific fluxes in phase III 
through the central metabolic pathways in the induced culture of E. coli 
MG1655(pQR446) were only slightly lower than in phase II. This was expected due to the 
substrate uptake and product formation patterns during this phase. Flux distributions in 
these two cultures cannot be directly compared for phase III because the cultures are in 
different stages of growth.
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Figure 6.3 Time course profiles of biomass (•), residual glucose (o ), acetate concentration 
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MG1655(pQR446) induced. The data is partitioned into four phases where the rate of change 
of each variable is approximately linear.
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Table 6.4 Measured input fluxes and calculated output fluxes for E. coli MG1655(pQR445) 
and E. coli MG1655(pQR446) induced for phases I, II and III.
E. coli MG1655(pQR445) E. coli MG1655 (pQR446) 
induced
Phase I Phase II Phase III Phase I Phase II Phase III
INPUTS
Reaction 1: p 0.63 0.27 0.044 0.22 0.21 0.22
Reaction 6: Glc PTS up 11.5 3.9 0.67 9.3 15.1 13.1
Reaction 12: Lac ex 0.2 0.01 0.26 12.0 21.2 19.5
Reaction 14: Ac ex 9.4 0.75 0.27 1.3 2.8 1.0
OUTPUTS
Reaction 2: 02_up :
21.9 10.3 0.8 8.0 12.3 8.6
Reaction 3: N_up :
6.7 2.9 0.5 2.4 2.3 2.4
Reaction 4: C 0 2 _ e x :
23.5 11.0 0.8 8.5 12.6 8.2
Reaction 5: S_up :
0.2 0.07 0.01 0.07 0.06 0.06
Reaction 7: Glc_ATP_up :
0 0 0 0 0 0
Reaction 8: Succ_ex :
0 0 0 0 0 0
Reaction 9: Glyc_up :
0 0 0 0 0 0
Reaction 10: Glyc::Glyc3P :
0 0 0 0 0 0
Reaction 11: DHAP::Glyc3P :
0.1 0.04 0.01 0.03 0.03 0.03
Reaction 13: Eth_ex :
0 0 0 0 0 0
Reaction 15: Glucn_up :
0 0 0 0 0 0
Reaction 16: Form_ex :
0 0 0 0 0 0
Reaction 17: G6P::F6P :
7.1 2.9 0.4 8.2 14.7 12.2
Reaction 18: F16P::F6P :
0 0 0 0 0 0
Reaction 19: F6P::F16P :
9.5 3.4 0.5 8.7 14.8 12.7
Reaction 20: F16P::T3P :
9.5 3.3 0.5 8.7 14.0 12.7
Reaction 21: DHAP::G3P :
9.9 3.3 0.5 8.7 14.8 12.6
Reaction 22: G3P::DPG :
20.0 6.8 1.1 17.7 30.0 25.4
Reaction 23: DPG::3PG :
20.0 6.9 1.1 17.7 30.0 25.4
Reaction 24: 3PG::2PG :
18.9 6.4 1.0 17.3 29.2 25.1
Reaction 25: 2PG::PEP :
18.9 6.4 1.0 17.3 29.2 25.1
Reaction 26: PEP::PYR :
5.0 1.5 0.2 7.2 13.3 11.1
Reaction 27: Pyr::PEP :
0 0 0 0 0 0
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Reaction 28: PYR::AcCoA:
14.3 4.6 0.5 3.9 6.6 4.0
Reaction 29: AcCoA::Cit:
3.1 3.0 0.08 2.0 3.2 2.4
Reaction 30: Cit::ICit:
3.1 3.0 0.08 2.0 3.2 2.4
Reaction 31: ICit::alKG :
3.1 3.0 0.08 2.0 3.2 2.4
Reaction 32: alKG::SuccCoA :
2.4 2.7 0.08 1.7 2.9 2.1
Reaction 33: SuccCoA::Succ :
2.0 2.5 0.08 1.6 2.8 2.0
Reaction 34: Succ::Fum :
2.4 2.7 0.03 1.7 2.9 2.1
Reaction 35: Fum::Succ:
0 0 0 0 0 0
Reaction 36: Fum::Mal:
3.0 2.9 0.08 1.9 3.1 2.4
Reaction 37: Mal::OxA :
3.0 3.0 0.08 2.0 3.1 2.4
Reaction 38: ICit::Glyox :
0 0 0 0 0 0
Reaction 39: Glyox::Mal:
0 0 0 0 0 0
Reaction 40: G6P::PGIac :
4.3 1.0 0.4 1.0 0.4 0.9
Reaction 41: AcCoA::Adh :
0 0 0 0 0 0
Reaction 42: Adh::Eth :
0 0 0 0 0 0
Reaction 43: PGIac::PGIuc :
4.3 1.0 0.4 1.0 0.4 0.9
Reaction 44: Glucn::PGIuc:
0 0 0 0 0 0
Reaction 45: PGIuc::RI5P :
4.3 1.0 0.4 1.0 0.4 0.7
Reaction 46: RI5P::X5P :
2.4 0.5 0.2 0.5 0.1 0.4
Reaction 47: RI5P::R5P :
1.8 0.5 0.2 0.5 0.3 0.4
Reaction 48: Transketl :
1.4 0.3 0.1 0.3 0.1 0.3
Reaction 49: Transaldo :
1.1 0.1 0.1 0.2 0.008 0.2
Reaction 50: Transket2 :
1.4 0.3 0.1 0.3 0.1 0.3
Reaction 51: PGIuc::KetoPGIuc :
0 0 0 0 0 0
Reaction 52: KetoPGIuc::G3P_Pyr:
0 0 0 0 0 0
Reaction 53: OxA::PEP :
0 0 0 0 0 0
Reaction 54: PEP::OxA :
1.9 0.8 0.1 0.6 0.6 0.6
Reaction 55: AcCoA::AcP :
9.0 0.6 0.2 1.1 2.7 0.9
Reaction 56: AcP::Ac:
9.0 0.6 0.2 1.1 2.7 0.9
Reaction 57: Pyr::Form :
0 0 0 0 0 0
Reaction 58: Pyr::Lac :
0.2 0.01 0.3 12.0 21.2 19.5
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Figure 6.4 Simplified diagram of an E. coli cell, showing the differences in carbon flow 
through the central metabolic pathways during phase I, in cultures of E. coli MG1655 
harbouring (A) the control plasmid pQR445, and (B) plasmid pQR446 expressing putative 
ackA antisense RNA.
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Figure 6.5 Simplified diagram of an E. coli cell, showing the differences in carbon flow 
through the central metabolic pathways during phase II, in cultures of E. coli MG 1655 
harbouring (A) the control plasmid pQR445, and (B) plasmid pQR446 expressing putative 
ackA antisense RNA.
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6.6 D isc u ssio n  and  C o nclusio ns
This chapter discussed the processes involved in performing metabolic flux analysis to 
examine the impact of putatively expressed antisense RNA on the carbon fluxes in E. coli 
MG1655. The studies presented in this chapter aimed to provide a more detailed insight 
into the effect of pta and ackA antisense RNA on E. coli MG 1655 metabolism and 
complement the results from physiological studies presented in the previous chapter 
(Chapter 5). However, E. coli cultures that exhibited similar physiological profiles gave 
rise to very similar metabolic flux distributions, and only limited information could be 
gained from these analyses. Therefore, the results from this study suggest that metabolic 
flux analysis is most suited to analysing the impact of genetic or environmental 
perturbations that cause a pronounced change in the physiology of the E. coli strain. 
Cultures of E. coli MG1655 harbouring pRQ446 exhibited dramatically altered substrate 
uptake and product formation patterns, compared to the control culture. MFA was able to 
predict that the changes in growth and by-product secretion in this strain were a 
consequence of increased flux through the glycolytic pathway, and decreased flux 
through the pentose phosphate pathway.
Metabolic flux analysis is a useful tool for examining carbon flow through metabolism. 
However, the incorporation of enzyme data and regulatory information into future 
metabolic models will enable more detailed and accurate predictions of the dynamic 
behaviour in cellular metabolism.
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7.1 Summary
This thesis described a metabolic engineering approach that was used to reduce acetate 
production by E. coli. The research involved using antisense RNA as an experimental 
tool to suppress expression of the enzymes phosphotransacetylase and acetate kinase, 
which catalyse the conversion of acetyl CoA to acetate in E. coli. The challenge was to 
determine the effectiveness of this antisense RNA strategy in reducing the target enzyme 
levels, and in re-directing carbon flow through central metabolism.
The research had three main components, each of which represented a phase of the 
metabolic engineering cycle. The metabolic engineering cycle involves design, 
modification and subsequent analysis of metabolism for the purpose of strain 
improvement. The design phase involves proposing genetic modifications to be carried 
out in order to achieve a specific bioprocessing goal. Modification involves the 
construction of a novel strain using recombinant DNA technology. Analysis involves 
characterisation of the resulting strain, which may include physiological studies and 
metabolic flux analysis. Results from the analytical studies may suggest additional 
modifications that could be made in order to improve the new strain further, and so the 
cycle continues (Nielsen, 2001). This research completed a full sequence of the 
metabolic engineering cycle. Design and construction of recombinant E. coli strains 
expressing putative pta and ackA antisense RNA was described in Chapter 4. 
Physiological characterisation of the resulting recombinant E. coli strains was described 
in Chapter 5, and metabolic flux analysis was presented in Chapter 6. This chapter aims 
to discuss broader aspects of the study and suggest future experiments that could be 
carried out to further the research.
7.2  Expression o f  Antisense RNA in E. coli
In this study, the plasmids pTrc99A and pMMB66EH were selected to use for expression 
of antisense RNA in E. coli. One of the reasons that these plasmids were chosen was 
that they possess the strong promoters, trc and tac, which make them ideal for high level 
expression of antisense RNA. This was important because it was anticipated that the 
artificially designed antisense RNA that was produced in vivo would not be very stable in 
the cell. Therefore, it was thought that if a large excess of antisense RNA was produced, 
this might compensate for the impact of antisense RNA degradation. An alternative 
method of overcoming the problem of antisense RNA stability in the cell would have been 
to incorporate stability control elements such as hairpin structures, on to the ends of the 
antisense RNA molecules (Carrier and Keasling, 1997; Carrier and Keasling, 1999).
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Hairpin structures have been characterised in naturally occurring antisense RNA in E. 
coli and were found to be very important for the longevity of the antisense RNA molecule 
(Bricker and Belasco, 1999). Stability elements were not incorporated into the antisense 
RNA molecules in this study, however it would be interesting to investigate whether their 
presence would increase the stability, and possibly the impact, of pta and ackA antisense 
RNA on acetate production by E. coli.
Another important feature of the trc and tac promoters on plasmids pTrc99A and 
pMMB66EH respectively, is their regulation. Under repressed conditions, an inhibitor 
molecule, which is produced from the /aclq gene present on each plasmid, prevents 
expression from the trc and tac promoters. Conditional expression from the trc and tac 
promoters is achieved by adding IPTG to the culture medium. In this study, IPTG was 
added to the culture medium to induce expression of antisense RNA at a selected point 
mid-way during E. coli fermentation. The idea was to examine cellular metabolism before 
and immediately after enzyme downregulation, which is not possible with the alternative 
approach of permanent gene inactivation (Datsenko and Wanner, 2000). However, the 
results from this study indicated that antisense RNA was produced from pTrc99A and 
pMMB66EH-derived plasmids that were grown under repressed conditions. This was 
shown in Chapter 5, sections 5.2 -  5.4 by the similarity in enzyme levels and organic acid 
production in the uninduced and induced cultures of E. coli harbouring plasmids that 
encoded antisense RNA. Therefore, an expression system with tighter control would 
have been more suitable for this study.
The problem is that the majority of expression vectors that are currently available were 
originally designed for the purpose of over-expressing heterologous proteins (Baneyx, 
1999), and are not ideal for metabolic engineering. Typically, expression vectors are 
multicopy plasmids that replicate in a relaxed fashion, and are present at 15-60 (e.g. 
pMB1/ColE1- derived plasmids) or a few hundred copies per cell (e.g. the pUC series of 
plasmids). They usually possess relatively strong promoters, such as the trc or tac 
promoters used in this study, or the T7 promoter which is present on the pET series of 
vectors (Baneyx, 1999). These characteristics are ideal for achieving a high yield of 
recombinant protein. However, expression from high copy number plasmids can reduce 
cell growth due to the metabolic burden placed on the host cell, and strong promoters 
often have leaky expression of the recombinant products. Numerous researchers have 
found that these vectors produce significant amounts of protein even when grown under 
repressed conditions. Therefore, in recent years there has been a move towards 
developing expression vectors with lower copy numbers and tighter control of expression 
from the promoter (Anthony et al., 2004; Jones and Keasling, 1998; Warren et al., 2000).
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These plasmids are useful for controlled expression of toxic genes, and may be more 
suitable for expressing products to manipulate cellular metabolism.
An alternative method of expressing antisense RNA in vivo would be to incorporate an 
expression cassette into the E. coli genome. This would overcome the problem of 
plasmid instability because the antisense RNA expression cassette would be replicated 
along with the rest of the E. coli chromosome and segregated at cell division. However, it 
would be more complicated technically and more time consuming. Furthermore, the 
amount of antisense RNA produced from one expression cassette inserted in to the 
genome is likely to be lower than the amount produced from a multicopy plasmid, due to 
a lower gene dosage. This could possibly be overcome by using a strong promoter or by 
duplicating the expression cassette so that multiple copies of the antisense RNA product 
were encoded by the E. coli genome. To the best of our knowledge this method has not 
be attempted for expression of antisense RNA in E. coli.
As previously mentioned in Chapter 4, the plasmids used in this study differ significantly 
in copy number. This was shown in Figure 4.14 by the difference in band intensities of 
the isolated plasmids, following analysis by agarose gel electrophoresis. Plasmid 
pTrc99A is a medium-high copy number plasmid, which is present in -50-80 copies per 
cell (Lin-Chao and Bremer, 1986), and pMMB66EH is a relatively low copy number 
plasmid, which is present in -10-15 copies per cell (Morales et al., 1990). It was 
hypothesised that the difference in plasmid copy number may affect the total amount of 
antisense RNA that was produced by each plasmid type, and result in different levels of 
gene silencing. However, only one copy of each of the target genes is present on the E. 
coli genome, therefore the antisense RNA molecules that are produced should still out­
number the target mRNA molecules. In addition, both plasmids possess strong 
promoters, and therefore it was thought that an excess amount of antisense RNA would 
be produced by the constructs that were derived from both plasmid types.
In this study, an identical fragment of the E. coli acetate kinase gene was cloned in the 
antisense orientation into both pTrc99A and the pMMB66EH-derivative, pQR445 (see 
Chapter 4). Comparing the impact of ackA antisense RNA in each of the resulting E. coli 
strains should have indicated, whether there was a noticeable difference in the total 
amount of antisense RNA that was produced from each construct. For example, if the 
ackA antisense RNA expressed from the pMMB66EH-derivative had less of an impact on 
E. coli metabolism than an identical ackA antisense RNA expressed from pTrc99A, then 
it would suggest that the total amount of antisense RNA produced from the former 
construct was less. These hypothetical results could be confirmed by quantitative
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analysis of the antisense RNA produced. However in this study, the recombinant E. coli 
strain expressing putative ackA antisense RNA from pQR446 (derived from pMMB66EH, 
see section 4.3.2.3) had a dramatically altered metabolism compared to the recombinant 
E. coli strain expressing ackA antisense RNA from pQR441 (derived from pTrc99A, see 
section 4.3.2.1). This was highly unexpected, and may have been due to complex 
interactions between components of the pQR446 plasmid and the E. coli genome, as 
discussed in Chapter 5, section 5.5.
7.3 A c e ta te  P ro d u ctio n  by E. cou
As discussed in Chapter 1, it has long been thought that acetate production by E. coli is a 
result of metabolite ‘overflow’ in central metabolism, and is caused by an imbalance in 
the rate of carbon uptake into the cell and the rate of carbon utilisation for the production 
of biomass (Holms, 1986). The imbalance is thought to arise due to a limited capacity of 
the TCA cycle, leading to accumulation of acetyl CoA and subsequent ‘overflow’ of 
carbon flux to acetate (Han et al., 1992; Majewski and Domach, 1989). However, 
because acetate is relatively toxic to E. coli, the reason why E. coli has evolved to 
produce such high amounts under aerobic conditions has remained somewhat of a 
mystery. One theory is that acetate production allows E. coli to maintain a rapid growth 
rate by balancing the carbon flow, and by generating ATP during the conversion of acetyl 
phosphate to acetate (Han et al., 1992; Holms, 1986). Another probable function of the 
acetate production pathway is to generate the pathway intermediate acetyl phosphate, 
which has been implicated as a phosphate donor in range of cellular reactions (Fox et al., 
1986b; Heyde et al., 2000; McCleary and Stock, 1994; Nystrom, 1994; PruB and Wolfe, 
1994; Shin and Park, 1995; Wanner and Wilmes-Riesenberg, 1992).
Since the completion of this research, a new study has been published which used 
mutant strains of E. coli and enzyme active site directed inhibitors to investigate the role 
of acetate production by E. coli (El-Mansi, 2004). This study found that the abolition of 
carbon flux to acetate in E. coli ML308 was balanced by excretion of lactate as well as 2- 
oxoglutarate, isocitrate and citrate. Based on the observations a novel function for the 
acetate production pathway was proposed, which states that phosphotransacetylase has 
an anapleurotic function: replenishing the central metabolic pathways with free CoA. As 
shown in Figure 7.1, the conversion of acetyl CoA to acetyl phosphate liberates free CoA. 
It was suggested that reduced levels of free CoA in the cell cause a ‘bottle-neck’ effect at 
the level of 2-oxoglutarate in the TCA cycle, which is alleviated by the free CoA produced 
by phosphotransacetylase in the conversion of acetyl CoA to acetyl phosphate. 
Previously, it has been shown that increasing the intracellular concentration of free CoA
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results in a higher yield of central metabolites (San et al., 2002), which lends support to 
this hypothesis.
In conclusion, it is becoming increasingly clear that abolishing the main acetate 
production pathway (ackA-pta pathway) is detrimental to E. coli, and that more advanced 
strategies are required in order to optimise metabolism for efficient conversion of glucose 
to biomass. In order to achieve this goal it is likely that a number of reactions would need 
to be manipulated in both the central metabolic pathways and the glucose 
phosphotransferase system. As we gain a greater understanding about the interactions 
of metabolites in the cell and the regulatory mechanisms that govern cellular activity, we 
will be better equipped to approach the rational optimisation of E. coli.
An idea for a future metabolic engineering strategy would be to over-express the enzyme 
acetyl CoA synthetase in E. coli, which is normally repressed during growth on glucose. 
This enzyme coverts acetate to acetyl CoA, therefore over-expressing this enzyme might 
allow acetate that has been produced by the ackA-pta pathway to be re-channelled back 
into central metabolism. Another idea would be to reduce expression of the glucose 
phosphotransferase enzymes using an antisense RNA approach.
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Figure 7.1 Representation of the TCA cycle, highlighting the possible anapleurotic function 
of phosphotransacetylase (replenishing the central metabolic pathways with free CoA). The 
arrows with dashed lines show the conversion of acetyl CoA to acetyl phosphate and the 
generation of free CoA. Key enzymes: 1, phosphotransacetylase; 2, acetate kinase; and 3, 2- 
oxoglutarate dehydrogenase. The diagram was adapted from El-Mansi (2004).
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7 .4  C o n c l u s io n s
The research presented in this thesis represents a metabolic engineering approach to 
examine acetate production by E. coli MG1655, using antisense RNA technology. The 
investigation attempted to combine physiological characterisation with metabolic flux 
analysis to determine the effectiveness of antisense RNA in suppressing expression of 
enzymes in the acetate production pathway, and redirecting the flow of carbon in E. coli 
central metabolism. To this end, a series of recombinant plasmids were constructed to 
express putative antisense RNA targeted against phosphotransacetylase and acetate 
kinase mRNA. The results indicated that the antisense RNA strategy used in this study 
reduced acetate production by E. coli MG1655, and resulted in redirection of carbon flow 
to lactate production.
This research could be the starting point for further metabolic engineering strategies to 
manipulate carbon flow through central metabolism using antisense RNA to selectively 
downregulate the expression of key enzymes involves in by-product formation. Metabolic 
engineering of organisms for reduced by-product formation is an important issue because 
many of the organisms used in industry produce large amounts of waste products, which 
diminishes the efficiency of carbon conversion to biomass and desirable end-products.
Metabolic engineering is a powerful tool that enables the rational design and optimisation 
of organisms that produce important products in the Biotechnology industry. Each new 
piece of research contributes to and advances the field of metabolic engineering. With 
these efforts, the strategies and tools to generate efficient and economical 
biotechnological processes will increasingly become available.
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9.1 C a ta b o lic  R eac tio n s  and Synthesis o f  M onom ers in 
S to ic h io m e tric  M o d e l o f  E. coli M etab o lism
Reaction 1: mue : 0.14176 Glyc3P + 26.2949 ATP + 0.60097 Ala + 0.10124 Cys + 0.26647
Asp + 0.30747 Glu + 0.2048 Phe + 0.67725 Gly + 0.10473 His + 0.32116 lie + 0.37935 Lys + 0.49804 
Leu + 0.16989 Met + 0.26647 Asn + 0.24436 Pro + 0.29091 Gin + 0.32698 Arg + 0.38031 Ser + 
0.28044 Thr + 0.46778 Val + 0.062835 Trp + 0.15244 Tyr + 0.1489 rATP + 0.18319 rGTP + 0.11366 
rCTP + 0.12273 rUTP + 0.023904 dATP + 0.024582 dGTP + 0.024582 dCTP + 0.023904 dTTP + 
0.28352 avg_FS + 0.0069264 UDPGIc + 0.010368 CDPEth + 0.010368 OH_myr_ac + 0.010368 
C14_0_FS + 0.010368 CMP_KDO + 0.010368 NDPHep + 0.0069264 TDPGIcs + 0.01656 UDP_NAG + 
0.01656 UDP_NAM + 0.01656 di_am_pim + 0.0924 ADPGIc =
Reaction 2: 02_up : = 1 02
Reaction 3: N_up : = 1 N
Reaction 4 :  C02_ex : 1 C 02 =
Reaction 5: S_up : 4  ATP + 4  NADPH = 1 S
Reaction 6: Glc_PTS_up : 1 PEP = 1 G6P + 1 Pyr
Reaction 7: Glc_ATP_up : 1 ATP = 1 G6P
Reaction 8: Succ_ex : 1 Succ =
Reaction 9: Glyc_up : = 1 Glyc
Reaction 10: Glyc::Glyc3P : 1 ATP + 1 Glyc = 1 Glyc3P
Reaction 11: DHAP::Glyc3P : 1 DHAP + 1 NADH = 1 Glyc3P
Reaction 12: Lac_ex: 1 Lac =
Reaction 13: Eth_ex : 1 Eth =
Reaction 14: Ac_ex : 1 Ac =
Reaction 15: Glucn_up : = 1 Glucn
Reaction 16: Form_ex : 1 Form =
Reaction 17: G6P::F6P : 1 G 6 P = 1 F6P
Reaction 18: F16P::F6P : 1 F16P = 1 F6P
Reaction 19: F6P::F16P : 1 F6P+ 1 ATP = 1 F16P
Reaction 20: F16P::T3P : 1 F16P = 1 DHAP + 1 G3P
Reaction 21: DHAP::G3P : 1 DHAP = 1 G3P
Reaction 22: G3P::DPG : 1 G3P = 1 DPG + 1 NADH
Reaction 23: DPG::3PG : 1 DPG = 1 3PG + 1 ATP
Reaction 24: 3PG::2PG : 1 3PG = 1 2PG
Reaction 25: 2PG::PEP : 1 2PG = 1 PEP
Reaction 26: PEP::PYR : 1 PEP = 1 Pyr + 1 ATP
Reaction 27: Pyr::PEP : 1 Pyr + 2 ATP = 1 PEP
Reaction 28: PYR::AcCoA: 1 Pyr = 1 AcCoA + 1 NADH + 1 C02
Reaction 29: AcCoA::Cit: 1 AcCoA + 1 OxA = 1 Cit
Reaction 30: Cit::ICit: 1 Cit = 1 ICit
Reaction 31: ICit::alKG : 1 ICit = 1 alKG + 1 NADPH + 1 C02
Reaction 32: alKG::SuccCoA: 1 alKG = 1 SuccCoA + 1 NADH + 1 C02
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Reaction 33: SuccCoA: :Succ: 1 SuccCoA = 1 Succ + 1 ATP
Reaction 34: Succ::Fum : 1 Succ = 1 Fum + 1 QuiH2
Reaction 35: Fum::Succ : 1 Fum + 1 QuiH2 = 1 Succ
Reaction 36: Fum::Mal: 1 Fum = 1 Mai
Reaction 37: Mal::OxA: 1 Mai = 1 OxA + 1 NADH
Reaction 38: ICit::Glyox : 1 ICit = 1 Succ + 1 Glyox
Reaction 39: Glyox::Mal: 1 AcCoA + 1 Glyox = 1 Mai
Reaction 40: G6P::PGIac : 1 G6P = 1 PGIac + 1 NADPH
Reaction 41: AcCoA: :Adh : 1 AcCoA + 1 NADH = 1 Adh
Reaction 42: Adh::Eth : 1 NADH + 1 Adh = 1 Eth
Reaction 43: PGIac::PGIuc : 1 PGIac = 1 PGluc
Reaction 44: Glucn::PGIuc : 1 Glucn + 1 ATP = 1 PGluc
Reaction 45: PGIuc::RI5P : 1 PGluc = 1 RI5P + 1 NADPH + 1 C02
Reaction 46: RI5P::X5P : 1 RI5P = 1 X5P
Reaction 47: RI5P::R5P : 1 RI5P = 1 R5P
Reaction 48: Transketl : 1 R5P + 1 X5P = 1 G3P + 1 S7P
Reaction 49: Transaldo: 1 G3P + 1 S7P = 1 F6P + 1 E4P
Reaction 50: Transket2 : 1 E4P + 1 X5P = 1 F6P + 1 G3P
Reaction 51: PGIuc::KetoPGIuc : 1 PGluc = 1 KetoPGluc
Reaction 52: KetoPGIuc::G3P_Pyr: 1 KetoPGluc = 1 G3P + 1 Pyr
Reaction 53: OxA::PEP : 1 OxA + 1 ATP = 1 PEP + 1 C02
Reaction 54: PEP::OxA: 1 PEP + 1 C02 = 1 OxA
Reaction 55: AcCoA: :AcP : 1 AcCoA = 1 AcP
Reaction 56: AcP::Ac : 1 AcP = 1 ATP + 1 Ac
Reaction 57: Pyr:.Form : 1 Pyr = 1 AcCoA + 1 Form
Reaction 58: Pyr::Lac: 1 Pyr + 1 NADH = 1 Lac
Reaction 59: NADH Dehydro : 1 NADH = 1 QuiH2 + 2 H_ex
Reaction 60: Oxidase: 1 QuiH2 + 0.5 0 2  = 2 H_ex
Reaction 61: TransHydro : 1 NADH + 1 H_ex = 1 NADPH
Reaction 62: ATPSynth : 3 H_ex = 1 ATP
Reaction 63: ATPdrain : 1 ATP =
Reaction 64: Chor_Synth : 2 PEP + 1 E4P + 1 ATP + 1 NADPH = 1 Chor
Reaction 65: PRPP_Synth : 1 R5P + 2 ATP = 1 PRPP
Reaction 66: M THFSynth : 1 ATP + 1 NADPH = 1 MTHF
Reaction 67: Ala_Synth : 1 Pyr + 1 Glu = 1 alKG + 1 Ala
Reaction 68: Val_Synth : 2 Pyr + 1 NADPH + 1 Glu = 1 alKG + 1 C02 + 1 Val
Reaction 69: Leu_Synth : 2 Pyr + 1 AcCoA + 1 NADPH + 1 Glu = 1 alKG + 1 NADH 
C 02 + 1 Leu
Reaction 70: Asn_Synth : 2 ATP + 1 N + 1 Asp = 1 Asn
Reaction 71: Asp_synth : 1 OxA + 1 Glu = 1 alKG + 1 Asp
Reaction 72: Lys_Synth : 1 di_am_pim = 1 C02 + 1 Lys
Reaction 73: Met_Synth : 1 SuccCoA + 1 ATP + 2 NADPH + 1 MTHF + 1 Cys + 1 
= 1 Pyr + 1 Succ + 1 N + 1 Met
Reaction 74: Thr_Synth : 2 ATP + 2 NADPH + 1 Asp = 1 Thr
Reaction 75: lle_Synth : 1 Pyr + 1 NADPH + 1 Glu + 1 Thr = 1 alKG + 1 C02 + 1
2 2 1
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Reaction 76: His_Synth 
Reaction 77: Glu_synth 
Reaction 78: Gln_Synth 
Reaction 79: Pro_Synth 
Reaction 80: Arg_Synth
Reaction 81: Trp_Synth :
Reaction 82: 
Reaction 83: 
Reaction 84: 
Reaction 85: 
Reaction 86: 
Reaction 87:
Tyr_Synth : 
Phe_Synth : 
Ser_Synth : 
Gly_Synth : 
Cys_Synth : 
rATP_Synth
Reaction 88: rGTP_Synth :
Reaction 89: rCTP_Synth : 
Reaction 90: rUTP_Synth : 
Reaction 91: dATP_Synth : 
Reaction 92: dGTP_Synth : 
Reaction 93: dCTP_Synth : 
Reaction 94: dTTP_Synth : 
Reaction 95: avg_FS_Synth : 
Reaction 96: UDPGIc_Synth : 
Reaction 97: CDPEth_Synth : 
Reaction 98: OH_myr_ac_Synth 
Reaction 99: C14_0_FS_Synth : 
Reaction 100: CMP_KDO_Synth 
Reaction 101: NDPHep_Synth : 
Reaction 102: TDPGIcs_Synth : 
Reaction 103: UDP_NAG_Synth 
Reaction 104: UDP_NAM_Synth 
Reaction 105: di_am_pim_Synth
Reaction 106: ADPGIc_Synth :
1 lie
1 ATP + 1 PRPP + 1 Gin = 1 alKG + 2 NADH + 1 His 
1 alKG + 1 NADPH + 1 N = 1 Glu 
1 ATP + 1 N + 1 Glu = 1 Gin 
1 ATP + 2 NADPH + 1 Glu = 1 Pro
1 AcCoA + 4 ATP + 1 NADPH + 1 C02 + 1 N + 1 Asp + 2 
Glu = 1 alKG + 1 Fum + 1 Ac + 1 Arg 
1 Chor + 1 PRPP + 1 Gin + 1 Ser = 1 G3P + 1 Pyr + 1 C02 + 
1 Glu + 1 Trp
1 Chor + 1 Glu = 1 alKG + 1 NADH + 1 C02 + 1 Tyr 
1 Chor + 1 Glu = 1 alKG + 1 C02 + 1 Phe 
1 3PG + 1 Glu = 1 alKG + 1 NADH + 1 Ser 
1 Ser = 1 MTHF + 1 Gly 
1 AcCoA + 1 S + 1 Ser = 1 Ac + 1 Cys
5 ATP + 1 C02 + 1 PRPP + 2 MTHF + 2 Asp + 1 Gly + 2 Gin 
= 2 Fum + 1 NADPH + 2 Glu + 1 rATP
6 ATP + 1 C02 + 1 PRPP + 2 MTHF + 1 Asp + 1 Gly + 3 Gin 
= 2 Fum + 1 NADH + 1 NADPH + 3 Glu + 1 rGTP
1 ATP + 1 Gin + 1 rUTP = 1 Glu + 1 rCTP 
4 ATP + 1 N + 1 PRPP + 1 Asp = 1 NADH + 1 rUTP 
1 NADPH + 1 rATP = 1 dATP 
1 NADPH + 1 rGTP = 1 dGTP
1 NADPH + 1 rCTP = 1 dCTP
2 NADPH + 1 MTHF + 1 rUTP = 1 dTTP
8.24 AcCoA + 7.24 ATP + 13.91 NADPH = 1 avg_FS 
1 G6P + 1 ATP = 1 UDPGIc
1 3PG + 3 ATP + 1 NADPH + 1 N = 1 NADH + 1 CDPEth
7 AcCoA + 6 ATP + 11 NADPH = 1 OH_myr_ac 
7 AcCoA + 6 ATP + 12 NADPH = 1 C14_0_FS
1 PEP + 1 R5P + 2 ATP = 1 CMP_KDO 
1.5 G6P + 1 ATP = 4 NADPH + 1 NDPHep 
1 F6P + 2 ATP + 1 N = 1 TDPGIcs 
1 F6P + 1 AcCoA + 1 ATP + 1 Gin = 1 Glu + 1 UDP_NAG 
1 PEP + 1 NADPH + 1 UDP_NAG = 1 UDP_NAM 
1 Pyr + 1 SuccCoA + 1 ATP + 2 NADPH + 1 Asp + 1 Glu = 1 
alKG + 1 Succ + 1 di_am_pim 
1 G6P + 1 ATP = 1 ADPGIc
2 2 2
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Synthesis of Macromolecules:
Prot = 39.9455 ATP + 0.88727 Ala + 0.15818 Cys + 0.41636 Asp + 0.45455 Glu + 0.32 Phe +
1.0582 Gly + 0.16364 His + 0.50182 lie + 0.59273 Lys + 0.77818 Leu + 0.26546 Met + 
0.41636 Asn + 0.38182 Pro + 0.45455 Gin + 0.51091 Arg + 0.37273 Ser + 0.43818 Thr + 
0.73091 Val + 0.09818 Trp + 0.23818 Tyr
RNA = 1.2488 ATP + 0.80488 rATP + 0.99024 rGTP + 0.61436 rCTP + 0.66341 rUTP
DNA = 4.4129 ATP + 0.7968 dATP + 0.8194 dGTP + 0.8194 dCTP + 0.7968 dTTP
Lip = 1.4176 Glyc3P + 2.8352 ATP + 1.4176 Ser + 2.8352 avg_FS
LPS = 0.46176 UDPGIc + 0.69118 CDPEth + 0.69118 OH_myr_ac + 0.69118 C14_0_FS +
0.69118 CMP KDO + 0.69118 NDPHep + 0.46176 TDPGIcs
PepGly = 5.52 ATP + 2.208 Ala + 1.104 Glu + 1.104 UDP NAG + 1.104 UDPJMAM + 1.104
di_am_pim
Glyc = 6.16 ADPGIc
PolyPhos = 12.66 ATP
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9.2 L is t  o f  M e ta b o lite  A b b r ev ia tio n s
Abbreviation Metabolite Name
AcCoA Acetyl-coenzyme A
ADP Adenosine diphosphate
alKG a-Ketoglutarate
Ala Alanine
AMP Adenosine monophosphate
Arg Arginine
Asn Asparagine
Asp Aspartate
ATP Adenosine triphosphate
Chor Chorismate
Cit Citrate
CMP Cytosine monophosphate
C02 Carbon dioxide
CoA Coenzyme A
Cys Cysteine
DHAP Dehydroxyacetone phosphate
E4P Erythrose-4-phosphate
F6P Fructrose-6-phosphate
FAD Flavin adenine dinucleotide-0
FADH Flavin adenine dinucleotide-R
FTHF N5-Formyl-tetrahydrofolate
Fum Fumarate
G1P Glucose-1-phosphate
G3P Glyceraldehyde-3-phosphate
G6P Glucose-6-phosphate
Glc Glucose
Gin Glutamine
Glu Glutamate
Gly Glycine
Glyc Glycerol
Glyc3P Glycerol-3-phosphate
Glyox Glyoxylate
GMP Guanosine monophosphate
H20 Water
His Histidine
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ICit
lie
IMP
Leu
Lip
LPS
Lys
Mai
MDAP
Met
MTHF
MUR
MYC
N
NAD
NADH
NADP
NADPH
NH4
N02
N03
02
OxA
PCOA
PEP
2PG
3PG
PHE
Pro
Prot
PRPP
Pyr
R5P
RI5P
RMMCoA
RNA
S7P
Ser
Isocitrate
Isoleucine
Inosine monophosphate
Leucine
Lipid
Lipopolysaccharide
Lysine
Malate
meso-diaminopimelate
Methionine
N5-Methyl-tetrahydrofolate
Murine
Mycarose
Nitrogen
Nicotinamide adenine dinucleotide-0
Nicotinamide adenine dinucleotide-R
Nicotinamide adenine dinucleotide phosphate-O
Nicotinamide adenine dinucleotide phosphate-R
Ammonia
Nitrite
Nitrate
Oxygen
Oxaloacetate
Propionyl-Coenzyme A
Phosphoenolpyruvate
2-Phosphoglycerate
3-Phosphoglycerate 
Phenylalanine 
Proline
Protein
5-Phosphoribosyl-1-pyrophosphate 
Pyruvate
Ribose-5-phosphate 
Ribulose-5-phosphate 
R-Methylmalonyl Coenzyme A 
Ribonucleic acid 
Sedoheptulose-7-phosphate 
Serine
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SMMCoA S-Methylmalonyl Coenzyme A
Succ Succinate
SuccCoA Succinyl Coenzyme A
THF Tetrahydrofolate
THR Threonine
TMP Thymidine monophosphate
Trp Tryptophan
Tyr Tyrosine
UDPNAG Uridine diphosphate-N-acetyl glucosamine
UDPNAM Uridine diphosphate-N-acetyl muramic acid
UMP Uridine monophosphate
Val Valine
X5P Xylulose-5-phosphate
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